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The aim of the wise is not to secure pleasure, but to avoid pain 
 Aristotle 
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ABSTRACT 
Chronic pain is a complex experience that involves sensory, 
emotional, and cognitive aspects. The neurobiological mechanisms 
are therefore expected to be complex, widespread and largely 
maladaptive. Recent research of neuroimaging in chronic pain 
suggests cerebral re-organization on a structural level as a 
consequence of chronic pain. However, a combined and large-scale 
brain morphological profile in chronic pain to investigate its neural 
substrates has not been elucidated. The research presented aims 
to investigate morphological brain correlates and putatively related 
behavioural and cognitive aspects of chronic pain due to primary 
nociceptive knee osteoarthritic disorder using advanced imaging 
techniques for manual, voxel-based, and surface-based analysis, 
and questionnaire-based SDUWLFLSDQWV¶characterization.   
31 participants with chronic painful knee osteoarthritis (age= 
64.6± 8.4 years, 15 females, mean duration of pain=9.6 years) 
and 22 healthy controls (age= 61.3± 7.5, 13 females) underwent 
high-resolution anatomical MRI at 3 Tesla, and detailed pain 
characterization and psychometric assessment. 
Findings from this thesis challenge the common belief that chronic 
pain leads to hippocampal volume reduction and allegedly cognitive 
dysfunction. Indeed, general cognitive function and delayed recall 
memory were normally preserved in the studied cohort, and 
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moreover the hippocampal volume was significantly enlarged. The 
volume of the rostral part (emotional) of anterior cingulate showed 
significant positive correlation with pain catastrophizing behaviour 
suggesting that it may underlie the pain catastrophizing tendency 
in patients with chronic knee pain. Higher scores of mechanical 
pain sensitivity correlated with reduced cortical thickness in the 
anterior cingulate indicating its potential key role in the process of 
central pain sensitization.   
Sufferers of chronic knee OA pain exhibited less grey matter 
volume in the left dorsolateral prefrontal cortex, which has a 
modulatory role in nociceptive transmission namely, pain 
perception inhibitory effect. Although the mechanism of this 
reduction is unknown, such a change may suggest functional 
disturbance with subsequent aberrant contribution to pain 
sustainability and chronification.  
Whole brain cortical thickness was investigated in patients and 
results revealed wide spread cortical thinning progresses with pain 
duration, preferentially in females, and in areas largely outside the 
known pain matrix, but including the posterior default mode 
network.  
Finally, preliminary results from investigating the potential 
mechanism of chronic pain related neocortical plasticity will be 
presented that may provide framework for future studies.  
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1.1 Overview of the concept of pain  
1.1.1 Background 
Pain is essential for life. Under normal physiological conditions and 
in its acute form pain warns us against danger to tissue damage or 
life-threatening events. It also teaches us to avoid such damage. 
However, in contrast to acute pain, chronic pain is a maladaptive 
syndrome that does not serve any protective function. It is the 
most common reason people seek medical care. Chronic pain is a 
leading cause for long-term disability with direct impacts on 
LQGLYLGXDO¶V KHDOWK DQG RYHUDOO TXDOLW\ RI OLIH (SLGHmiological risk 
factors include age, sex, socioeconomic factors, psychological 
stress (McBeth and Jones, 2007), and there is an association with 
increased cardiovascular risks (Cimmino et al., 2011).  
It was revealed in a large European survey (Breivik et al., 2006a), 
that about 19% of adult Europeans had chronic pain of moderate 
to severe intensity affecting the quality of their social and working 
lives. In Europe alone it is estimated that chronic pain costs over 
¼ELOOLRQSHU\HDUDQGLQWKH8QLWHG6WDWHVWKHFRVWLVHVWLPDWHG
around $ 150 billion (Tracey and Bushnell, 2009b). According to 
the British Pain Society, 7.8 million people in the UK live with 
chronic pain. Prescriptions for pain are estimated to cost around 
£584 million annually. Back pain alone costs the British economy 
around £12.3 billion per year. Additionally 49% of patients with 
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chronic pain experience depression, 25% lose their jobs and 16% 
of sufferers feel their chronic pain is unbearably bad that they 
sometimes want to die (BPS, 2009).  
It is not understood why only some people develop chronic pain 
despite the fact that pain is a universal experience (Rodriguez-
Raecke et al., 2009). Exhibiting discrepancy with the degree of 
tissue damage further complicates our understanding of chronic 
pain. The pain intensity in knee osteoarthritis for instance is quite 
variable ranging from hardly perceptible to immobilizing, and the 
severity of pain in knee osteoarthritis cannot often be predicted 
from the degree of structural damage at the joint. Several studies 
(Kornaat et al., 2006, Link, 2009, Phan et al., 2006) have reported 
no significant correlation between the severity of pain and 
structural knee osteoarthritic lesions. 
Chronic pain is increasingly recognized as a disease in its own right 
(Tracey and Bushnell, 2009b, Niv and Devor, 2004), with 
subsequent strong research interest to characterize its 
neurobiological substrates. Neuroimaging has played a major role 
in investigating chronic pain mechanisms at supraspinal levels. 
Continuous advances in technology and availability of magnetic 
resonance imaging and dedicated image analysis software have 
enabled an unprecedented insight into the structural, functional 
and neurochemical central correlates of chronic pain.  
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1.1.2 Pain and chronicity definitions 
The current definition endorsed by the International Association for 
the Study of Pain (IASP) states that pain is ³DQXQSOHDVDQWVHQVRU\
and emotional experience associated with actual or potential tissue 
GDPDJH RU GHVFULEHG LQ WHUPV RI VXFK GDPDJH´ (Merskey and 
Bogduk, 1994). The definition addressed the shortcomings of 
previous attempts that were confined to sensory aspects or limited 
to linguistic expressions. For example, Mountcastle (Mountcastle, 
1974) GHILQHGSDLQDV³that sensory experience evoked by stimuli 
that injure or threaten to destroy tissues, defined introspectively by 
every individual as that which hurts´$QRWKHUPRUHRIQXUVLQJRU
clinical use definition was offered by McCaffrey and Beebe 
(McCaffery M and Beebe A, 1989) who described pain as "whatever 
the experiencing person says it is, existing whenever the 
experiencing person say it does".  
Pain is a universal experience that is very subjective, and 
multidimensional in nature that involves sensory, emotional and 
cognitive aspects. It is important that a proper definition of pain is 
agreed in order to enable a meaningful scientific research and to 
provide adequate medical care (Price and Barrell, 2012). The IASP 
definition has been arguably recognized as the current international 
and comprehensive definition of pain. 
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The standard definition of pain chronicity also comes from the 
International Association for the Study of Pain, which describes it 
as pain without apparent biological value that persists beyond the 
normal time for healing (Bonica, 1953, cited in Merskey and 
Bogduk 1994). However, the healing time can vary between 
different types of tissue. Under optimum conditions, skin wound, 
for instance heals in 3-7 days, bone fracture takes about 6 weeks, 
and tendons and ligaments can take up to 3 months to achieve 
normal healing (Marcus. et al., 2009). A fixed time of persistent 
pain has also been proposed. For example 3 and 6 months of 
persistent pain in post herpetic neuralgia and back pain 
respectively would entitle the condition to be characterized under 
chronic pain state (Apkarian et al., 2009). Loeser and Melzack 
(Loeser and Melzack, 1999) emphasise that it is not the duration 
that distinguishes acute from chronic pain but rather the inability of 
the body to restore its normal physiological functions. In the case 
of painful osteoarthritis a definition of pain for most days of the 
prior month was used (Altman et al., 1991). However and from a 
neurobiological correlations perspective, it is conceivable that 
structural adaptive changes may take several years to develop. 
Moreover, duration alone regardless the persistency status may 
indicate episodicity rather than chronicity. Therefore the definition 
of chronic pain used in the experimental work presented in this 
WKHVLV LV µSULPDULO\ NQHH SDLQ WKDW ODVWHG PRUH WKDQ D \HDU DQG
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experienced most of the day on most days of the week for at least 
WKHODVWPRQWK¶$GDSWHGIURP(Peat et al., 2006a).   
1.1.3 Pain characteristics and dimensions 
Chronic pain, tends to be less localized than acute pain and it often 
fluctuates in severity (Marcus. et al., 2009). With no clear 
biological function, chronic pain can persist long after the normal 
healing time.  
As previously stated pain is a complex and multidimensional in 
nature that involves sensory, affective and cognitive dimensions. 
This model was first conceptualized by Melzack and Casey (Melzack 
R. and Casey K., 1968), with subsequent descriptions of 1) 
sensory-discriminative; concerned with the intensity, location, 
quality and duration of pain, 2) affective-motivational; refers to the 
emotional and motivational changes experienced as suffering and 
unpleasantness and the urge to avoid and escape it, and 3) 
cognitive-evaluative;  relates to the judgemental aspects. Socio-
cultural dimension has been considered by some as a fourth 
dimension, which suggests that the responses to pain is in part due 
WR WKH SHUVRQ¶V VRFLDO LGHQWLW\ DQG H[SHFWDWLRQV RWKHUV PD\ KDYH
(Lynch and Vasudevan, 1988).  
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1.1.4 Ascending pathways and central pain 
mechanisms 
Noxious signals are transmitted from nociceptors mainly via 
afferent A-į DQG & fibres to the dorsal root of spinal cord (or 
medulla for cranial regions) and subsequently to the dorsal horn 
from thence via the ascending tracts to supraspinal centres 
involved in the conscious appreciations of pain. Psychogenic pain, 
pain arising from damage to the nervous system tissue (Boivie et 
al., 1989), as well as vicarious pain (Danziger et al., 2009) do not 
however require stimulation to the peripheral nociceptors. Of note 
WKDW VRPH QRFLFHSWRUV FDOOHG µsilent¶ ZLOO EHFRPH DFWLYDWHG RQO\ LI
sensitized by, for example inflammation. These kinds of 
nociceptors are abundant in the joints and they were first recorded, 
in preclinical studies, from afferent nerves in the knee joint 
(Schaible and Schmidt, 1988). In very rare cases nociceptors can 
be congenitally defected (Cox et al., 2006) leading to inability of 
the affected person to experience pain with subsequent dramatic 
threatening effects. 
The main ascending spinal pathways (Fig. 1), through which 
nociceptive information is transmitted from the body to the brain 
include the spinothalamic tract (STT) that is further subdivided into 
lateral and medial parts, spinoreticular (SRT), and 
spinomesencephalic (SMT) tracts. The lateral STT is considered 
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phylogenetically recent, and hence called neospinothalamic tract 
(nSTT) whereas, the medial STT, SRT, and SMT, are collectively 
called paleospinothalamic tract (pSTT) (Raj, 1996). Axons in the 
nSTT terminate in ventro-postero-lateral nucleus of the thalamus 
(VPL), from which, third order neurons take over and project to the 
somatosensory cortex. Axons in the pSTT project to the reticular 
formation, periaqueductal grey, hypothalamus, and medial and 
intralaminar thalamic nuclei, which then interconnect with neurons 
that are interlinked with limbic forebrain structures and further 
widespread projections to other areas in the brain (Raj, 1996). The 
precise role of each pathway remains largely obscure, and indeed a 
putative multiplicity of ascending pain pathways is proposed 
(Villanueva and Bernard, 1999). In addition to the main ascending 
pathways other tracts are involved, which collectively are 
considered to subserve two major pain systems namely the lateral 
and medial systems (Albe-Fessard et al., 1985).   
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Figure 1: Lateral (A) and medial (B) pain transmission systems [Image modified from 
http://www.pharmacology2000.com/] 
 
The lateral pain system comprises long tracts that project to the 
ventral posterior lateral nucleus of the thalamus (VPL), thence to 
the primary and secondary sensory cortices. These fibres are 
relatively thick allowing for fast conduction, and hence the lateral 
system is thought to be involved in processing acute pain where 
rapid transmission of information regarding the sensory-
discriminative aspects (onset, location, intensity, duration) of pain 
is required (Jones and Derbyshire, 1996). On the other hand the 
medial pain system is composed mainly of relatively thin fibres with 
slower conduction rate projecting to the medial nuclei of the 
thalamus with subsequent important connections with the anterior 
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cingulate cortex (ACC) (Vogt et al., 1993), prefrontal cortex  
(Tsubokawa et al., 1981), insula, periaqueductal grey (PAG), and 
brain stem (Jones and Derbyshire, 1996). The medial pain system 
is concerned with the affective-motivational and cognitive-
evaluative components of pain response and it is thought to be 
largely involved in processing chronic pain (Jones and Derbyshire, 
1996). Cortical centres, which receive projections from thalamic 
nuclei where pain fibres end, have been recently reinforced with 
findings from a plethora of functional brain imaging techniques. 
Neuroimaging studies of brain areas that are involved in pain 
processing have produced varying results. However a meta-
analysis of pain imaging studies revealed that by large 
convergence the most commonly activated areas include primary 
somatosensory (S1), secondary somatosensory (S2), ACC, insula, 
prefrontal cortex, thalamus, basal ganglia, and cerebellum 
(Apkarian et al., 2005). It is not unexpected for pain processing 
with its complex multidimensionality to recruit extensive network in 
WKHEUDLQZKLFKLVDUJXDEO\UHIHUUHGWRDVWKH³SDLQPDWUL[´ 
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1.1.5 Descending pain modulatory systems: 
inhibition and facilitation  
Several factors are thought to affect the pain experience either by 
LQKLELWLRQ µDQWLQRFLFHSWLRQ¶ RU IXUWKHU HQKDQFHPHQW
µSURQRFLFHSWLRQ¶  (PRWLRQDO VWDWH DQ[LHW\ DWWHQWLRQ DQG
distraction, expectations, past memories and experiences, and 
other factors can modulate the pain experience and may explain 
the variability between subjects in levels of pain perception to 
same noxious stimuli (Ossipov et al., 2010). One of the earliest 
reported observations that pain can be modulated (endogenously 
inhibited), was by Henry Beecher (Beecher, 1946), who noted that, 
strikingly reduced rates of pain perception were reported by 
conscious soldiers in the battlefield with complicated fresh wounds. 
Similar observations were seen in other stressful conditions, and 
further investigated in, for example, athletes in competitions (Geva 
and Defrin, 2013). The suppression of pain during stressful or 
fearful circumstances is considered as an in-built system in 
mammals leading to stress-induced analgesia (Butler and Finn, 
2009).  
The neurobiological mechanisms of the descending pain modulatory 
circuits (Fig. 2) have been widely explored. According to preclinical 
and clinical studies, the pain modulatory system involves inputs 
from higher centres including the hypothalamus, amygdala, rostral 
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ACC, and prefrontal cortex, interconnecting with the periaqueductal 
grey, with outputs to the medulla (Ossipov et al., 2010, Bingel and 
Tracey, 2008). In addition to the PAG, other structures including 
the locus ceruleus, the nucleus raphe magnus (NRM), and several 
nuclei of the bulbar reticular formation are involved in the 
descending pathways down to the neurons in the spinal cord. 
Several different neurotransmitters such as opioids, serotonin, and 
catecholamines are utilized (Willis and Westlund, 1997). 
 
Figure 2: Schematic representation of pain modulatory circuits [Image from (Ossipov et 
al., 2010, Bingel and Tracey, 2008)] 
 
PAG has been shown to play a key role in the descending pain 
inhibition system. Microinjection of opiates or focal electric 
stimulation of PAG can lead to remarkable pain inhibition. Morphine 
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microinjection into PAG showed a profound analgesic effect in 
rabbits (Tsou and Jang, 1964). David Reynolds in 1969 was able to 
strikingly induce antinociceptive effect in a number of rats by 
electrically stimulating the PAG enabling him to perform 
laparoscopic procedure apparently painlessly without the use of 
chemical anaesthetics. In humans, focal simulation of PAG also 
exerted some analgesic effects, but accompanied by side effects 
such as anxiety and distress and therefore it has been discontinued 
(Ossipov et al., 2010). Similarly, placebo analgesia is considered as 
an example of cognitive modulation of pain that has shown to 
recruit the rACC, PAG, and amygdala to induce endogenous pain 
control (Bingel et al., 2006b). 
Conversely, activation of the descending facilitation system can 
lead to enhanced nociception. Indeed, sustained activity of the 
descending modulatory system with subsequent pain transmission 
facilitation has been suggested to contribute to pain chronicity 
(Fields, 1992). Early in the twentieth century, Sherrington noticed 
an enhancement in the nociceptive reflexes following spinal cord 
transection (Sherrington, 1906). Over the following years a large 
body of evidence has emerged revealing that several brain regions 
including the frontal lobe, ACC, insula, thalamus, amygdala, as well 
as PAG and nucleus cuneiforms (NCF) and rostroventromedial 
medulla (RVM) are involved in this descending modulation (Tracey 
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and Mantyh, 2007). The proposed key relay structure in 
descending pain facilitation has been the rostroventromedial 
medulla (RVM), though its role is controversial with some lines of 
evidence suggesting that under different circumstances it can 
accordingly have a bidirectional contribution i.e. inhibition and/or 
facilitation (Porreca et al., 2002). 
Functional MRI studies in humans had a crucial role in elucidating 
the normal and aberrant functional connectivity of pain inhibitory 
network in health (Bingel et al., 2006a, Scheef et al., 2012) and 
disease (Jensen et al., 2012, Song et al., 2006) respectively. The 
descending pain modulatory system, in both its inhibitory and 
facilitatory aspects, enables the subject to regulate nociceptive 
processing according to different circumstances and demands. 
However dysfunction of this powerful and dedicated endogenous 
system may underlie some states of chronic pain (Tracey and 
Bushnell, 2009a).  
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1.1.6 Central sensitization  
Central sensitization as defined by the International Association for 
WKH 6WXG\ RI 3DLQ LV ³an increased responsiveness of nociceptive 
neurons in the central nervous system to their normal or 
subthreshold afferent input´ (Merskey and Bogduk, 1994). In 
contrast to peripheral sensitization, which involves local pain 
hypersensitivity restricted to the damaged area, central 
sensitization can further produce pain hypersensitivity in remote 
non-injured areas and may persist without clear peripheral 
nociceptive conduction. The abnormal state of exaggerated 
responsiveness is reflected by a triad of pain sensitivity, which 
includes 1) hyperalgesia- amplified nociception response, 2) 
allodynia- perception of pain to innocuous stimulus, and 3) pain 
expansion- spread of pain beyond local area of pain (Marcus. et al., 
2009). The change in the properties of nociceptive neurons in CNS 
is modulated by certain neurotransmitters with subsequent 
enhancement of postsynaptic transmission to higher centres 
include thalamus, ACC, insula, and somatosensory cortex (Meeus 
and Nijs, 2007).  
Central sensitization, indexed by reduced pain thresholds (as a 
possible biomarker) at remote sites, has been widely reported in 
different chronic pain conditions (Banic et al., 2004, Staud et al., 
2001, Bendtsen et al., 1996), particularly osteoarthritic chronic 
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pain (Suokas et al., 2012). Central sensitization can also be 
introduced experimentally e.g. following induced peripheral injury 
or inflammation (LaMotte et al., 1991).  
The mechanistic investigation of central sensitization has been 
widely studied in animal models and early evidence of central 
component was presented over thirty years ago (Woolf, 1983). It 
ZDV IRXQG LQ :RROI¶V H[SHULPHQW WKDW XQGHU QRUPDO FRQGLWLRQV LQ
rats 1) there was no spontaneous activity from motor neurons as 
recorded from flexor reflex withdrawal response, 2) activation of 
neurons required high threshold nociceptive stimulus and 3) the 
receptive field was spatially limited. However after a repeated 
noxious stimulation-induced peripheral inflammation, long lasting 
increased excitability of motor neurons was noted as well as a 
reduction in pain threshold (e.g. a non-noxious stimulus like touch 
could induce pain), and expansion of cutaneous receptive field. 
These findings were further reproduced preclinically, and some 
mechanistic explanation later emerged in humans (LaMotte et al., 
1991). LaMotte and colleagues showed that hyperalgesia to 
punctate stimuli following intradermal injection of capsaicin in the 
volar forearm can be maintained long after anesthetizing the 
injection site. The cutaneous hyperalgesia could be prevented by 
locally anaesthetising the site before capsaicin injection or by 
anaesthetically blocking the peripheral nerve proximal to the 
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injection site. These findings suggest that secondary hyperalgesia 
develops after noxious tissue damage though the latter is not 
needed for its maintenance.  
The persistence of pain hypersensitivity long after the healing time 
cannot be explained simply by peripheral sensitization. 
Nonetheless, peripheral neural mechanisms are likely to contribute 
during early stages of tissue damage and inflammation. It is now 
known that different kinds of CNS plasticity (molecular, structural, 
functional) are involved in the process of central sensitization. 
Following noxious stimulation, neurons are sensitized in the dorsal 
horn of spinal cord as well as in other areas along the 
somatosensory pathways (Coderre et al., 1993). Direct 
measurements of CNS neuronal activity in humans cannot be made 
and therefore direct evidence of neuronal hyper-excitability cannot 
be provided (Curatolo et al., 2006). However, with the expanding 
use of advanced functional neuroimaging techniques such as 
functional MRI and magnetoencephalography (MEG), the 
contribution of supra-spinal structures to central sensitization can 
be elucidated. Studies have reported increased activities in 
structures including the brain stem, thalamus, cingulate, insula, 
middle frontal, posterior parietal, and primary and secondary 
somatosensory cortices, in association with experimentally induced 
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mechanical hyperalgesia (Lee et al., 2008, Maihofner et al., 2010, 
Mainero et al., 2007, Zambreanu et al., 2005).  
Central sensitization may provide explanation for many intractable 
chronic diseases including musculoskeletal and as such offer 
therapeutic approaches such as pain physiology education, which 
has reportedly proven effective for changing pain cognitions and 
health status in patients and showing better outcomes prior to 
active treatment (Nijs et al., 2011b). Pharmacological options 
aiming at desensitizing the CNS in chronic unexplained pain 
conditions is getting a great deal of awareness and research 
interest (Nijs et al., 2011a).  
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1.2 Chronic Pain in knee OA 
1.2.1 Overview 
Osteoarthritis has been known as the most common form of 
DUWKULWLV ZLWK VXEVWDQWLDO LPSDFW RQ LQGLYLGXDO¶V TXDOLW\ RI OLIH DQG
health care economics (Arden and Leyland, 2013).  A report by the 
world health organization states that globally the knee OA is likely 
to become the fourth most important cause of disability in women 
and the eighth in men (Murray and D., 1997). Moreover, it was 
found to be one of the most disabling disorder in the elderly, along 
with stroke, depression, hip fracture, and heart disease (Guccione 
et al., 1994).  Risk factors include age, sex, obesity, joint injury or 
instability as well as genetic and occupational factors (Felson et al., 
2000). The prevalence of OA is higher in women and increases with 
age in both sexes, although OA is uncommon before the age of 40 
years (Office for National Statistics, 2006). The peripheral 
pathophysiological mechanism of OA arises mainly from a 
disruption of the dynamic equilibrium, which is maintained by 
articular chondrocytes, between synthesis and degeneration of 
extracellular matrix components, resulting in progressive loss of 
cartilage and apoptosis of cells (Lee et al., 2013).  
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Despite other debilitating symptoms, pain remains as the major 
presenting problem of OA that is activity-related and induced 
mainly by specific weight bearing activities such as walking up and 
down stairs, as in case of knee OA (Felson, 2009). However, the 
experience of pain in OA is far more complicated as revealed by a 
large qualitative study (Hawker et al., 2008) showing that two 
distinct types of pain were described by hip and knee OA patients: 
a chronic dull aching pain with less changeability over time, which 
GLGQRWDIIHFWSDWLHQWV¶DFWLYLWLHVEXW LQFUHDVLQJO\ LQWHUFDODWHGE\D
flickering unpredictable pain that is intense, stressful and 
emotionally draining. Furthermore, the non-linear relationship of 
pain severity with joint pathology makes it difficult to fully explain 
the degree of perceived pain (Kornaat et al., 2006, Link, 2009, 
Phan et al., 2006). Among other knee joint problems osteoarthritis 
is considered as the most common cause of knee pain.  
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1.2.2 Definitions 
1.2.2.1 Knee OA 
The American College of Rheumatology (ACR) (Altman et al., 
1986) GHILQHG 2$ DV ³D KHWHURJHQHRXV JURXS RI FRQGLWLRQV WKDW
lead to joint symptoms and signs which are associated with 
defective integrity of articular cartilage, in addition to related 
FKDQJHVLQWKHXQGHUO\LQJERQHDQGDWWKHMRLQWPDUJLQV´$&5DOVR
developed clinical criteria of classifying primary knee OA based on 
clinical and radiological findings. The classification algorithm 
involved the presence of pain experience irrespective of quality, 
duration, or periodicity, and a selective combinations of findings 
from other co-existing variables such as radiographic, laboratory 
and medical history or physical examination (Altman et al., 1986). 
However these criteria have been criticized for being insensitive to 
early and mild OA in primary care (Peat et al., 2006b), and 
therefore no standard definition of OA is agreed to be used in 
research especially in epidemiological studies (Lawrence et al., 
1998). 
 
1.2.2.2 Chronic painful knee OA 
In the Literature of chronic pain imaging, the definition of pain 
chronicity in OA and eligibility criteria has varied widely between 
studies. Parks and colleagues (Parks et al., 2011a) used a duration 
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RIPRQWKVDQGSDLQVHYHULW\RIZKHUHDV5RGULJXH]-
Raecke et al (Rodriguez-Raecke et al., 2009) used a duration of 
longer than 12 months, and Gwilym and co-workers (Gwilym et al., 
2010b) adopted a definition of pain that is of sufficient magnitude 
to warrant joint replacement surgery. However and from a 
neurobiological correlations perspective, it is conceivable that 
neurobiological adaptive changes may take several years to 
develop. Moreover, duration alone regardless the persistency 
status may indicate episodicity rather than chronicity. Therefore 
the definition of chronic pain that I will use in the experimental 
ZRUN SUHVHQWHG LQ WKLV WKHVLV LV µSULPDULO\ NQHH SDLQ WKDW ODVWHG
more than a year and experienced most of the day on most days of 
WKHZHHN IRU DW OHDVW WKH ODVWPRQWK¶ $Gapted from (Peat et al., 
2006a). 
 
1.2.3 Epidemiology 
,W ZDV HVWLPDWHG LQ D ODUJH VWXG\ µWKH )UDPLQJKDP RVWHRDUWKULWLV
VWXG\¶WKDWLQYROYHGVXEMHFWVZLWKNQHHUDGLRJUDSKVDYDLODEOH
in 1424 (Felson et al., 1987), that  the prevalence of radiographic-
evidenced knee OA in elderly ranged between 27% in subjects 
under 70 years, to 40% in those over 80. The rate was however 
higher in females, and in particular and significantly the 
symptomatic OA.  The incidence rate was also recorded as higher 
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in females (1.7 times) as well as the frequency of disease 
progression rate (Felson et al., 1995).  
As the perceived pain and degree of knee joint pathology are often 
discordant, radiographic changes thus constitute only a modest risk 
factor for the pain reported in knee OA (Felson and Schaible, 
2009). Indeed other factors such as psychosocial and demographic 
variables play important roles (Davis et al., 1992).  Creamer and 
other researchers (Creamer et al., 1999) investigated the 
association between anxiety and depression and self-reported knee 
SDLQLQYROXQWHHUVDJLQJ\HDUV$Q[LHW\OHYHOVFRUUHODWHG
significantly with the reported pain in women but not in men 
participants (adjusted for age), whereas depression had no 
predictive relation in either sex. Other factors, which have been 
found to predict pain and/ or OA changes, include hypochondriasis, 
health phobia or health anxiety (Lichtenberg et al., 1986), aging 
(Blagojevic et al., 2010), sex (Jones et al., 2000, Srikanth et al., 
2005), obesity (Hart and Spector, 1993), race (Valdes et al., 
2007), educational level (Hannan et al., 1992), genetics (Spector 
and MacGregor, 2004), occupational activity (Cooper et al., 1994), 
and lower extremity muscular strength (Slemenda et al., 1998).  
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1.2.4 Individual and socioeconomic impact 
Knee osteoarthritis is a major cause of pain and disability in elderly 
with profound impact on quality as well as quantity of life, and 
there is an association with cardiovascular diseases (Philbin et al., 
1996). The immobility associated with knee OA may impose 
significant life-shortening effects as shown in a study by Landi and 
colleagues (Landi et al., 2010). The disability in elderly patients 
exerted significant influence on mortality independent of age and 
other clinical and functional variables. In another recent large 
population study (Nüesch et al., 2011) authors investigated cause 
and disease specifiF PRUWDOLW\ LQ  SDWLHQWV   \HDUV ZLWK
knee or hip OA and found excess mortality in OA patients 
compared with the general population irrespective of the cause of 
death, and furthermore  the risk of mortality from cardiovascular 
causes was higher in those with walking disability. 
 
The pain in knee OA is known for its typical transition from an 
intermittent weight-bearing to a more persistent chronic pain 
(Neogi, 2013). In OA and similar conditions, pain probably is the 
PRVWFRQFHUQLQJLVVXHIURPDSDWLHQW¶VSHUVSHFWLYHDVUHYHDOHGLQD
large survey conducted in a Norwegian cohort (Heiberg and Kvien, 
2002). Around 70% of patients preferentially wanted to see 
improvement in pain as a top priority, followed by function (45%) 
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walking and bending (33%), household tasks (25%), social activity 
(13%), self care (11%), and work (9%). Health care practitioners 
PD\ QRW DOZD\V DSSUHFLDWH WKH SDWLHQWV¶ SULRULWL]DWLRQ RI
improvements in areas of health, which importantly calls for 
DZDUHQHVV WKDW WKHSDWLHQW¶VDQGSK\VLFLDQ¶V JHQHUDOYLHZVRI WKH
disease are drawn from different perspectives (Studenic et al., 
2012).  
In an eight-year prospective follow-up study (Dieppe et al., 2000) 
of 500 patients with peripheral OA including knee OA (111 knee OA 
alone, and 87 with hand and knee OA at baseline), knee OA 
patients showed deterioration in physical activity, with higher levels 
of  anxiety and depression and an increase in the utilization of 
health care resources such as joint replacement, medications, and 
walking aids was noted.  
7KH LPSDFWRI FKURQLFSDLQ LQ2$FDQH[WHQG WR VXIIHUHU¶V VSRuse 
and negatively affect their emotional and physical health and 
marital relationship (Flor et al., 1987) as well as sleep quality 
SXWWLQJWKHVSRXVH¶VKHDOWKDWULVNWRR(Martire et al., 2013). 
 
OA results in major economic costs with estimations that the 
musculoskeletal disorders, of which OA is the most prevalent, costs 
between 1 and 2.5% of the gross national product (GNP) of some 
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developed countries including USA, Canada, UK, France, and 
Australia (March and Bachmeier, 1997). The costs of OA can be 
direct as a result of medical care and management expenses or 
indirect from e.g. loss of productivity or expenditures on disease-
related dependency consequences (Bitton, 2009). In a Canadian 
study (Maetzel et al., 2004) the indirect costs were estimated at 
$1760 per person per year as opposed to the direct costs of $3952.  
In the UK the economic burden of OA has a major negative impact 
and is estimated as equivalent of 1% of GNP per year. In year 
1999/2000 the British economy lost £3.2 billion, as 36 million 
working days were recorded as lost days due to OA alone, and 
moreover £43 million and £215 million were spent on community 
and social services respectively, for OA (National Collaborating 
Centre for Chronic Conditions, 2008).  
 
1.2.5 Peripheral mechanisms and correlates of 
pain in knee OA 
The osteoarthritic disease involves a local tissue damage and 
inflammation including a cartilage loss, but the cartilage itself is a 
non-innervated tissue. Thus the peripheral mechanism and 
correlates of pain can be quite complex. The intriguing question 
therefore is; what structures in the knee that have nociceptors and 
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able to conduct pain and what triggers nociception in these 
structures?  
A useful review on the sources of pain in knee OA was presented 
by David Felson (Felson, 2005). Evidence from the reviewed 
studies suggests that type 3 (myelinated) and type 4 (C-
unmyelinated) fibres innervate most joint structures, though with 
inconsistent findings on the existence of nociceptive fibres in the 
synovium or in the inner avascular portion of the meniscus, and no 
evidence of their presence in hyaline articular cartilage. These pain 
fibres are high threshold fibres and can be activated by noxious 
mechanical stimulation of the joint that is mediated by a range of 
pain molecular substances. The pain-innervated structures include 
the periostium, the subchondral bone and the marrow underneath, 
the fat pad, the capsule, and at the junction between the bone and 
cartilage. There is also some evidence that the internal retinaculum 
of the patella and ligamentous insertions are also pain-innervated 
(Felson, 2005).      
 
Research studies suggest that the presence of synovitis and bone 
marrow lesions are likely to mediate pain in knee OA (Sofat et al., 
2011). Felson et al (Felson et al., 2001) examined 401 patents with 
radiographic knee OA, 351 had knee pain and 50 had no knee pain. 
Of those with pain 78% presented with bone marrow lesions as 
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opposed to only 30% of non-painful knee OA group (p<0.001). 
Furthermore larger sizes of bone marrow lesions were associated 
with the knee pain.  
In a recent systematic review by Yusuf and co-workers (Yusuf et 
al., 2011), authors evaluated the association between pain and a 
wide range of knee OA MRI-based findings: (cartilage defects, bone 
marrow lesions, osteophytes, meniscal lesion, effusion or synovitis, 
ligamentous abnormalities, subchondral cysts and bone attrition). 
Researchers found that the pain in knee OA is associated with bone 
marrow lesions and effusion or synovitis.   
 
1.2.6 Central mechanism of knee OA pain 
As mentioned above, from reviewing the peripheral correlates of 
pain in knee OA, the exact pathological elements in knee OA pain 
remain largely unclear. The disparity between peripheral changes 
and pain as well as other observations such as the placebo effect- 
where placebo surgery resulted in a significant long-term pain relief 
(Moseley et al., 2002), and the unresponsiveness to surgical 
treatment (Wylde et al., 2011), taken together all suggest 
additional causative factors in chronic OA pain beyond the direct 
nociceptive tissue damage, such as neural plasticity or predisposing 
factors. 
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Figure 1: The major nociceptive system in knee OA: from periphery to higher centres. 
(Image from Hans-Georg Schaible, 2012) 
 
Pain that is generated from nociceptive activation in the knee joint 
is transmitted to central areas via two types of neurons that are 
functionally different (Felson, 2005).  The first is responsible for 
producing nociception and has relatively small receptive field in the 
periphery but bridges both the knee joint and deep soft tissue e.g. 
muscle. The second type of nociceptive neuron with a receptive 
field in the periphery, which covers the joint and overlying skin and 
a wide territory of skin and joint, is a wide-dynamic-range neuron 
that produces pain in response to both noxious and innocuous 
mechanical stimuli. However the transmitted signal is interpreted 
as one or the other based on the frequency of firing (Felson, 2005). 
The ascending pain pathways have been previously described 
(Chapter 1), and further illustrated as a simple schematic 
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representation in Fig. 1. The inflammatory processes at the joint, 
mediated by inflammatory compounds (Schaible et al., 2011), 
cause complex changes in the CNS with subsequent enhancement 
of postsynaptic transmission to higher centres include thalamus, 
ACC, insula, and somatosensory cortex (Meeus and Nijs, 2007). 
This amplification of nociceptive processing has both spinal and 
supraspinal components, yet the mechanism is not fully understood 
in humans but has been extensively investigated in animal models 
(Schaible, 2012). The abnormal state of exaggerated 
responsiveness at the affected joint can be reflected by a triad of 
pain sensitivity, which includes hyperalgesia, allodynia, and pain 
expansion- spreading beyond local area of pain (Marcus. et al., 
2009). 
 
Functional MRI has been widely implemented in neuroscience and 
brain imaging to measuring specific task- (or in some occasions 
task-free) related activities in the brain.  Neuroimaging studies of 
pain in knee OA to investigate the cortical and subcortical areas 
involved in pain processing have been scarce in the literature. The 
difficulty in conducting such studies in knee OA arises partially from 
the fact that pain is not always feasibly possible to induce while in 
the scanner. Kulkarni and colleagues (Kulkarni et al., 2007) used 
positron emission tomography of the brain in knee OA patients and 
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recorded an increased brain activity as a result of both 
spontaneous arthritic and experimentally induced pain, in the 
cingulate cortex, the thalamus, and the amygdala suggesting that 
arthritic pain is processed in centres concerned with emotions and 
fear. Baliki et al (Baliki et al., 2008b) were able to induce pain (via 
MRI compatible machine that delivered controlled pressure) in a 
preliminary study involved 5 knee OA patients. Pain perception was 
associated with higher brain activity in bilateral thalami, S2, insula, 
and cingulate cortices, and unilaterally in the putamen, and 
amygdala. Of note that these areas are part of what is know as the 
pain matrix (Derbyshire et al., 1997), and overlaps largely with 
areas involved in acute pain processing (Apkarian et al., 2005).  
 
As pain is a multi-dimensional experience involving sensory, 
emotional, and cognitive aspects it is expected that it would recruit 
multiple areas in the brain with different functional domains. 
Recently, a study was conducted to dissociate the brain activity 
induced by evoked pain from that induced by spontaneous pain, in 
chronic knee OA patients (Parks et al., 2011b).  It was found that 
the pain in both cases recruited different networks. Evoked pain 
activated areas similar to those observed for acute pain in healthy 
subjects, whereas spontaneous pain was particularly engaged in 
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activating prefrontal-limbic areas, which indicates involvement of 
emotional components in chronic pain.    
Both fMRI techniques and pain neuroimaging are relatively recently 
developed fields but expanding rapidly with promising findings that 
will help, from a neurobiological perspective, better understanding 
how the brain process arthritic pain as well as other intractable 
chronic pain conditions.  
 
1.2.7 Treatment options and outcome 
There seem to be no effective preventive strategies for OA, and 
therefore treatment options are directed towards relieving 
symptoms, maintaining function, and preventing further damage 
(Kidd, 2006). The European League Against Rheumatism (EULAR) 
(Jordan et al., 2003) identified three lines of management of knee 
OA: non-pharmacological (e.g. education, exercise, life style 
adjustments), pharmacological (medications such as non-steroidal 
anti-inflammatory, tropical treatment), and invasive interventional 
(e.g. intra-articular injections, lavage, joint replacement). EULAR 
concluded that there is a wide range of treatment to knee OA 
however there is no single right or wrong approach and the 
evidence-based recommendation was a combination of 
pharmacological and non-pharmacological interventions in order to 
achieve better results of knee OA treatment. The evidence for the 
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efficacy of physical interventions (e.g. electro-acupuncture EA, low 
level laser therapy LLLT, pulsed electromagnetic field, 
transcutaneous electrical nerve stimulation TENS, ultrasound) in 
knee OA pain was evaluated and presented in a systematic review 
and meta-analysis (Bjordal et al., 2007). Researchers concluded 
that TENS, EA, and LLLT under optimum administrational 
conditions could offer short-term pain relief.  
 
The efficiency of pharmacological treatment of knee OA including 
the use of topical non-steroidal, capsaicin, and intra-articular 
steroid injections, is controversial (Kidd, 2006), however some 
studies have shown significant benefit of Paracetamol and systemic 
non-steroidal anti-inflammatory drugs over placebo (Felson, 2006). 
Moore and co-workers (Moore et al., 2013a) reviewed relevant 
studies and examined rates of success and failure (defined as 50% 
pain relief or its equivalent) of commonly used pain relief 
medications. In OA it was found that the failure rate of non-
steroidal anti-inflammatory drugs is up to 70%, and in a combined 
analysis for OA and chronic back pain, the failure rates for opioids 
(tapentadol and oxycodone), were 90% and 100% respectively. On 
top of the list of medications that show promise for pain relief in 
OA comes Tanezumab (10mg) with a success rate of 29% followed 
by Etoricoxib 60mg and Naproxen 1000mg (27% each), Celecoxib 
  
 
Chapter 2: Chronic Pain in Knee OA  
 
  
34 
200 (22%), Topical Diclofenac 1.5% (20%), Ibuprofen 2400mg 
(16%), and Duloxetine 60/100mg (14%) (Moore et al., 2013a). 
Other non-pharmacological options, though with smaller effect 
sizes of pain relief are available such as complementary and 
alternative medicine reviewed by Lapane et al (Lapane et al., 
2012), and Tai Chi (a series of dance-like movements) and medical 
leech therapy reviewed by Lauche et al (Lauche et al., 2013); 
(Lauche et al., 2014).   
 
Joint replacement surgery is the only known effective treatment 
with large effect size, but is only appropriate for a small percentage 
of patients who have advanced disease and severe symptoms (Juni 
et al., 2006). The outcome of total knee arthroplasty, indicated by 
primary knee OA, has been studied in 1244 procedures (with loss 
of follow up of 1.4% one year post-operatively) by Hamilton and 
colleagues (Hamilton et al., 2012). The satisfaction rate reached 
81% with significant improvements in pain and function. Beswick 
and co-workers systematically reviewed published studies of knee 
replacement for the treatment of OA focusing mainly on reporting 
proportions of people by pain intensity (Beswick et al., 2012). 
Researcher found that the percentage of patients with adverse 
long-standing pain outcome ranged between 10-34% (as compared 
to 7-23% in hip arthroplasty). Authors concluded that these 
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proportions of unfavourable pain outcomes were significant, which 
requires further awareness. 
 
1.2.8 The problem and knowledge gap 
Patients with chronic pain are in desperate need of pain relief 
(Heiberg and Kvien, 2002) that tends to be under-estimated by 
care providers (Moore et al., 2013b). The available analgesic drugs 
may work well, but only in a small percentage of patients (Moore et 
al., 2013a), as do surgical interventions however with larger effect 
size.   Moore et al argue that focusing on average pain relief 
response in research studies is not as useful as seeking out what 
works for each patient (Moore et al., 2013a).  
Although some intractability of chronic pain in knee OA after 
arthroplasty can be ascribed to surgical techniques and implant 
factors (Mont et al., 1996), much of persistent pain and disability 
seen post-operatively remains largely unexplained. Several risk 
factors may contribute to developing the un-explained persistency 
of chronic pain, which include socio-demographic (e.g. low social 
support, low social class, female sex and older age), psychological 
(depression, pain catastrophizing), and biological factors (e.g. 
central sensitization) (Wylde et al., 2007).  The bio-psycho-social 
model is now increasingly recognized as an important perspective 
that will help better understanding chronic pain aetiology and 
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management (Roth et al., 2012). The bio part of the model from an 
imaging-based neurobiological perspective will be the main focus of 
this thesis.  
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1.3 Introduction to neuroplasticity, brain 
morphometry and measurement techniques 
1.3.1 Neuroplasticity in health and disease 
Neuroplasticity is a general term that subsumes different kinds of 
structural or functional neuronal reorganization in response to 
experience or sensory stimulation. It is an intrinsic feature of the 
human nervous system and a mechanism for development and 
learning as much as a cause of pathology (Pascual-Leone et al., 
2005). In healthy people, learning new tasks or adhering to certain 
habits and life styles e.g. playing Tetris (Haier et al., 2009), 
juggling (Draganski et al., 2004), learning new language (Mechelli 
et al., 2004), alcohol drinking (Momenan et al., 2012, Pfefferbaum 
et al., 1992), opioids consumption (Younger et al., 2011), or 
practicing meditation (Grant et al., 2010),  can induce significant 
neuroplastic changes. Performing music, for instance requires 
intensive integration of sensory and motor information in addition 
to precise monitoring of the performance. Therefore, musicians 
have offered an ideal model (Munte et al., 2002) to investigate 
both functional (Elbert et al., 1995) and structural (Gaser and 
Schlaug, 2003) neuroplasticity under normal circumstances. The 
study of neuroplasticity in humans is a fairly recent development 
and has been massively facilitated by the advances in 
neuroimaging that allow neuroplastic changes to be studied in vivo. 
  
 Chapter 3: Introduction to Neuroplasticity, Brain Morphometry, and Measurement 
techniques  
 
  
38 
Different types of disease and damage to the nervous system can 
also trigger functional and structural reorganization of the brain. 
Neuroplastic changes have been described in a wide range of 
conditions including psychiatric disorders (Frodl et al., 2002, 
Pantelis et al., 2003, Radua et al., 2010, Shenton et al., 2001, 
Thompson et al., 2001) $O]KHLPHU¶V GLVHDVH (Thompson et al., 
2003), diabetes (Kumar et al., 2008), trigeminal neuralgia (DaSilva 
et al., 2008) and many other genetic and acquired conditions 
(Peper et al., 2007, Kolb et al., 2011).  
While in some cases the structural changes are clearly indicative of 
neuro-degeneration or neuronal loss, the mechanism in most 
diseases remains largely unknown.  
 
1.3.2 Structural plasticity in chronic pain 
It is just recently that the study of structural brain changes 
associated with chronic pain has become a research interest. The 
advance in medical imaging techniques, in particular magnetic 
resonance imaging, and dedicated image processing software, has 
opened new exciting avenues to study the central processing of 
chronic pain at supra-spinal levels and also provided insights into 
the structural as well as functional and neurochemical brain 
changes associated with chronic pain.  
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The first in vivo findings of MRI-based grey matter changes in 
chronic pain were reported in 2004 in patients with chronic low 
back pain (Apkarian et al., 2004). Ever since the published articles 
on grey matter changes in chronic pain have risen dramatically 
from just (6) in 2005 to (114) in 2013, (based on PubMed search, 
www.ncbi.nlm.nih.gov/pubmed performed on 23 December 2013).  
The commonly used study design to investigate structural 
differences in chronic pain is often a cross sectional case-control, 
where the averaged grey matter volume, density or cortical 
thickness in chronic pain patients is compared with that in age and 
sex matched healthy controls. Some studies may however 
correlate significant differences with the duration of the disease, 
pain severity and other aspects of pain. Longitudinal studies are 
scarce in the literature, as they require more time and resources, 
albeit they may prove more informative in elucidating the causal 
relationship between chronic pain and structural changes. 
 
Previous neuroimaging studies have reported morphological 
cerebral changes in various chronic pain states (Kuchinad et al., 
2007, Schmidt-Wilcke et al., 2006, Rodriguez-Raecke et al., 2009, 
Apkarian et al., 2004, Draganski et al., 2006, Burgmer et al., 2009, 
Buckalew et al., 2010b, Schmidt-Wilcke et al., 2005, Seminowicz et 
al., 2010, Schmidt-Wilcke et al., 2008, Gwilym et al., 2010b). Most 
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studies found a reduction in grey matter (GM) density, volume or 
cortical thickness. However, the distribution of brain structures, 
which show pain-related GM changes, is highly varied between and 
within different primary aetiologies of chronic pain disorders. A 
recent systematic review and meta-analysis of voxel-based 
morphometric studies in patients with chronic pain of any cause 
compared to healthy controls (Smallwood et al., 2013b) found 
several clusters of reduced grey matter volume in known pain 
processing areas and beyond, but also an enlarged hippocampus 
and parahippocampus cluster.  A wide range of underlying 
disorders, disease duration and sample size (8-56; median 18 per 
group) were included.  The mechanisms by which these changes 
occur and which factors may explain heterogeneity of results are 
largely unknown. A causative link to the pain experience can be 
inferred from a few longitudinal studies showing that these changes 
can be at least partially normalized upon pain relief (Rodriguez-
Raecke et al., 2009, Gwilym et al., 2010b, Seminowicz et al., 
2011). 
There seems to be an overlap among studies regarding the 
involvement of certain areas in the brain including thalamus, 
DLPFC, cingulate cortex, and brain stem. Most of the regions found 
with grey matter changes are believed to be part of the central 
SDLQSURFHVVLQJQHWZRUNRUWKDWKDVEHHQUHIHUUHGWRDVµThe Pain 
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0DWUL[¶ (Melzack, 1989).  
1.3.3 Underpinnings and neuroanatomical basis 
of structural plasticity 
Direct histological evidence for structural reorganization is available 
from animal studies. In support of the mechanism of synaptic 
plasticity and formation of new connections, animal studies have 
revealed that exposure to new environmental challenges such as 
spatial learning tasks (Holahan et al., 2006), or exposure to 
enriched environment (Galimberti et al., 2006) can remarkably 
induce axonal remodelling. Following experimentally induced 
lesions in monkeys, Jain Nerraj and others (Jain et al., 2000) found 
new axonal growth taking place from the trigeminal nucleus in the 
brainstem into the cuneate nucleus, after several months following 
transection of the dorsal column of the spinal cord, as confirmed by 
examination of autopsy slices. These findings provide evidence that 
structural plasticity in the form of new connections growing into 
regions in the brain that no longer receive primary afferent input as 
a result of damage, also has a subsequent impact on function i.e. 
functional plasticity as confirmed by microelectrode recordings in 
the aforementioned study. Axonal dynamics have also been shown 
in pathological conditions such as brain injury (Dancause et al., 
2005) and focal retinal lesions (Darian-Smith and Gilbert, 1994). 
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Production of new neurons as a mechanism of plasticity in adult 
human brain (neurogenesis) was long considered as a non-existent 
event. However, using advanced techniques, several lines of 
evidence have relatively recently emerged revealing that 
neurogenesis can indeed occur in the sub-granular zone of 
hippocampal dentate gyrus (Eriksson et al., 1998, Roy et al., 2000) 
and sub-ventricular zone of lateral ventricle which contributes 
interneurons to the olfactory bulb (Bedard and Parent, 2004). 
 
These mechanisms of generating new neurons or axonal 
connections may partially explain morphometric increases in 
volume or density as a directional pattern of structural plasticity. 
On the other hand, the mechanism of morphometric reductions 
reported in several specific and non-specific regions in association 
with a multitude of pathological conditions including chronic pain 
diseases, remains poorly understood.  All up to date explanations 
available for the structural changes in humans are based on 
assumptions and have been open to speculations.  
 
It has been proposed that these changes may represent 
neuroanatomical substrate for the disease, an epiphenomenon or 
even an artefact (Reiss et al., 2004b). Simple change in cell size, 
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shrinkage or atrophy of neurons or glia, changes in the intra-
cortical axonal architecture (synaptic loss) have been suggested 
(Rodriguez-Raecke et al., 2009, May, 2008). A concept of changes 
in the extracellular matrix without substantial involvement of 
neurons or neuroglia was offered by Schmidt-Wilcke and colleagues 
(Schmidt-Wilcke et al., 2008), supporting their idea by a piece of 
growing evidence showing that extracellular matrix influences 
neural cell activity. These mechanisms are thought to be secondary 
to, or in conjunction with a reduction in the cerebral blood flow, as 
proposed by Gwilym and co-workers (Gwilym et al., 2010b), and 
upheld by studies reporting reduced cerebral blood flow to the 
contralateral thalamus during pain that reverts to normal flow after 
analgesia is achieved (Di Piero et al., 1991, Garcia-Larrea et al., 
1999, Hsieh et al., 1995, Peyron et al., 1995). However, all cited 
studies had recruited very low sample sizes n= 5, 10, 8, and 2 
patients respectively, rendering generalizability of results 
questionable.  
 
The gold standard method to explain the mechanism of structural 
changes would be histopathology. However, histological data are 
lacking, and there are not known studies that provide direct 
histological evidence for global or regional brain atrophy in humans 
with chronic pain (Schmidt-Wilcke et al., 2008). It should be noted 
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that the evidence of reversibility of GM volume loss provided by 
some longitudinal studies (Rodriguez-Raecke et al., 2009, Gwilym 
et al., 2010b, Seminowicz et al., 2011), implies that an overt 
neurodegenerative process with irreversible damage is unlikely. 
  
1.3.4 Dynamic changes and reversibility of 
structural changes in chronic pain 
It is not clearly understood whether chronic pain is precedent to or 
a consequence of structural brain changes, i.e. regional brain 
variations due to factors other than chronic pain (e.g. genetic) 
predispose to pain chronicity. In the literature of chronic pain 
imaging, the vast majority of studies are of cross-sectional nature 
leaving the temporal relationship between chronic pain and brain 
morphology intriguingly uncertain. Longitudinal studies at various 
stages of chronic pain with same patients as their own controls 
would allow better understanding the causal relationships between 
structural brain changes and chronic pain. Findings that support 
the hypothesis that morphological brain changes are secondary to 
persistent pain include:  
x The reversibility of structural brain changes following 
therapeutic pain relief (Gwilym et al., 2010b, Rodriguez-
Raecke et al., 2009, Seminowicz et al., 2011),  
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x The changes in grey matter due to repetitive painful 
stimulation (Teutsch et al., 2008), and  
x The correlation between duration of pain and the degree of 
grey matter shrinkage i.e. GM decrease with longer pain 
(Apkarian et al., 2004, Schmidt-Wilcke et al., 2006, Kuchinad 
et al., 2007, Buckalew et al., 2010a, Baliki et al., 2011, 
Wartolowska et al., 2012). 
Chronic pain of osteoarthritic origin offers an ideal model to study 
the reversibility of pain-related GM changes. The pathological 
problem in OA can be treated with joint replacement yielding highly 
satisfactory rates in different aspects of life quality including pain 
relief and improved daily activity in as high as 85% of cases 
(Rodriguez-Raecke et al., 2009, Wylde et al., 2011). 
Two studies have investigated the dynamic grey matter changes in 
OA before and following hip replacement surgery; (Gwilym et al., 
2010b, Rodriguez-Raecke et al., 2009). It was found that 
structures that exhibited reductions in GM before surgery as 
compared to healthy controls were largely reversible to normal 
post-operatively. The time span for reversibility however took 
several months to show significant normalization. Strikingly, the 
regional changes in these two studies were dissimilar despite being 
associated with the same clinical condition i.e. hip OA. In the first 
study (Rodriguez-Raecke et al., 2009), authors found a significant 
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decrease of the GM in the anterior cingulate cortex, right insular 
cortex and operculum, DLPFC, amygdala, and brain stem, which all 
except the right insular cortex and operculum showed a significant 
increase (reversibility) post operatively. Whereas, in the second 
study (Gwilym et al., 2010b), pre and post surgical changes were 
limited to the thalamus (although postoperative analysis was 
restricted to thalamus as it was the only ROI that showed reduction 
pre-operatively). Patients however in both studies were similar in 
age, and the volumetric techniques were largely identical. This 
discrepancy is not easy to interpret and it could be attributed to 
other co-morbidities beyond pain such as medications, lack of 
mobility or other psychosocial and genetic factors (Nikolajsen et 
al., 2006). Some methodological differences in image processing 
and/or scanning protocol or time of scanning which was 4 and 9 
months postoperatively respectively, could also contribute to the 
inconsistency. 
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1.3.5 Imaging-based measurement techniques 
1.3.5.1 Manual morphometry 
Manual morphometry is considered as the gold standard technique 
for region of interest (ROI) volumetric measurements (Cherbuin et 
al., 2009, Morey et al., 2009, Shen et al., 2010). However it 
requires good understanding of anatomy and well-established 
protocol with clearly defined landmarks, and therefore it can be 
largely labour intensive as well as subjected to human error. The 
agreement among multiple measures and reliability of manual 
volumetric technique can be tested within and between observers.  
Intraclass correlation is recommended for such testing (Rousson et 
al., 2002), though  there is no consensus as to what constitutes 
poor, good, or excellent ICC-based reliability (Shrout, 1998). 
However low ICCs indicate that larger study sample is needed to 
detect a statistically significant effect (Perkins et al., 2000).  
In my experimental studies where manual morphometry was the 
technique of choice I have used 3D slicer version 4.1 (Pieper et al., 
2006) to obtain quantifiable measures. The software allows for 
exchangeable visualization and tracing of the ROI in three different 
planes as well as an automated calculation of ROI volumes. 
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1.3.5.2 Voxel-based morphometry 
Voxel based morphometry (VBM) is a voxel-wise automated 
technique to assessing MRI-based grey matter changes in the brain 
(Ashburner and Friston, 2000b, Wright et al., 1995). 
Using SPM8 (Statistical Parametric Mapping8, available from 
http://www.fil.ion.ucl.ac.uk) implemented in MATLAB (The Math 
Works Inc., Natick, MA, USA, http://www.mathworks.co.uk/), the 
processing steps briefly begin with the use of T1 structural brain 
MRI scans which are then spatially normalized to the same 
stereotactic space. Next step involves segmentation of the three 
major components of the brain; grey matter, white matter and 
cerebrospinal fluid followed by smoothing of the grey matter and 
finally performing statistical analysis to localize, and make 
inferences about within (correlation) or between group differences.  
The output is a statistical parametric map indicating significant 
differences of grey matter concentration within or between groups 
(Ashburner and Friston, 2000b). In the modulation sWHSµSUHVHUYH
YROXPH¶ FDQ EH FKRVHQ WR \LHOG *0 YROXPH UDWKHU WKDQ
concentration. DARTEL (Diffeomorphic Anatomical Registration 
using Exponentiated Lie algebra) (Ashburner, 2007), implemented 
in SPM8 can be used, which offers improvement in spatial 
normalization and more reliable analysis outcome (Mak et al., 
2011) largely comparable with manual morphometry. 
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As a fully and unbiased automated technique as well as relatively 
easy to use, VBM has grown widely in popularity since its 
development yielding biologically plausible results (Whitwell, 
2009). 
 
1.3.5.3 Surface-based morphometry 
Surface based morphometric changes can be measured following 
reconstruction of the cortical surface from high-resolution brain 
imaging data.  For cortical reconstruction and thickness estimation 
in this thesis studies I have used the Freesurfer software package 
(Mac version 5.1.0 available online 
http://surfer.nmr.mgh.harvard.edu/). Freesurfer allows for analysis 
and visualization of structural brain MRI data using semi automated 
processing steps. Briefly the processing steps involve removal of 
non-brain tissue (Segonne et al., 2004), transformation into 
Talairach space, intensity normalization (Sled et al., 1998), 
tessellation of the grey matter white matter boundary, automated 
topology correction (Segonne et al., 2007, Fischl et al., 2001), and 
surface deformation is then performed to indicate the grey/white 
and grey/cerebrospinal fluid borders based on detection of greatest 
shift in intensity (Fischl and Dale, 2000, Dale and Sereno, 1993, 
Dale et al., 1999). The method uses both intensity and continuity 
information from the entire three dimensional MR volume in 
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deformation procedures to produce representations of cortical 
thickness, calculated as the closest distance from the grey/white 
boundary to the grey/CSF boundary at each vertex on the 
tessellated surface. The reconstruction output is then visually 
inspected and any parcellation inaccuracies are manually corrected. 
Free-surfer brain construction output yields massive results of 
statistical data with regard to different aspects of cortical and 
subcortical morphometric measures. The output can be used to 
derive individual ROI morphometric statistics, or cortical data can 
be used for group-level statistical analysis by co-registration of the 
cortical surface into a common spherical space prior to vertex-wise 
statistical analysis. 
The maps produced are not restricted to the voxel resolution of the 
original data thus are capable of detecting changes at sub-
millimetre levels. Procedures for the measurement of cortical 
thickness have been validated against histological analysis (Rosas 
et al., 2002) and manual measurements (Salat et al., 2004).  
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1.3.6 Mechanistic imaging of structural 
plasticity 
Mechanistic imaging, which is relatively a new field, refers to the 
use of advanced imaging with a focus on specific pathophysiologic 
questions and pathways (Sorensen, 2013). For mechanistic 
neuroimaging, advanced molecular, structural, or functional 
techniques can be implemented. In this section I will introduce the 
use of diffusion tensor imaging-derived mean diffusivity (MD) 
measures to studying the microstructural changes in structural 
plasticity. This approach will be used chapter 9 to investigate the 
potential microstructural correlates that may elucidate the 
histopathological mechanisms of grey matter changes seen in 
patients with chronic knee OA pain.  
The cellular microstructure, within the parenchyma of brain tissue 
influences the overall mobility of diffusing molecules via numerous 
barriers and compartments formed by e.g. nerve cells, glial cells 
and axons within the tissue (Beaulieu, 2002). MD, which can be 
quantified from diffusion tensor imaging (DTI) (Pierpaoli et al., 
1996) provides as an index of the magnitude of water diffusion 
(Schmierer et al., 2007), and hence reflects the microstructural 
elements that effect water diffusion (particularly cellularity) of the 
brain tissue. DTI-derived measures e.g. MD and diffusion 
anisotropy can be altered by several brain microstructural 
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environmental factors such as inflammation, intra- or extra-cellular 
swelling, cell death, membrane damage, demyelination, cell 
growth, axonal loss or reorganization, or gliosis (Wheeler-Kingshott 
et al., 2003).   For example, clinical examples of higher MD values 
can be seen in e.g. chronic demyelinating lesions (Larsson et al., 
1992) DQG $O]KHLPHU¶V GLVHDVH (Kantarci et al., 2005). 
Underpinnings of reductions in MD may include any process that 
leads to hindered or restricted diffusion (Le Bihan, 1995), such as 
acute pathological reactions with subsequent putative cell swelling 
(Kumar et al., 2012), acute ischemia (Ahlhelm et al., 2002), and 
generally in cases of non-necrotic neoplasia (Alexander et al., 
2007).  
 
Literature regarding changes in MD of the cortex is sparse, 
although studies have shown changes in cortical MD in multiple 
VFOHURVLV 06 $O]KHLPHU¶V GLVHDVH DQG KHDOWK\ DJHLQJ  &RUWLFDO
MD increase has been proposed to reflect putative cortical grey 
matter integrity loss (Vrenken et al., 2006), but without the 
availability of histological data, the importance of its 
microstructural basis in disease states (including chronic pain) is 
unclear.   
In summary, MD is primarily affected by microstructural 
parenchymal components, and hence provides a potential means to 
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study the mechanism of alterations to cortical volume in both 
health and disease states. However, inferences from the correlates 
of MD changes alone are less specific unless combined with findings 
from other imaging metrics such as cortical thickness, MR 
spectroscopy, and fMRI, to provide more specific information about 
the neuro-histopathological substrates of grey matter changes in 
chronic pain.    
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1.4 Systematic review of the literature 
1.4.1 Overview and aims 
Chronic musculoskeletal (MSK) pain is a major health and societal 
burden affecting about 30% (13.5-47%) of the general population 
(Cimmino et al., 2011). There has been converging evidence in the 
literature that chronic MSK pain and morphological brain changes 
are associative. However, there is little consensus on correlation 
pattern or direction, temporal relation, and spatial location of these 
changes. ,Q WKLV UHYLHZ ,¶OO HPSOR\ D V\VWHPDWLF DSSURDFK LQ
searching the available literature for MRI studies that investigate 
grey matter changes in chronic pain in MSK disorders. The 
following objectives are set: 
 
x To investigate the association of musculoskeletal chronic pain 
with structural brain changes 
x To investigate the pattern of correlation if any, as well as 
evidence for whether chronic pain is an antecedent or a 
consequence of structural brain changes 
x To review the evidence for reversibility of structural brain 
changes associated with chronic pain following therapeutic 
treatment 
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1.4.2 Methodology 
1.4.2.1 Search strategy  
A computerized search for articles published in the last 10 years up 
to early June 2013 was performed using PubMed search engine, for 
structural brain MRI studies in MSK chronic pain. Chronic pain 
imaging is a relatively new research topic; the sentinel paper 
studying brain morphology in chronic pain was that by Apkarian et 
al (Apkarian et al., 2004). Based on initial searches of publications 
prior to this, only a single paper, though with negative findings, 
investigating morphological correlates of pain in migraine was 
identified (Matharu et al., 2003).  On this basis, the systematic 
review of electronic databases was limited to publications from 
2004 onwards, although references of relevant articles including 
review articles were hand searched.  
 
Search terms were derived from the key words (pain, brain, grey 
matter, musculoskeletal pain, and MRI). Possible derivatives of 
each key word were entered and complete search matrix was 
generated (Appendix 3, table1). PRISMA guidelines (Moher et al., 
2009)  were used to identify literature. Selection criteria were 
applied to the initially identified 1278 papers. Following cascading 
steps of screening and assessments (Fig 1, and appendix 3 table 
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1), based on information from titles and if needed from abstracts, 
and then a further assessment step was carried out based on 
information from abstract and if needed from full text, titles not 
pertaining to the research question or papers that deemed not 
relevant were accordingly removed.  
1.4.2.2 Eligibility criteria 
Studies were included if they were: 
x Original human research (adults only)  
x Using MRI anatomical scanning  
x Of any chronic pain condition that can be categorized under MSK disorder 
x Pain for PRQWKV 
x Published in Peer-reviewed journal in or translated into English 
 
Studies were excluded if they were if they were: 
x Non original research e.g. reviews, letters, or case studies 
x Preclinical  
x Using imaging modalities other than structural MRI 
x Pilot studies (in terms of being conducted to evaluate feasibility and 
predict requirements of mother study. Studies with small sample sizes 
are still considered) 
x Chronic pain condition other than MSK 
x Using acute  (< 3 months) or experimental pain paradigm  
A table by search terms and outcome records is shown in 
(appendix 3, table 1). Flow diagram is shown below (Fig 1). 
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PRISMA 2009 Flow Diagram* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. A flow chart of the process of identifying relevant literature 
*PRISMA chart from (Moher et al., 2009): The PRISMA Group (2009) www.prisma-statement.org 
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1.4.3 Results 
1.4.3.1 Search results 
The process of selection (Fig 1) resulted in 21 papers being 
considered for inclusion. Further detailed full-text read-through led 
to an exclusion of 3 papers (1 pilot, 1 non MSK, and 1 used 
experimental repetitive acute pain paradigm), and therefore the 
remained total number, which met eligibility criteria for final 
inclusion, was 18. Digital copies of all 18 studies were obtained. 
The earliest study was published in 2004 (Apkarian et al., 2004) 
and the most recent in June 2013 (Rodriguez-Raecke et al., 2013). 
 
1.4.3.2 Quality assessment and characteristics of studies  
Quality of studies was evaluated using the Critical Appraisal Skills 
Program (CASP) guidelines (Critical Appraisal Skills Programme 
CASP, 2004). The CASP guidelines for case control studies ask 
eleven questions to assess studies for clear and unambiguous 
focus, appropriate methodology, unbiased recruitment of cases and 
controls, unbiased measurements of exposure, control for 
confounders, and precision of results, trustworthy, generalizability 
and consistency with evidence from others.  These questions can 
be summarized under three categories: validity of the study, 
evaluation of the results, and assessment of generalizability of 
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results. I have omitted one question (what are the results of this 
study?) as it will be stated and answered in the results section, and 
combined two questions into one (How precise are the results? And 
do you believe the results? Into: are the results precise and 
believable?). 
Each paper included in the review underwent quality assessment. 
Findings are summarized in (Appendix 3, table 2). Overall, all 
studies addressed their aims and objectives clearly with not much 
difference in research approach. However, most studies appeared 
to be underpowered with small sample sizes included. No study 
provided a rationale for the investigated sample size or how it was 
calculated.  
The focus of the included studies was mainly to address the 
question of whether chronic pain is associated with morphological 
brain changes. A range of MSK disorders were studied, including 
chronic back pain, fibromyalgia, osteoarthritis, temporo-mandibular 
disorders, phantom limb, and rheumatoid arthritis. In all studies, a 
cross sectional case control design was implemented where 
average GM and/or cortical thickness of patient was compared with 
that of matched healthy controls. Some studies (table 1) 
investigated the interrelation between the morphological changes 
and duration of chronic pain, pain severity or other pain-related 
characteristics such as psychometrics. In three studies (Rodriguez-
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Raecke et al., 2009, Gwilym et al., 2010a, Seminowicz et al., 
2011), patients were further followed-up in a longitudinal design 
after therapeutic treatments that involved joint replacement to 
treat OA disease or spinal surgery or facet injection in case of 
chronic low back pain. The morphometric technique used was 
mostly voxel-based morphometry (VBM) with some exceptions 
(Moayedi et al., 2011, Seminowicz et al., 2011, Wartolowska et al., 
2012), where surface based morphometry (cortical thickness) was 
the used or additively used technique.  
Buckalew et al (Buckalew et al., 2010a) used in-house software. 
 
1.4.3.3 Participants 
480 patients were included in all 18 studies with an average age of 
52 years (based on mean of the mean ages in all groups). While 
sex distribution was well balanced in most studies some however 
had exclusively or mainly female patients due in part to the 
prevalence nature of the investigated disease e.g. fibromyalgia 
(Kuchinad et al., 2007, Schmidt-Wilcke et al., 2007, Hsu et al., 
2009, Moayedi et al., 2011, Robinson et al., 2011). All patients had 
experienced persistent pain for at least three months. 
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1.4.3.4 MRI scanning 
High resolution structural MR imaging was obtained by all studies. 
With the exception of (Apkarian et al., 2004, Draganski et al., 
2006, Schmidt-Wilcke et al., 2006, Kuchinad et al., 2007, Schmidt-
Wilcke et al., 2007), where 1.5 Tesla was used, in the rest of the 
studies scanning was performed with 3 Tesla scanners.  
 
1.4.3.5 Outcomes  
7KHVWXGLHV¶PDLQILQGLQJVDUHVXPPDUL]HGLQWDEOH0RVWVWXGLHV
found a reduction in grey matter (GM) density, volume or cortical 
thickness. However, the distribution of brain structures, which 
show pain-related GM changes, was highly varied between and 
within different primary aetiologies of chronic pain disorders. Some 
studies reported negative correlations i.e. less GM volume with 
longer pain (Apkarian et al., 2004, Schmidt-Wilcke et al., 2006, 
Kuchinad et al., 2007, Buckalew et al., 2010a, Baliki et al., 2011, 
Wartolowska et al., 2012), while others found positive 
correlations(Younger et al., 2010, Moayedi et al., 2011) or no 
correlation(Draganski et al., 2006, Schmidt-Wilcke et al., 2007, 
Buckalew et al., 2008, Hsu et al., 2009, Gustin et al., 2011).  
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Only few studies investigated the reversibility of GM changes 
longitudinally when chronic pain was alleviated (Rodriguez-Raecke 
et al., 2009, Gwilym et al., 2010b, Seminowicz et al., 2011) 
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*Expressed as (M± SD). CBP= chronic back pain, FM= fibromyalgia, OA= osteoarthritis, TM= temporo-mandibular, CRPS= chronic regional pain syndrome, RA= 
rheumatoid arthritis. 
¶
 $XWKRUVXVHGDGHILQLWLRQRIFKURQLFLW\DV³SDLQWKDWH[FHHGHGQRUPDOKHDOLQJWLPH´VR!PRQWKVZDVDVVXPHG 
Study Condition Sample size     
and age* (Y) 
Pain* 
duration (M) 
Main findings/Correlation with pain duration/reversibility  
1. (Apkarian et al., 
2004) 
CBP n= 26 
47.0± 12.6 
G2/G1=non/ 
neuropathic 
> 12  
G1 135.6± 
136.8 
G2 62.4 ± 
44.4 
Patients had less volume in total GM, DLPF, and thalamus. Pain duration 
correlated negatively with total GM volume corrected for age. DLPF had 
negative correlation with pain characteristics including duration. Thalamus 
had negative correlation only with pain duration. 
2. (Draganski et al., 
2006) 
Phantom 
limb 
n= 28 
41.9± 13.8 
> 9 
119.3± 140 
 
Significant decrease in GM of thalamus in patients which positively 
correlated with time span after amputation but not with frequency or 
magnitude of phantom pain 
3. (Schmidt-Wilcke 
et al., 2006) 
CBP n= 18 
50.4± 6.8 
> 36 
176 ±87.60 
Patients had larger GM in basal ganglia and thalamus but less GM in 
brainstem and S1, which -the latter- negatively correlated with pain 
intensity and unpleasantness but not with pain duration.  
 
4. (Kuchinad et al., 
2007) 
FM n= 10 
52 
> 3 Patients had less total GM, negatively correlated with pain duration 
corrected for age, also less GM in several clusters (uncorrected) 
5. (Schmidt-Wilcke 
et al., 2007) 
FM n= 19 
53.6± 7.7 
> 3 
173± 86.5 
GM increase and decrease in several areas though with no significant 
correlation with pain duration (both un/corrected results) 
6. (Buckalew et al., 
2008) 
CBP n= 8 
74.5± 4.2 
> 3 Patients had less GM in the posterior parietal but no correlation between 
pain duration and total grey matter or ROI volume 
7. (Hsu et al., 2009) FM n= 29 
41.7 
 
> 3 
153.6± 99.6 
Patients had less GM in Lt. anterior insula, which correlated negatively 
with trait anxiety, but not with pain duration  
8. (Rodriguez-
Raecke et al., 
2009) 
Primary 
hip OA 
n= 32 
66.8± 9 
> 12 
88.2 
Significant GM changes with pain in several areas and partial 
reversibility after arthroplasty but correlation with pain duration was not 
investigated 
9. (Buckalew et al., 
2010a) 
CBP n= 16 
74.6 
 
93 
Negative findings for GM, though a significant correlation between WM 
integrity and pain duration was found  
10. (Gwilym et al., 
2010a) 
Primary 
hip OA 
n= 16 
68 
NA¶ GM changes in patients mostly increase in several areas except thalamus, 
which showed a decrease that reversed to normal after arthroplasty. 
Correlation with pain duration was not investigated 
Table 1. Characteristics and main findings of the review studies 
  
Chapter 4: Systematic Review of the Literature 
 
  
64 
 
Study Condition Sample size     
and age* (Y) 
Pain* 
duration (M) 
Main findings/Correlation with pain duration/reversibility 
11. (Younger et 
al., 2010) 
Myofascial 
TM pain 
n= 15 
38± 13.7 
> 12 
52.8± 34.8  
GM changes in patients both increase e.g. S1 and decrease e.g. inferior 
frontal, anterior insula. ONLY positive correlation with pain duration in 
numerous regions 
12. (Baliki et al., 
2011) 
CBP 
CRPS 
Knee OA 
n=36; 
48.2±11.4 
n=28; 40.6 
±7.4 
n=20; 
53.5±7.4 
147.9±137.9 
39.3± 40.8 
146.7± 114 
Condition-specific GM reductions in several areas. No significant correlation 
with pain duration, intensity or their interaction for any group. However by 
combining and median-split all groups, longer pain group showed a 
significant negative correlation with the insula GM density. 
13. (Gustin et al., 
2011) 
TM 
disorders 
n1= 20 
n2=21 
45.7± 2.9 
> 18 
138± 40.8 
Significant GM reductions ONLY in the neuropathic group in several areas 
e.g. S1, insula. No significant correlation between GM volume and pain 
duration 
14. (Moayedi et 
al., 2011) 
TM 
disorders 
n= 17 
33.1± 11.9 
> 3 
117.7± 99 
Patients had thicker cortex in S1, and PFC. Positive correlation with 
WKDODPXV*0YROXPH3DWLHQWVZKRKDGWKHGLVHDVHIRU\HDUVVKRZHGD
progressive increase in thalamic GM 
15. (Robinson et 
al., 2011) 
FM n= 14 
43.1± 6.9 
 
> 3 
 
GM reductions in e.g. ACC, insula compared to HCs. No significant 
correlation between measures of negative affect and the grey matter 
volume. Pain duration was not investigated 
 
16. (Seminowicz 
et al., 2011) 
CBP n= 18 
46± 10.64 
> 12 
60± 57 
Significant changes with pain and reversibility of DLPFC after treatment 
(surgical or medical). Correlation with pain duration was not investigated. 
Recovery of GM was significantly correlated with reduced pain intensity and 
improvement in physical activity 
17. (Wartolowska 
et al., 2012) 
RA n= 31 
Median= 57 
> 18 
Median= 180 
Patients showed a GM increase in basal ganglia. Negative correlation 
between disease duration and gray matter density in the right thalamus, 
which abolished after controlling for age 
 
18. (Rodriguez-
Raecke et al., 
2013) 
Hip OA 
Coxarthro-
sis 
n= 20 
63.3± 9.5 
> 12 
88.2 
Extension of previous study (no. 8). Reversibility and significant changes 
after arthroplasty with progressive GM increase in frontal lobe areas. 
Correlation with pain duration was not investigated 
Continue Table 1.  
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1.4.4 Discussion 
Association of chronic MSK pain with structural brain changes 
 
Most studies included in the review have reported grey matter 
changes in association with chronic pain, though with striking 
inconsistency as to which areas are specifically affected. While 
predominantly reduction, GM enlargement in some areas has also 
been found. These discrepancies may reflect a random error due to 
small sample sizes, limitations of the grey matter volume 
estimation or true biological differences in underlying pain 
characteristics or predisposing factors. A spatial dissociation may 
be explained by the multidimensionality of chronic pain experience 
and related comorbidities. Chronic MSK pain can result in reduced 
quality of life (Reginster, 2002, Salaffi et al., 2005), reduced 
exercise, impaired sleep and long-term medication that may 
contribute to the pattern of progressive cortical thinning.  
 
Importantly, most studies have low power that is limited by their 
inability to control for the multitude of factors that influence brain 
morphometry. As these factors are usually not well controlled 
between patients and controls, they may significantly confound 
between group analyses.  
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GM reductions have been found in several cortical and subcortical 
areas including the thalamus, primary somatosensory, insular 
cortex, DLPFC, cingulate cortex, amygdala, posterior parietal 
cortex, orbitofrontal cortex, opercula, and brainstem. There seems 
to be an overlap among these studies in the (thalamus, DLPFC, 
insula, cingulate cortex, and brainstem). Most of the regions which 
showed structural changes are considered part of the central pain 
SURFHVVLQJQHWZRUNRUZKDWLVNQRZQDVµWKHSDLQPDWUL[¶(Melzack, 
1989). 
The mechanisms by which these changes occur and which factors 
may explain heterogeneity of results are largely unknown. As 
detailed previously in (chapter 2), the exact histopathological 
substrates of these changes remain intriguingly unclear, especially 
in the absence of any confirmatory histological evidence. Imaging-
based non-invasive techniques e.g. diffusion tensor imaging, and 
the derived mean diffusivity metrics (see chapter 2) along with 
other multimodal techniques such as MR spectroscopy and 
functional imaging may play a substantial role in elucidating the 
histopathological mechanisms of GM changes and provide 
unprecedented insights into the central mechanism of pain 
chronicity.  
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Most studies, with few exceptions, used voxel based morphometric 
technique in detecting differences between groups. Quantification 
of grey matter changes can be achieved using different image 
analysis techniques, however measuring the cortical thickness 
using a surface-based approach arguably improves robustness over 
standard volumetric methods: Cortical thickness assessment 
provides a directly interpretable metric, and is more sensitive 
allowing for detection of sub-voxel changes (Liu et al., 2012b, 
Pereira et al., 2012), less sensitive to inaccuracies of spatial 
normalization and smoothing (Bookstein, 2001, Augustinack et al., 
2013). However, it remains limited by its inability to investigate 
subcortical structures. Manual morphometry in some cases of ROI 
volumetric measurement is still considered the gold standard 
(Cherbuin et al., 2009, Morey et al., 2009, Shen et al., 2010). 
However, it can be time consuming and liable to human errors.  
 
The anatomical MRI and morphological brain measures, as 
biomarkers, have EHHQDOUHDG\XWLOL]HGWRHYDOXDWHHJ$O]KHLPHU¶V
disease (www.adni-info.org). The morphological brain signature in 
chronic pain can be an invaluable candidate as an objective 
biomarker for chronic pain to monitor pain therapy and 
responsiveness, determine eligibility for invasive treatment 
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(Gwilym et al., 2010a), and predict pre-existing vulnerability and 
disease-driven changes (Davis, 2011, Mansour et al., 2013). 
,QP\ UHVHDUFK ,¶OO FRPELQH ILQGLQJV IURPFRUWLFDO YHUWH[-based, 
(subcortical) voxel-based, and (ROI) manual morphometric 
techniques to overcome the limitations of using each approach 
individually and provide a framework to understand the basic 
mechanisms of structural brain changes in chronic pain.    
 
1.4.4.1 Reversibility, and the temporal relationship 
between structural brain changes and chronic pain: 
Which comes first? 
The dynamic influential relationship between chronic pain and brain 
morphology is poorly understood. There are no longitudinal studies 
to demonstrate the progression individually, and the slow 
progression would be challenging for such studies. However, there 
are few longitudinal studies before and after pain relief providing 
strong evidence for at least partial reversibility of morphometric 
findings (Rodriguez-Raecke et al., 2009, Gwilym et al., 2010b, 
Seminowicz et al., 2011).  
The cumulative effect of morphometric changes over several years 
to decades of chronic pain indexed by the correlations shown 
between GM volume or density and pain duration in MSK disorders 
in e.g. chronic back pain (Apkarian et al., 2004, Schmidt-Wilcke et 
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al., 2006), rheumatoid arthritis (Wartolowska et al., 2012) and 
fibromyalgia (Kuchinad et al., 2007) argue strongly for but cannot 
prove them to result from the chronic pain experience. 
In an experimental study (Teutsch et al., 2008), authors exposed 
healthy subjects to a long tem painful stimulation for reasonably 
long periods of time ~ 20 minutes, on a daily basis for 8 
consecutive days. The researchers were able to detect a substantial 
increase of grey matter in brain areas involved in pain processing 
including mid-cingulate and S1. These changes were thought to 
have convincingly resulted from the painful stimulations as they 
receded when the regular nociceptive input was stopped. However, 
the study can be criticised for lacking controls.   
In another more recent study (Stankewitz et al., 2013), authors 
were able to reproduce the aforementioned study findings yet with 
different results. A group of 27 healthy volunteers received 
repetitive painful stimuli for 11 consecutive days. They were 
compared to a control group, and behavioural data were analysed. 
The experimental group was divided in terms of behaviour into 
those who developed pain sensitization n= 14 and habituaters 
n=13. Only sensitizers developed grey matter reductions in pain 
centres (including ACC, insula, middle frontal cortex, and 
amygdala) as a result of the nociceptive stimulation.  
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Regardless the pattern of cerebral change, the above experiments 
provide some evidence that brain structural plasticity can occur 
secondary to pain. However, the complexity of pain experience 
arising not only from the multidimensionality nature of pain itself 
but also from the association of multiple co-morbidities, overall 
change in quality of life (Tuzun, 2007) and pain-related 
medications, all these factors make it difficult to infer a cause and 
effect relationship.  
Austin Bradford Hill (Hill, 1965) proposed criteria for assessing 
causal relationship, which were further summarized by (Petrie and 
Sabin, 2005) under the following points (with modification by 
myself to fit the pain and brain plasticity model): 
x The cause must precede the effect 
x The association should be plausible 
x Results should be consistent among studies 
x The association between the cause and the effect should be 
strong 
x Higher levels of the effect should lead to more severe disease 
or faster onset 
x Removing the nociceptive stimulus should reduce the pain-
related brain changes 
Some information can be obtained from cross sectional studies 
however to provide strong evidence for the casual role of chronic 
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pain in brain plasticity, longitudinal studies involving evaluation of 
the progressive brain changes with pain, and their reversibility 
upon pain relief are strongly required. 
 
1.4.5 Conclusion 
There is converging evidence that structural brain alterations are 
associated with persistent nociceptive stimulation. Theses changes 
seem to cumulate over the duration of the disease and may 
partially reverse to normal when the regular nociceptive input is 
stopped. Anatomical neuroimaging along with other neuroimaging 
modalities may play an important role in better understanding the 
central mechanism of pain chronification, monitor pain therapy and 
responsiveness, and provide a promising biomarker tool for 
evaluating chronic pain. 
 
 
 
 
 
 
  
 
Aims and Scope of the Thesis 
 
  
72 
1.5 Aims and scope of the thesis: 
In spite of the literature-based evidence presented above, that 
chronic musculoskeletal pain is associated with grey matter 
changes, the direction of such changes, spatial location, and 
correlation with pain characteristics and interlinked behaviours are 
still poorly understood and furthermore inconsistent between 
studies. The ultrastructural mechanism of such cerebral changes is 
largely unknown and has not been attempted previously in MSK 
pain disorders. Previous studies have mostly used individual 
modalities of image analysis, often implementing VBM approach, 
which can provide only partial information on the structural brain 
plasticity in association with chronic pain. Moreover, small samples, 
technical limitations of GM volume estimation may largely 
contribute to discrepancies between studies.  
In this research I choose to combine advanced imaging and 
morphometric techniques to investigate and mechanistically assess 
structural brain correlates of chronic pain due to knee 
osteoarthritis. By doing so, the researcher is aiming to provide a 
broad and more conclusive morphological profile of brain in chronic 
pain that can constitute a contribution to knowledge on the central 
processing of pain and pain chronification, as well as provide 
novelty and potential to understand pain phenotypes for stratified 
pain management.   
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The experimental part 2 will be concerned with a series of studies 
that I have conducted during my PhD registration period, and will 
be introduced here in brief: 
In chapter 5, a full description of the participants of the study 
(knee OA patients and HC) will be provided including their 
recruitment and scanning procedures. The demographic data, 
between-group differences in cognition, depressive disorders, pain 
catastrophizing, state and trait anxiety, as well as characteristics of 
pain dimensions in patient group will be detailed. This chapter will 
be referred to in the methods section of subsequent experimental 
chapters.   
Chapter 6 investigates the hippocampal volume and cognitive 
function in chronic knee OA patients using up-to-date manual 
morphometric techniques and tightly defined volumetric 
measurement protocol.  
In chapter 7, combined manual morphometric and cortical 
thickness techniques will be used to investigate the ACC (a pivotal 
limbic structure involved in central pain processing) and its sub 
divisional morphology in relation to cognitive and emotional 
aspects of pain as well as its potential role in the process of central 
pain sensitization. 
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Improved technique of voxel based morphometry using 
DARTEL (Diffeomorphic Anatomical Registration using 
Exponentiated Lie algebra) (Ashburner, 2007), will be presented in 
chapter 8 to investigate cortical and subcortical grey matter 
correlates of chronic pain and chronic pain severity. 
The effect of pain duration on cortical thickness will be the 
main focus of the first half of chapter 9, with stratification by sex to 
investigate its moderating effect between chronic pain and 
neocortical changes. 
The second half of chapter 9 will be dealing mainly with 
mechanistic explorations by means of investigating cortical mean 
diffusivity to inform on ultrastructural status of cortical tissue in 
association with cortical remodelling in chronic pain, and analyses 
will be performed to compute gyrification index to investigate the 
gyrification changes that may relate to the overall plasticity of 
brain in chronic pain. 
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2.1 Generic methods and 
characterisation of study participants 
2.1.1 Introduction  
The studied participants, both knee OA patients and healthy 
controls, will be described with regard to their recruitment 
pathways, data acquisition, and demographic, psychological and 
pain-related characteristics. This chapter will be referred to, in the 
methods sections in the subsequent chapters of experimental 
studies. Written informed consent was obtained from all 
participants, and Nottingham Research Ethics Committee2 
approved the study (10/H0408/115). 
2.1.2 Methods 
2.1.2.1 Recruitment pathways 
The recruitment process* for studies included in this thesis was 
facilitated by a research coordinator (Maggie wheeler) with my 
input and directions. I was responsible for confirming eligibility 
prior to inclusion. 
*My study was part of a bigger project run by the Arthritis Research UK pain centre, which is funded 
by a substantial award from the Arthritis Research UK (Grant number 18769), and operating as an 
umbrella under which several studies were conducted. Along with our neuroimaging studies, 
preclinical, pharmacological, questionnaires-based and other studies were also similarly performed. A 
research coordinator (Maggie Wheeler) was employed by the centre to help with SDUWLFLSDQWV¶ 
recruitment, quantitative sensory testing, and other administrative issues. The research coordinator 
relied on my input for my study recruitment via phone conversations, email exchange, and through 
several direct meetings regarding eligibility of participants and age and sex matching before liaising 
further or confirming bookings with potential participants. Once eligibility criteria were met, The 
research coordinator would confirm bookings, arrange transportation and send questionnaires to the 
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eligible participant by post. On scanning day, The research coordinator would meet (on few occasions 
I did) the participant at the main entrance of Queens Medical Centre and walk them through to our 
division, where I meet the participant, greet them and introduce myself. I would then receive 
questionnaires and make sure all sections were answered in the right way and no question was missed 
and/or un-answered. I would then start by explaining the study to the participant and answer their 
questions if any, consent them, and then I provisionally check their safety and eligibility for MR 
scanning before final approval is obtained by the radiographer (Anita French).  
The research coordinator would then take measures of pressure pain thresholds at the painful knee as 
well as at remote sites. Once finished, the research coordinator would hand over to me where I would 
conduct a face-to-face interview to assess the cognitive ability of the participant using the Montreal 
Cognitive Assessment test (MoCA) (Nasreddine et al., 2005), and also record educational level, pain 
duration and severity, and take measures of body weight and height.  
Next, I would escort the participant down to the scanning room where I would introduce the 
participant and the radiographer to each other and help with getting the participant to the scanning 
table. The radiographer would start scanning using the pre-defined protocol, which involved 
localization, T1 scanning, DTI, spectroscopy, resting state fMRI. 
As soon as the anatomical T1 scans became available I would visually inspect the images on the 
scanner console, check quality and request repetition if e.g. motion artefact or other correctable factors 
emerged. The radiographer, a co-worker, or I would then request a taxi for the participant and escort 
them to the main entrance of the medical school of University of Nottingham. 
 
 Participants with chronic knee OA pain 
The aim was to recruit 25 Patients with radiologically defined knee 
2$ LI WKH\ KDG FKURQLF SDLQ GHILQHG DV µSDLQ PRVW RI WKH GD\ RQ
most days of the week¶ IRU DW OHDVW WKH ODVW PRQWK (Peat et al., 
2006a). Patients were identified and contacted by mail from 15 
general practices in Nottinghamshire and Derbyshire (supported 
and organized by primary care research network, PCRN), 
orthopaedic outpatient clinics of Nottingham University Hospitals, 
and from previous questionnaire and trial studies that were carried 
out in the Rheumatology Department at the University of 
Nottingham. 
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Sample size was increased to (n= 31), by including eligible and 
quality assured cases from pilot study, powered to detect 0.25mm 
cortical thickness changes (Pardoe et al., 2013). 
 Inclusion Criteria: 
x Radiologically defined OA knee changes 
x Pre-operative status 
x &KURQLFNQHHSDLQµDFFRUGLQJWR WKHGHILQLWLRQDERYH¶ 
x Un-medicated (with the exception of traditional pain killers or 
antihypertensive drugs) 
x Able to give informed consent 
 
 Exclusion criteria:  
x Under 18 years 
x Pregnancy 
x MRI contraindications 
x Major medical or neuro-psychiatric comorbidities such as: 
o Diabetes 
o Strokes 
o All types of cancer 
o Epilepsy 
o $O]KHLPHU¶VGLVHDVH 
o Chronic hepatitis 
o Chronic renal failure 
 
 
These criteria were selected based on my literature search during 
the first few months of my PhD studies. Having had read several 
structural neuroimaging studies on chronic pain during the period 
of my literature review, I came to know factors and confounders 
that need to be considered when selecting patients. This knowledge 
was further enhanced by discussions with my supervisors and 
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colleagues in the pain centre during our internal scientific 
meetings.  
Due to some recruitment difficulties (acknowledged in the 
limitation section - general discussion part 3) it was quite 
challenging to avoid recruiting elderly patients who have been on 
antihypertensive or diuretic medications.  The impact of such drugs 
on brain volumetric measurements cannot be underrated. 
However, having searched the literature, the exact effect is not 
clearly understood and no studies on such influential relationship 
could be found.  
 
 Healthy control participants 
The aim was to recruit 25 pain-free healthy controls age- and sex 
matched to the knee OA patients. HCs were recruited via posters 
advertised in general public places¶ including libraries, community 
centres and hospitals waiting areas and also through invitations to 
SDWLHQWV¶SDUWQHUV5HFUXLWPHQWSRVWHUFDQEHIRXQGLQDSSHQGL[4) 
 Inclusion criteria: 
x Pain-free and generally fit and healthy  
x Un-medicated (with the exception of occasional acute states 
medication) 
x Age and sex matched to the included knee OA participants 
x Able to give informed consent 
 
 Exclusion criteria 
x Under 18 years 
x Pregnancy 
x MRI contraindications 
x Major medical or neuro-psychiatric comorbidities such as: 
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o Diabetes 
o Strokes 
o All types of cancer 
o Epilepsy 
o $O]KHLPHU¶VGLVHDVH 
o Chronic hepatitis 
o Chronic renal failure 
 
 
________________________________________________________________ 
¶The healthy control recruitment poster was printed out by myself and distributed locally in around 2 
miles radius where it was advertised in public places such as libraries, community centres and 
churches, as well as locally around the Queens Medical Centre, and University of Nottingham 
campus- all with permissions from people in charge whenever required. I also sensibly approached 
patients to invite their partners, if they were interested, to take part as healthy volunteers. I 
acknowledge help and assistance from Maggie Wheeler in speeding up the HC recruitment process by 
advertising the posters in the city hospital and taking a number of posters to public places in her 
local district. 
 
2.1.2.2 Power calculation 
The statistical model provided by Pardoe and colleagues (Pardoe et 
al., 2013) that has been SXEOLVKHG LQ WKH³+XPDQ%UDLQ0DSSLQJ´
journal, was used to calculate how many subjects are required for 
a well-powered cortical thickness analysis.  The model relies 
basically on pre-determined parameters including the cortical 
thickness differences to be detected, smoothing factor, and type I 
error rate. Using these parameters an equation is developed that 
can be run using ³R´ software available at (http://www.r-
project.org/). R is an open access software environment for 
statistical computing and graphics that runs on UNIX platforms. R 
was downloaded on (MacBook Pro 17-inch, Late 2011) for personal 
use by the author.   
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 ³5´VRIWZDUHSDFNDJHXVHGRQ81,;SODWIRUPIRUSRZHUFDOFXODWLRQV 
 
The sample size was powered to detect 0.25mm cortical thickness 
between-group differences, using a smoothing factor of 25mm and 
type one error rate was accepted at 0.05. Therefore, 21 subjects 
were required per group. As there were some cases scanned during 
the pilot study that met the eligibility criteria for the main study, 
these cases were added for added high power at no extra human 
or financial cost. 
 
2.1.2.3 Protocol for MRI scanning 
Prior to scanning, every participant was checked for safety to 
undergo MRI. Safety questionnaire is provided in the appendix 4. 
High reliability of brain morphometric measurements requires 
excellent image quality in terms of spatial and contrast resolutions. 
Freesurfer software package (http://surfer.nmr.mgh.harvard.edu/) 
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used to estimate cerebral cortical thickness, for instance, relies 
mainly on a good contrast between grey matter and white matter 
in one end and grey matter and CSF in the other from the entire 
three dimensional MR volume to produce representations of cortical 
thickness, calculated as the closest distance from the grey/white 
boundary to the grey/CSF boundary in an un-intervened fully 
automated process. Same requirements of good image quality 
apply to the manual and voxel-based morphometric measurement 
techniques.  
 
It is conceivable that higher field strength scanners (e.g. 3T vs. 
1.5T) provide significantly improved anatomical images in terms of 
better signal to noise ratio resulting in improved detailed spatial 
resolution, and better validity and sensitivity to morphometric 
changes as well as a faster scanning time (Schmitt et al., 2004, 
Stankiewicz et al., 2011, Stehling et al., 2007). For all anatomical 
scanning (T1 weighted imaging) of studies included in this thesis, 
MRI was performed at 3T (Discovery 750, GE Medical Healthcare, 
Milwaukee, US) using a 32-channel head coil. 
3D anatomical brain scans were acquired using axial T1 FSPGR-
BRAVO sequence (FOV= 256x256mm, voxel size= 1mm3, 
TE=3.3ms, TR=8.5ms, TI=450, FA=12, Acceleration factor= 2, 
acquisition time= 4min 10s). 
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2.1.2.3.1 . Steps used to optimize MRI scans for morphometric analysis 
The anatomical scanning protocol was developed empirically where 
the same subject (myself) underwent anatomical MR scanning as 
part of an on going REC-approved MRI protocol development 
project. Three candidate protocols with different imaging 
parameters were tested (Fig 1). Each volume of images underwent 
a fully automated step of analysis using Freesurfer  (Mac version 
5.1.0 available online http://surfer.nmr.mgh.harvard.edu/). The 
protocol with which best analysis outcome could be achieved (i.e. 
the least segmentation errors) was selected (by agreement from 
two consultant neuroradiologists and one medical physicist and my 
self) as a standard for all-subsequent scanning of experimental 
studies.  
 
Figure 1: Three T1 scans  (top) with slightly different scanning parameters were used to 
select a protocol with best achievable image quality. Corresponding Freesurfer analysis 
outputs are shown in the bottom row 
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2.1.2.3.2 Diffusion weighted MRI 
Diffusion weighted magnetic resonance imaging (DWI) provides 
image contrast based on the random Brownian motion of water 
molecules in a given voxel. Normally with time there will be a 
chance for an individual molecule to be found at a distance from its 
original location. However, the cellular microstructure, within the 
parenchyma of brain tissue, influences the Brownian molecular 
motion via barriers and compartments formed by tissue 
components such as nerve and glia cells, axons, intracellular 
organelles, myelin sheaths and intra- and extracellular matrix 
(Beaulieu, 2002).  
Using DWI, water motion can be quantified in vivo using T2 
weighted spin-echo sequence and bipolar gradients  (Apparent 
diffusion) (Stejskal and Tanner, 1965). As the image volume is 
formed of a number of voxels, each voxel intensity indicates the 
highest estimate of water molecular diffusion at that particular 
voxel. The motion is detected as attenuation of the signal intensity, 
and the degree of attenuation has been found to proportionate with 
motion of water, for which sensitivity detection can be varied by 
FKDQJLQJWKHJUDGLHQWDPSOLWXGHNQRZQDV³E´YDOXHWKHGXUDWLRQ
of the applied gradient, and the time interval between the paired 
gradients. (Koh and Collins, 2007). In vivo, large diffusion will 
show signal attenuation at small b values whereas restricted 
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diffusion will require larger b values to be detected (Koh and 
Collins, 2007). 
Mean diffusivity (MD) measures the magnitude of water diffusion 
(Schmierer et al., 2007), and is sensitive to pathological disruption 
of brain tissue integrity (Pierpaoli et al., 1996), and to adaptive 
histomorphologial changes following learning tasks as recently 
shown in an animal model (Blumenfeld-Katzir et al., 2011). 
Diffusion weighted images were acquired with the same MR 
scanner using spin-echo echo-planar imaging (EPI) with b=1000 
s/mm2 along 30 evenly spaced and non-collinear directions, plus 
one b=0 volume, TR=5600ms, TE=89.0ms. Voxel sizes were 1.75 
x 1.75 x 2.2 mm3 or 2.2 x 2.2 x 2.2 mm3.  A medical physicist PhD 
student Diane Reckziegel checked quality assurance of DTI data. 
 
2.1.2.4 Participant characterization by questionnaires 
and face-to-face interview 
To carefully phenotype participants and account for potential 
confounders, a set of questionnaires was used to record personal, 
psychological, and pain related characteristics of participants. 
These questionnaires were used based on a number of 
considerations including mainly the ease of administration and 
interpretation, self-reporting whenever suitable, and importantly 
adoption by arthritic pain literature. All questionnaires were 
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checked for completeness on the day of scanning and scored 
exclusively by myself, and will be individually and briefly explained. 
Copies of questionnaires used are included in appendix 4. Face to 
face completion of MoCA, educational level and pain scores was 
performed by myself on the day of scanning. 
1. Edinburgh handedness inventory (EHI) 
EHI (Oldfield, 1971), which is a self-administered questionnaire, 
was used to classify hand dominance of participants. Ten questions 
are asked to assess the hand dominance that relate to preferences 
of hand use in normal daily activities. The score for handedness 
ranges from -100 for strong left-handed to +100 for strong right-
handed.  
Handedness can be assessed by one of two main ways, either by 
asking a number of questions to determine preference or by 
physically testing for performance (Rigal, 1992). However, studies 
have shown that inventory-based preference is a reliable laterality 
indicator relative to the performance test (Raczkows.D et al., 1974, 
Coren and Porac, 1978), and furthermore it is much quicker and 
more convenient to administer without the need for the presence of 
an examiner (Bishop et al., 1996). Various types of criteria from 
different questionnaires are used to determine handedness 
dominance in everyday activities (Bryden, 1977, Chapman and 
Chapman, 1987). However, the advantage of EHI over other 
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available questionnaires is that it is brief and the items of the 
inventory are simple and self-explanatory especially when 
considering use with elderly people, as is the case in the type of 
cohort required for the studies in this thesis. Moreover EHI has 
been widely used in the literature (Veale, 2014), and a simple 
search using web of knowledge (www.webofknowledge.com) 
revealed that the original publication (Oldfield, 1971) has been 
cited more than sixteen thousand times as per 23 December 2014, 
making any results emerging from this work comparable with the 
literature when considering publication. EHI was received by each 
participant either in hand or by post to be filled in and brought by 
the participant on scanning day.  
2. Educational level  
Education scores were derived based on eight ordinal categories 
represent the British education system levels where 1= higher 
degrees and 8= none [modified from (Egerton and Mullan, 2006)]. 
The educational attainment (nature and quality of learning) rather 
than the number of years spent in schooling is believed to imply on 
health status (Feinstein et al., 2006), hence the highest 
educational achievement was recorded by myself for each subject 
during an interview prior to MRI scanning. 
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3. Visual analogue scale (VAS) 
VAS is a 10-cm line starting with zero, which indicates no pain, and 
10 at the end, representing the worst pain imaginable. It is used to 
translate the subjective feeling of pain sensitivity into a quantifiable 
measure. It is a one-dimensional measure of pain intensity and it 
has been widely and reliably used in research and clinical practice 
(McCormack et al., 1988). It is very convenient and almost instant 
to administer and quite easily appreciated by elderly participants 
and furthermore it is recommended by the European Federation of 
Neurological Societies (EFNS) (Cruccu et al., 2004).  
Pain catastrophizing scale (PCS) 
PCS (Sullivan et al., 1995) consists mainly of 13 statements 
regarding various thoughts and feelings while in pain. The scores 
can range between 0 and 52, and subscales for rumination, 
magnification and helplessness levels can be derived.  PCS has 
been widely used and validated in different age groups and 
different cultures (Garcia Campayo et al., 2008, Fernandes et al., 
2012, Sehn et al., 2012, Cho et al., 2013). There are a few 
questionnaires available to measure pain catastrophizing e.g. the 
Catastrophizing scale by Rosenstiel and Keefe (Rosenstiel and 
Keefe, 1983), which is derived as a sub-scale from the Coping 
Strategies Questionnaire (CSQ) by the same researchers with only 
TXHVWLRQVXVHGWRDVVHVVLQGLYLGXDO¶Vcatastrophizing tendency in 
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pain states. The PCS has the advantage of being easily and 
conveniently self-administered and more comprehensive in 
assessing the different components of pain catastrophizing. PCS 
questionnaire was received by each participant either in hand or by 
post to be filled in and brought by the participant on the scanning 
day. 
4. McGill pain questionnaire 
Two indices can be derived from McGill pain questionnaire 
(Melzack, 1975); the pain rating index (PRI), and present pain 
index (PPI). The PRI is scored from a set of descriptive words 
included within 20 questions and ranked in ascending order of 
intensity. Each patient has to select the best word that describes 
his or her pain. Sub-scores for sensory, affective and evaluative 
aspects of pain can be acquired From PRI. PPI is a 5-point (1=mild, 
2=discomforting, 3=distressing, 4=horrible, 5=excruciating) pain 
intensity scale that evaluates the severity of pain as a general 
experience including the present pain in question. Scores for PRI 
can range from 0-78 and for PPI 0-30. 
Several tools are available as measures of pain in adults 
particularly in arthritic diseases. The advantage of using McGill pain 
questionnaire is that it is a multidimensional (sensory, affective, 
evaluative and intensity) measuring tool that gives broad 
information about the various aspects of pain impact upon 
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individuals. Furthermore, McGill pain questionnaire has been 
validated and has shown high reliability (Burckhardt and Jones, 
2003) since its publication in 1975. However, the disadvantage of 
the questionnaire is that it uses a sophisticated wording for pain 
description that may be difficult to understand by non-English 
native speakers and moreover its translation into other languages 
may not always match the exact original meaning (Burckhardt and 
Jones, 2003),  which requires more caution when including people 
from different cultures. McGill pain questionnaire was received by 
each participant either in hand or by post to be filled in and 
brought by the participant on the scanning day. 
5. PainDETECT 
The PainDETECT (Freynhagen et al., 2006) questionnaire records 
the nociceptive and neuropathic components of pain. The scores 
range 0-38 with 0-12 indicating a likelihood of nociceptive, 13-18 
indeterminate, and 19-38 indicating neuropathic-like pain 
components. There are several questionnaires available for 
distinguishing nociceptive from neuropathic pain. For instance, the 
'1 ³'RXOHXU 1HXURSDWKLTXH HQ  4XHVWLRQV´ (Bouhassira et al., 
2005), which combines self-report and physical tests, is another 
useful screening tool, but however it has been criticised for its 
limited sensitivity (Spallone et al., 2012). Other tools are also 
available such as the Leeds Assessment of Neuropathic Symptoms 
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and Signs (LANSS) (Bennett, 2001), The Neuropathic Pain 
Questionnaire (NPQ) (Krause and Backonja, 2003) and others. The 
European Federation of Neurological Societies (Cruccu et al., 2004) 
recommends that most screening tools have been sensitive in 
randomised controlled trials. In addition to its simplicity and self-
administration features, PainDETECT was found among the highest 
tools in terms of sensitivity and specificity, in distinguishing 
neuropathic from non-neuropathic pain components, which was 
recorded at 85% and 80% respectively (Cruccu et al., 2004). 
PainDETECT questionnaire was received by each participant either 
in hand or by post to be filled in and brought by the participant on 
the scanning day. 
6. %HFN¶VGHSUHVVLRQLQYHQWRU\%', 
%HFN¶V'HSUHVVLRQ,QYHQWRU\%',-II (Beck et al., 1996) consists of 
21 multiple choice questions that record the severity of depression 
in participants, and it is widely used in research as well as in 
clinical practice. Scores can range from 0 to 63, though in practice 
the scores threshold for different categories may be lowered to 
increase the sensitivity of detecting symptoms of depression (Beck 
et al., 1996). In research the following scores and corresponding 
indicative categories can be used 0-9; normal, 10-15: minimal 
depression, 16-19; mild to moderate depression, 20-29; moderate 
to severe depression, 30-63 severe depression (Spreen, 1998).   
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The most relevant self-report depression and depressive symptoms 
measuring tools in the research context of musculoskeletal 
disorders according to the review published in the arthritis care and 
research (the official journal of the America College of 
Rheumatology) (Smarr and Keefer, 2011) include DORQJZLWK%HFN¶V
Depression Inventory; the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond and Snaith, 1983), the Patient Health 
Questionnaire-9 (Löwe et al., 2004), the Centre for Epidemiologic 
Studies Depression Scale (CES-D) (Radloff, 1977), and the 
Geriatric Depression Scale (GDS) (Yesavage et al., 1983). BDI has 
been of high research usability making results emerging from this 
thesis comparable with the literature, and furthermore it has 
recorded high sensitivity and responsiveness to change (Smarr and 
Keefer, 2011), rendering it ideal for use in longitudinal studies. A 
concern has been raised that symptoms may overlap between BDI 
and medical conditions (Norris et al., 2004), which requires more 
caution when interpreting any evolving findings. Evidence for 
Reliability (internal consistency Į  (Joe et al., 2008), and 
validity (Grothe et al., 2005), has been independently assessed.   
BDI was received by each participant either in hand or by post to 
be filled in and brought by the participant on the scanning day. 
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7. Spielberger, State-Trait Anxiety Inventory (STAI) 
(STAI) (Spielberger et al., 1983), consists of two questionnaires 
each of 20 items with a 4-point likert scale. The questionnaire 
measures two types of anxiety; state (feelings at present), and 
trait (feelings overall or generally) anxiety, with higher scores 
indicating greater anxiety. Other anxiety screening tools are 
DYDLODEOHVXFKDV WKH³'LDJQRVWLFDQGVWDWLVWLFDOPDQXDORIPHQWDO
GLVRUGHUV´ (Spitzer et al., 1980), the ³Hospital and Anxiety 
Depression Scale (HADS)´ (Zigmond and Snaith, 1983), the ³Beck 
Anxiety Inventory´ (Beck and Steer, 1988), and the ³Anxiety 
Sensitivity Index (ASI)´ (Reiss et al., 1986). However, the ability of 
distinguishing a temporary condition and general tendency of 
anxiety makes STAI a perfect choice to use in assessing both 
short-term and long-term neurological impacts particularly when 
considering the use of functional and structural MRI techniques 
respectively as it is the case in our divisional neuroimaging studies. 
Since its development in 1983, STAI has been widely used as a 
self-report measure of anxiety in research studies and has proven 
high degree of reliability and validity (Quek et al., 2004). It uses 
non-sophisticated wording that can be conveniently self-
administered specially by elderly. STAI was received by each 
participant either in hand or by post to be filled in and brought by 
the participant on the scanning day. 
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8. Montreal cognitive assessment (MoCA) 
MoCA (Nasreddine et al., 2005), is a 30-point test to assess the 
different cognitive aspects of participants including visuospatial/ 
executive, naming, memory, attention, language, abstraction, 
delayed recall, and orientation. The test has been validated to 
detecting a mild cognitive impairment. Scores range from 0-30 and 
a cut-RIIVFRUHRIare considered normal.  It is also available 
in several different languages. 
³0LQLPHQWDO VWDWH´ TXHVWLRQQDLUH (Folstein et al., 1975) is also a 
well-known cognitive impairment measuring tool that has been 
widely used in clinical and research settings (Pangman et al., 
2000). However, studies have shown superiority of MoCA over 
³0LQLPHQWDOVWDWH´LQGHWHFWLRQRIDJH- (Gluhm et al., 2013), and 
neurological disorders- (Oudman et al., 2014) related decrements 
of cognitive functions.  
While the use of MoCA has the advantage of being relatively easy 
to administer (in around 12 minutes on average), I however 
acknowledge that it provides a summary of cognitive performance, 
but does not provide detailed assessment of individual cognitive 
domains.  MoCA was administered by my self during a face-to-face 
interview that involved explanation and giving instruction to 
perform the test prior to MRI scanning.  
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2.1.2.5 Quantitative sensory testing 
Quantitative sensory testing has been widely used to characterize 
sensory and pain perception in both normal and chronic pain 
conditions (Suokas et al., 2012, Pavlakovic and Petzke, 2010). 
Pressure pain thresholds (PPTs) were recorded by a trained single 
rater (MW)ͤ by applying three individual repetitions at the index 
finger, sternum, medial tibia, and at the medial and lateral joint 
lines of the painful knee. Each participant was instructed to press a 
hand-held button (Fig. 2A) as soon as they feel the gradually 
applied pressure is perceived as pain.  Measurements (kPa) were 
obtained using a digital algometer (Somedic AB, Sweden), 
(Fig.2B). The average of the last two readings for the three non-
local sites was used to indicate non-knee PPTs, and those from 
knee joint lines to indicate knee PPTs. 
  
 
Chapter 5: Generic Methods and Characterization of Study Participants 
 
  
96 
 
Figure 2: Mechanical pain threshold examination kit, A: patient response unit, B: 
algometer deep tissue transducer, C: the complete examination kit. Images taken from 
SOMEDIC (www.somedic.com) 
 
 
 
 
 
 
 
 
ͤAll QST data were acquired by Maggie Wheeler (except 2 cases because of 
exceptional incident, I had to acquire data for the subjects under direct guidance 
and supervision by MW). However I carried out the final calculations and data 
input and analysis. 
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2.1.2.6 Image archiving and initial processing steps 
 Anatomical (T1) data 
Data access and protection was in compliance with study protocol 
approved by the local ethics committee. The raw images were 
received in the scanner native format (DICOM), and uploaded from 
DVDs onto the locally protected server in our division (PNJPUCK). 
Using in-house dtoa¸ Unix based programme, DICOM data were 
converted into ANALYZE format which then could be used and 
accepted by 1) 3D Slicer software (Pieper et al., 2006) for manual 
morphometry, 2) SPM8 VBM (Ashburner and Friston, 2000a) upon 
conversion to NIfTI data format using MRIcro¥ for voxel-based 
morphometry, and by 3) Freesurfer 
(http://surfer.nmr.mgh.harvard.edu/) following  conversion by 
Freesurfer (mri_convert) into (.mgz) data (the native Freesurfer 
format), for surface-based (vertex wise) cortical morphometry. 
 
 
 
 
 
¸ In-house software written by Prof. Paul Morgan, University of Nottingham 
(http://www.nottingham.ac.uk/~msapm1/software/dtoa.html) 
¥ Software developed by Dr Chris Rorden 
(http://www.mccauslandcenter.sc.edu/mricro) 
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 DTI and cortical MD analysis 
Diffusion tensor imaging data were analysedڸ using FSL version 5.0 
(Smith et al., 2004). Following eddy correction, brain mask was 
created and non-brain voxels were removed using the FSL brain 
extraction tool (BET) (Smith, 2002). MD maps were derived using 
FSL diffusion toolbox (FDL), and subsequently underwent partial 
volume (PV) correctionڸ using in-house software to account for CSF 
partial volume effects (Jeon et al., 2012, Koo et al., 2009). 
Regional and whole-brain (global) cortical MDs were calculated 
using Freesurfer software package (Unix-based calculation tools), 
as described more fully in chapter X. 
   
 
 
 
 
 
ڸThe preliminary DTI processing analysis was carried out by Diane Reckziegel 
(PhD student) as part of her studies,. I used the output of DTI processing 
including mean diffusivity data for further cortical MD analysis. Calculations and 
analyses of cortical MD metrics were carried out by myself 
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2.1.3 Results 
2.1.3.1 Recruitment of study participants  
The recruitment process resulted in 34 knee OA patients and 22 HC 
being identified as eligible for scanning. Three datasets from knee 
OA patients were excluded due to poor image quality. The final 
imaging data, which passed quality assurance assessment and 
hence were analysed were (n= 53: 31 knee OA patients vs. 22 
HCs). In addition, five subjects were recruited but not scanned due 
to the following reasons; claustrophobia n=2, metal in the eye 
n=1, voluntarily withdraw n=1, and MRI un-safe n=1 (potential 
vascular clips around the heart that was inserted decades ago 
DFFRUGLQJ WR WKH SDUWLFLSDQW¶V GHVFULSWLRQ KRZHYHU QHLWKHU
existence nor absence of risk could be verified, so it was decided 
not to scan). 
 
2.1.3.2 Demographic data 
Knee OA and HC did not differ in age or sex, (Knee OA patients, 
n=31, age= 64.61± 8.36; 15 females) and (Healthy controls, 
n  DJH     IHPDOHV 'HWDLOHG SDUWLFLSDQWV¶
characteristics are shown in table 1. Patients suffered from chronic 
knee pain as their main complaint (17 with dominant right, and 14 
with dominant left knee pain), and had not undergone knee or 
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other joint replacement. Fourteen out of 31 patients were on 
regular medication mostly anti-hypertensive drugs (n=8) or pain-
killers (Paracetamol; n=5, see supplementary data, table1 
appendix X). Healthy controls were pain-free and non-medicated 
except for three subjects. n=1 on Zopiclone for insomnia, n=1 on 
eye drops for glaucoma and n=1 on oestrogens (post-
menopausal), respectively.  
 
2.1.3.3 Pain characteristics 
Most patients described nociceptive or unclear pain symptoms 
according to painDETECT scores (0- µQRFLFHSWLYH¶n=19, 61%, 
13- µLQGHWHUPLQDWH¶ n=9, 29%), with only three (<10%) 
considered to have neuropathic-like symptoms (painDETECT scores 
19-38). For further details on pain-related characteristics see 
Table. 1, and supplementary table 1 appendix X. 
 
2.1.3.4 Psychological and pain-related characteristics 
Knee OA patients and HC showed significant differences only in 
depression and state anxiety scores, where patients exhibited 
higher rates in both scales (p=0.001 and p=0.04 respectively) 
Table 1. 
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Table 1: characteristics of study participants 
 
Age 
(Y) 
Sex 
(M: F) 
BMI H 
(R: L) 
Educ. 
level 
1-8 
MoCA 
Max. 30 
 
BDI 
0-63 
PCS S/ 
Anx. 
T/ 
Anx. 
Pain 
duration 
(Months) 
Ch. Pain 
severity 
0-10 
VAS 
0-10 
Sen-
sory 
0-42 
Affect-
ive 
0-14 
Pain-
DETECT 
0-38 
 
 
 
OA 
Mean 64.61  28.7  4.2 27.4 6.3 11.8 14.3 18.5 114.6 4.8 2.4 11.6 1.2 11.5 
SD 8.36  4.9         2.4  7.5  6 
Median     4 28 7 10 14 17.5 96  2.2  0  
Range 45.4- 
81.0 
 20-39  1-8 20-30 0-19 0-41 10-26 11-37 12-456 1-10 0-9 0-29 0-11 0-25 
Ratio  16:15  28:2  
(1NA) 
            
 
 
HC 
Mean 61.30  26.7  5.7 27.2 2.2 12.1 12 15.6  
SD 7.46  5.4        
Median     6 27 1 11 10 16 
Range 46.8- 
72.9 
 18.9-41.4  1-8 23-30 0-9 0-29 10-23 11-23 
Ratio  9:13  19:3       
P-Value .14§ .44ĭ .16§ .6ĭ .15ĭ .6¶ .001¶ .7¶ .04¶ .16¶ 
 
BMI= Body Mass Index, Education scores based on 8 categories 
represent the British education system levels where 1= higher 
degrees and 8= none [modified from (Egerton and Mullan, 
2006)@  0R&$  0RQWUHDO &RJQLWLYH $VVHVVPHQW %',  %HFN¶V
Depression Inventory. PCS= pain catastrophizing scale, S/T anx. 
= State-trait anxiety. Ch. Pain severity= chronic pain severity; 
average pain intensity over the past four weeks on a scale from 0 
to10. VAS= visual analogue scale. §= Independent t-test. ¶= 
Independent samples Mann-Whitney U Test. ĭ= Chi-squared 
7HVWVRU)LVKHU¶V([DFW7HVWZKHQVDPSOHVL]HLVLQDQ\FHOO. 
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2.1.3.5 Quantitative Sensory Testing (Pressure pain) 
One KOA dataset was discarded due to a technical error. Knee PPTs 
were significantly lower in KOA vs. HC (p=0.03, table 2), but no 
differences were noted in PPT at remote sites.  
 
Table 2: Pressure pain threshROGPHDVXUHPHQWVIRUSDUWLFLSDQWV¶VXEJURXSV 
 Average knee PPT 
KPa (M± SD) 
Average non-knee PPT 
KPa (M± SD) 
Knee OA 
(n=30) 
281.4± 152.4 227.3± 106.5 
HC  
(n=22) 
385.1± 182.9 253.3± 107.2 
P value 0.03 0.39 
SPD 
 (n= 12) 
260.2± 126.1 253.2± 100.6 
LPD  
(n=18) 
295.5± 169.6 210.1± 109.6 
P value 0.54 0.28 
SPD= short pain duration, LPD= Long pain duration, PPT= pressure pain 
threshold 
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2.1.4 Summary 
This chapter explained and summarized the cohort, which will be 
included in the experimental part of this thesis. Some data may be 
quoted in the subsequent chapters; however most information in 
this chapter will be rather referred to from other chapters 
particularly in the methods section of subsequent studies. 
  
2.1.4.1 Study participants  
The recruitment process overall was efficient and the target 
number of knee OA patients was satisfactory achieved. The number 
of HC participants was slightly below target, however this was 
already accounted for in the study design as it was expected, 
based on previous experience, that 20% of data may be non-
usable due to patient and/ or technical factors. Nevertheless the 
sample size was powered enough to detect 0.25mm grey matter 
differences/ changes (Pardoe et al., 2013), and compares 
favourably with most previous morphometric studies.  
 
2.1.4.2 Demographics 
Patients and healthy controls were age and sex matched and 
further more similar in body mass index, handedness preferences, 
and educational levels. However it was difficult in the beginning to 
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matching both groups as responders from healthy volunteers 
tended to be from an age range far younger from patients and 
predominantly from females. Therefore we (I and colleagues, as a 
team studying same participants from different perspectives) had 
to write an amendment to limit the minimum age of healthy 
volunteer to 45 years, which then worked more efficiently.  
2.1.4.3 Psychological and pain-related characteristics 
Compared to healthy controls, KOA presented with similar levels of 
cognitive ability, pain catastrophizing, and trait anxiety. However, 
patients had significantly higher scores of state anxiety (p=0.04) 
and greater depressive symptoms (p=0.001, table 1), ranging from 
minimal to upper limit of mild depression (Spreen, 1998).  Pain 
related depression has been consistently reported in 
epidemiological studies (Munce and Stewart, 2007), however the 
temporal relationship between chronic pain and depression is 
poorly understood (Banks and Kerns, 1996), with some emerging 
evidence that pain is precedential (Hilderink et al., 2012). 
Mechanical pain hypersensitivity recorded locally at the painful joint 
was significantly higher in knee OA patient. No difference could be 
detected for remote sites. 
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2.2 Hippocampal volume in health and 
disease: characteristics in healthy population 
and correlates of chronic pain  
2.2.1 Study I: Hippocampal volume and 
asymmetry in healthy population  
2.2.1.1 Introduction 
Several studies have investigated the hippocampal asymmetry in 
healthy subjects and provided converging evidence that the right 
larger than left asymmetry is present in normal people. A 
systematic review and meta-analysis (Pedraza et al., 2004) of 82 
studies that involved 3564 participants, revealed that there exists a 
significant right larger than left hippocampal asymmetry in a wide 
range of population. However, variations in scanning factors and 
acquisition techniques had a major impact on the outcome of 
volumetric measurements. Studies that used a magnetic field 
strength of less than 1.5 Tesla and/or slice thickness of more than 
2mm were less likely to find asymmetry compared to those of 
higher magnetic field strength and less slice thickness. 
It has been consistently reported that different asymmetry patterns 
in HV occur in patients with certain clinical disorders when 
compared to healthy controls. The direction of the asymmetry has 
been linked to a variety of clinical observations; (1) right larger 
than left, as found in semantic dementia (Barnes et al., 2006), 
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depression (Mervaala et al., 2000), and unsuccessful psychopaths 
(Raine et al., 2004), (2) left larger than right as found in mood 
disorder (Boccardi et al., 2010) and marijuana abuse (Medina et 
al., 2007). (3) The normal asymmetry can be lost in schizophrenic 
patients (Fukuzako et al., 1997). 
An understanding of the normal characteristics of hippocampal 
volumes is essentially required prior to assessing any disorder-
related changes. Hippocampal volume characterization in healthy 
subjects has been widely attempted in a substantial number of 
studies (Woolard and Heckers, 2012b, Watson et al., 1992, Tae et 
al., 2008, Pruessner et al., 2000, Li et al., 2007a, Jeukens et al., 
2009, Jack et al., 1989a, Honeycutt and Smith, 1995). However, 
studies were mostly limited by low magnetic field strength, image 
resolution and slice thickness, which imply that the normative 
ranges provided are not necessarily relevant to current high-
resolution HV studies at 3T and higher (Levy-Reis I, 2000). 
Furthermore, the extent to which HV asymmetry is determined by 
lobar or hemispheric asymmetry is unclear.   
We* conducted a high-resolution and high field strength volumetric 
study with a primary aim of providing characterisation of normal 
hippocampal volume and asymmetry in healthy adults with 
stratification for age and gender. Given that the asymmetry may 
be a consequence of inter-temporal or ±hemispheric volumetric 
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variations, the secondary aim is to attempt an explanatory 
investigation as to whether HV asymmetry can be explained by 
global or lobar inter-hemispheric volumetric variations.  
2.2.1.2 Material and Methods 
Subjects 
Fifty-three healthy adults who were free of any neurological, 
psychiatric and major medical conditions volunteered to undergo 3-
Tesla structural brain MRI scanning as healthy controls in local 
Research Ethic Committee approved neuroimaging studies 
conducted at the Radiological Sciences Research Group of our 
institution. Informed consent was obtained from all participants 
prior to scanning. The mean age was 35.6 years ± 11.8 SD (range 
18-65 years), 31 males and 22 females. Subjects were further 
subdivided into three equal-range age groups 18-33y (n=25; 21 
males), 34-49y (n= 21; 7 males) and 50-65y (n= 7; 3 males). 
 
 
 
 
*Data for this study (ONLY) were collected by previous PhD students (Robert 
Dineen, Antonio Napolitano, Maryam Abaei) as part of their research. However, 
all manual volumetry work and data analysis were carried out solely by myself 
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Data Acquisition and analysis 
MRI scanning was performed using 3 Tesla Philips Achieva Scanner 
and 8-channel head coil. Three-dimensional magnetization-
prepared rapid gradient-echo (3D MP RAGE) T1-weighted images 
were obtained using the following parameters: TE= 3.7ms, TR= 
8.1ms, 1-mm contiguous slices, TI=960ms, FA= 8° and FOV= 
25.6x25.6x16cm. 3D-Slicer, open source software version 2.5 
alpha (Pieper et al., 2006) was used for manual delineation of 
individual hippocampal and intracranial volumes. The software 
allows for exchangeable visualization and tracing of the region of 
interest (ROI) in three different planes as well as an automated 
calculation of ROI volumes. Hemispheric and lobar volumetric 
segmentations were carried out using FreeSurfer image analysis 
package (Jack et al., 1989a, Fischl et al., 1999) version 5.1 
available at http://surfer.nmr.mgh.harvard.edu/. The volumetric 
measurements of different brain structures are obtained following a 
fully automated parcellation process. The technique involves 
assigning a neuroanatomical label to each voxel using probabilistic 
information based on a manually labelled tainting set (Fischl et al., 
2001, Fischl et al., 2004), (Fischl et al., 2002). The segmentation 
technique has been reliably used to detect significant brain volume 
changes (Cerasa et al., 2009, Lehmann et al., 2010, Insausti et al., 
2011).  
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Hippocampal morphometry, boundary definition, and protocol 
development 
3D-Slicer, open source software Mac version 4.1 (Pieper et al., 
2006) was used for manual delineation of individual hippocampal 
and intracranial volumes. The software allows for exchangeable 
visualization and tracing of the region of interest (ROI) in three 
different planes as well as an automated calculation of ROI 
volumes. HV was traced and measured on coronal images with the 
use of sagittal and axial views to aid defining borders and 
complement accurate delineation. To reduce observer bias images 
were duplicated and flipped (Fig. 1), so that all hippocampi were 
outlined on the left side of the image, and the observer blinded to 
image laterality. I carried out all manual segmentations, and high 
intra-rater, and inter-rater reliability against a second experienced 
observer (Dr. R Dineen) using 20% of original data, was achieved; 
intra- and inter-class correlations recorded 92% and 80%; 95% 
CI= 0.73-0.97 p<0.001 and 0.42-0.95 p=0.001, respectively. 
 
Figure 1: Right and left hippocampi segmented on the left side of the image. (A) un-
flipped right and, (B) left hippocampus subsequent to flipping 
  
 
Chapter 6: Hippocampal Volume in health and disease 
 
  
110 
The hippocampal grey and white matters can be differentially 
influenced by gender, disease condition or their interactions 
(Konrad et al., 2009). Therefore, grey matter only was segmented, 
which included (Cornu Ammonis CA, Gyrus dentatus, and 
hippocampal part of subiculum) (Fig. 2). The alveus and fimbria are 
white matter structures in the hippocampal formation that carry 
the hippocampal efferent axons along through the fornix to the 
mammillary bodies or directly to the anterior thalamus respectively 
(Duvernoy, 2005). Both structures were excluded. Anatomical 
boundaries were traced following a tightly defined protocol derived 
from previously published studies (Jack, 1994, Pantel et al., 2000, 
Pruessner et al., 2000, Watson et al., 1992). 
 
Figure 2: Entire length of segmented hippocampus shown on sagittal view (A), and 3D-
Slicer segmented and volume-rendered hippocampus (B), compared to gross anatomy 
(C). Gross anatomy image from (Duvernoy 2005) 
 
Hippocampal boundary definition 
1- Rostral and caudal parts: Prior to manual outlining of 
hippocampus in the coronal view, auxiliary guidelines drawn on the 
sagittal plane were used to provide tangible separation between 
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anterior-most and posterior-most parts of the hippocampus and 
the surrounding non-hippocampal structures. A number of 
delineations were drawn on sagittal slices then switching to coronal 
and scrolling through the slices until the most anterior and 
posterior markers for the hippocampal boundaries are identified. A 
hippocampal anatomy text book (Duvernoy, 2005) was used as an 
external guideline. At the middle segment of the hippocampal tail 
structural modifications appear caudally where margo denticulatus 
extends to form fasciola cinerea, the fimbria ascends to join the 
crus fornix, Cornu Ammonis part CA3 covered with the alveus 
forms gyrus fasciolaris and the CA1 part bulges to form gyrus of 
Andreas Retzius (Duvernoy, 2005). The very terminal parts of the 
tail (Gyrus fasciolaris, Fasciola cinerea, and Gyrus of Andreas 
Retzius) were included. The posterior-most end is defined when the 
crura of the fornix are seen in full profile. 
2- Head of Hippocampus: Superiorly the hippocampal head is 
defined by the alveus and/or cerebrospinal fluid (CSF) of inferior 
horn of lateral ventricle and/or auxiliary sagittal outline. Lateral 
border is delineated by the inferior horn of lateral ventricle. The 
grey/white matter junction between subiculum and 
parahippocampal gyrus demarks its inferior border. The medial 
border is defined superiorly by the CSF in the ambient cistern and 
inferiorly by a straight imaginary line with an angle of ~45° 
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connecting the most inferior part of the hippocampal head medially 
to the ambient cistern (Pruessner et al., 2000). 
3- Body of Hippocampus: Superiorly, the alveus and/or CSF 
and/or choroidal fissure delineate the hippocampal body. The 
temporal stem and inferior horn of lateral ventricle define the 
lateral border. The grey/white matter junction between subiculum 
and parahippocampal gyrus labels its inferior border. The medial 
border is superiorly defined by the CSF in the ambient cistern and 
inferiorly by a line representing the semi-straight OLQHRI OHWWHU µ6¶
formed by the body together with the entorhinal cortex with an 
angle of ~45° connecting the most inferior part of the hippocampal 
body medially to the ambient cistern (Pruessner et al., 2000). 
4- Tail of Hippocampus: Superiorly the tail is defined by the 
quadrigeminal cistern and/or crus fornices. Lateral border is 
determined by the temporal horn of the lateral ventricle. Further 
caudally, crus fornices and CSF of the atrium of the lateral ventricle 
define the tail. The inferior border is demarked by the white matter 
of the parahippocampal gyrus and the CSF of the quadrigeminal 
cistern defines its medial border.  
 
Intracranial volume 
Intracranial volume (ICV) was measured following the method of 
Eritaia et al (Eritaia et al., 2000), which involves ICV 
segmentations at a rate of one every ten slices. The reliability 
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exceeds 0.999 compared to the strategy of ICV measurement by 
segmenting every slice and, as per the study of Eritaia et al, this 
approach allows a 12-fold time reduction in measurement time. 
Results were used to correct HV for differences in head size 
following the adjustment method by Jack et al (Jack et al., 1989b). 
For volumetric normalization of HV the following equation was 
used: 
Normalized HV = raw HV ± [b (ICV ± group mean ICV)], 
where b is the slope of  regression of HV on ICV across the study 
population.    
Asymmetry index 
Asymmetry index (AI) expressed as a R-L percentage difference 
was calculated for each subject as [(R-L)/0.5*(R+L)]*100 
(Galaburda et al., 1990).  To further explore the nature and 
possible ontogeny of any asymmetry identified, we tested for the 
correlation between total raw hippocampal volume (THV) 
comprising the sum of bilateral volumes, and the magnitude of the 
asymmetry index. As argued by Galaburda et al., a negative 
correlation between the two variables indicate that asymmetry 
results from reduction in size of one hippocampus compared to the 
symmetrical condition, a positive correlation indicates that 
asymmetry results from enlargement of one hippocampus 
compared to the symmetrical condition and no correlation indicates 
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that asymmetry results from an increase in volume of one 
hippocampus and a reduction in the other compared to the 
symmetrical condition (Galaburda et al., 1990). 
Statistical Analysis 
Analyses were performed using IBM-SPSS v20. Data were tested 
for normality. Paired t-test was used to determine if there was a 
significant difference between right and left hippocampal volumes 
within the study group, and independent t-test (2-tailed) was used 
to compare corrected mean differences between sexes. ANOVA 
tests were performed to detect any hippocampal volume or 
asymmetry differences between age groups. Correlation analysis 
was performed using Pearson correlation. 
 
2.2.1.3 Results 
Volumetric and asymmetry findings 
Volumetric data for both right and left hippocampi were normally 
distributed. ICV-Normalized measurements in cm3 were as follow: 
Right HV =2.51± 0.28; Mean± SD with a range of (1.94±3.07). 
Left HV= 2.45±0.29; Mean± SD, with a range of (1.96±2.93). 
Right larger than left HV (Fig. 1) was found significant (p=0.028), 
and the significant right larger than left relationship was 
maintained, though the mean hippocampal asymmetry index was 
reduced by 11%, when HV was normalized to ipsilateral temporal 
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lobe (p=0.045) (Fig. 2b). A reduction by 15% in the mean 
hippocampal asymmetry index, only suggestive a trend for 
rightward asymmetry, was achieved when controlled for ipsilateral 
hemisphere volumes (p=0.06) (Fig. 2c). Asymmetry index ranged 
from -15.2 to +19.7 (+2.5± 8.1, mean± SD) with right dominance 
was prevalent (Fig 2a). Table 1 summarizes the volumetric and 
asymmetry results.  
 
Figure 1: Raw right and left HV in all participants. Error bars represent mean±1SD  
 
 
Figure 2: Diagrams of asymmetry index (Mean and SE for all subjects). A: Hippocampal 
raw volumes, B: Hippocampal volume normalized to ipsilateral temporal lobe, C: 
Hippocampal volume normalized to ipsilateral hemisphere 
 
  
 
Chapter 6: Hippocampal Volume in health and disease 
 
  
116 
Table 1: Hippocampal, lobar and hemispheric volumes and asymmetry  
 Volume (cm3) 
Mean± SD 
p Value AI  Mean± SD 
Raw Rt. HV 
Raw-Lt. HV 
2.51± 0.32 
2.45± 0.31 
0.028 (+)2.51±8 
Rt. HV-N-ICV 
Lt. HV-N-ICV 
2.51± 0.28 
2.45± 0.29 
0.027 (+)2.54±8 
Rt. HV-N-Rt. Temp. 
Lt. HV-N-Lt. Temp. 
2.52± 0.25 
2.47± 0.25 
0.045 (+)2.25±7.6 
Rt. HV-N-Rt. Hem. 
Lt. HV-N-Lt. Hem. 
2.52±0.26 
2.47± 0.24 
0.06 (+)2.15±8.1 
Rt. Temporal Volume 
Lt. Temporal Volune 
54.32± 6.73 
56.10± 7.76 
0.0001 (-)3.03±5.3 
Rt. Hemisphere 
Volume 
Lt. Hemisphere 
Volume 
511.27± 50.58 
511.58± 52.10 
0.74 (-)0.03±1.2 
HV= hippocampal volume, Rt.= right, Lt.= left, ICV= intracranial volume, N= normalized to, 
Temp= temporal lobe, Hem= hemisphere. Paired t-test was used to test for significant difference 
between right and left HV. 
 
Effect of age and gender 
HV decreased bilaterally and significantly with increasing age (right 
-0.0137cm3/year; left -0.0130cm3/year (p< 0.02). There was a 
significant difference (p< 0.05) in total hippocampal volume 
between age groups, but not between sexes (p> 0.6) men= 4.99± 
0.51 and women= 4.93± 0.54 (mean± SD). Age did not show any 
significant correlation with any asymmetry. No significant 
differences were found between age groups for either raw or 
normalized asymmetry data p>0.4 ANOVA, nor between sexes 
p>0.09 independent t-test.  
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Correlation of raw total hippocampal volume with asymmetry index 
There was no significant correlation between raw total HV and raw 
asymmetry index scores (r=-0.01; p>0.9) (Fig. 3). 
 
Figure 3: Scatterplot of total raw hippocampal volume and asymmetry index scores, with 
regression line showing absence of correlation (r=-0.01; p> 0.9) 
 
2.2.1.4 Discussion  
We provide hippocampal volumetric measurements in normal 
adults using high resolution and high magnetic field strength 
data. In our segmentation protocol we endeavoured to minimize 
any anatomical inaccuracy using a tightly defined protocol aided by 
conjoint reference of classic anatomy books and modern software 
techniques. We attempted to reduce any rater-dependent laterality 
bias in segmentation by using the flipping technique, which has 
shown to fundamentally eliminate putative right-left asymmetry 
observer bias (Maltbie et al., 2012). Our results are largely 
consistent with previously published studies and meta-analysis 
(Honeycutt and Smith, 1995, Li et al., 2007b, Pedraza et al., 2004, 
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Shi et al., 2009). However, there has been marked heterogeneity 
in the values reported among different studies with a mean 
hippocampal volume ranging from 1.73 to 5.68 cm3 (Honeycutt 
and Smith, 1995). Sample heterogeneity, methodological issues 
such as image acquisition and processing, anatomical boundary 
definition, and structural inclusion/exclusion criteria may account 
for this variation. Konrad et al., (Konrad et al., 2009) reviewed 71 
different published anatomical protocols and ascribed major points 
of discrepancy to 1) inclusion/ exclusion of while matter 2) the 
definition of the anterior-superior border of the head 3) the 
terminal part of the tail 4) the inferior-medial border and 5) the 
use of varying arbitrary lines.  To date, there has been no 
consensual hippocampal volumetry protocol to adhere to, though 
an attempt by a multicentre group is under-development to 
harmonize a standard and shared protocol (www.hippocampal-
protocol.net/). 
Significant although modest right-dominant HV asymmetry was 
found in the studied cohort, although left-dominant asymmetry was 
present in a number of individuals (Fig 1). The asymmetry was 
found across all age and gender groups without significant 
differences between groups. This is consistent with the outcome of 
hippocampal asymmetry meta-analyses by (Pedraza et al., 2004) 
and (Shi et al., 2009).     
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Our data suggest that a relatively small part of hippocampal 
asymmetry is explained by lobar and hemispheric volume 
differences.  By accounting for temporal lobe asymmetry, the mean 
hippocampal asymmetry index was reduced by 11% but remained 
significantly right dominant. A similar magnitude of reduction by 
15% in hippocampal asymmetry was achieved when ipsilateral 
hemispheric volume variation was accounted for, and the right 
dominance was no longer significant.  
We explored the possible ontogenic basis for hippocampal 
asymmetry by testing for correlation between total raw 
hippocampal volume and magnitude of asymmetry index, and the 
lack of correlation identified suggests that the asymmetry is likely 
to be due to a conjoint bilateral change involving an increase in the 
right hippocampal volume and a reduction in the left hippocampal 
volume relative to the symmetrical condition. It is however 
conceivable that the right ward hippocampal asymmetry could exist 
in early developmental stages at neonatal age (Thompson et al., 
2009). This may suggest that genetic, developmental and 
environmental factors are influential. On the other hand molecular 
and functional asymmetry may as well be predictive of the 
structural asymmetry (Hou et al., 2013). The right hippocampus 
has been strongly linked to the spatial memory and navigation 
(Smith and Milner, 1981, Kessels et al., 2001) and further more 
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neurogenesis in the sub-granular zone of the dentate gyrus is now 
a well established fact that can be activity dependent (Ma et al., 
2009, Ming and Song, 2005). 
In a relatively larger sample size study of 110 healthy adults 
(Woolard and Heckers, 2012a), it was found that the raw right 
ward asymmetry is limited to the anterior part of hippocampus. 
This would probably highlight the need for further evaluation of 
sub-divisional hippocampal volumetric in future studies.  
Although our study is large compared to many published studies, it 
remains limited by the overall small sample size and in particular of 
elderly subjects. We were unable to investigate the effect of 
handedness as the study was limited by very few number of left 
handed participants compared to right handed. 
 
2.2.1.5 Conclusion 
In conclusion, we confirm the right ward hippocampal asymmetry 
in healthy adults, which is neither age, nor sex dependent.  The 
findings show that hippocampal asymmetry is in part explained by 
hemispheric asymmetry. Accounting for hemispheric volume 
reduced hippocampal asymmetry by 15% such that the significant 
hippocampal asymmetry was no longer present. Researchers who 
relate hippocampal asymmetry to disease states need to be aware 
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that associations with hippocampal asymmetry may in part reflect 
hemispheric asymmetry as opposed to specific asymmetry of the 
hippocampi. 
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2.2.2 Study II: Hippocampal volume and 
cognitive function in chronic pain due to knee 
osteoarthritis 
2.2.2.1 Introduction 
The hippocampus, a crucial limbic area best known for its role in 
cognition (particularly learning and memory), is one of the most 
widely investigated regions of the brain. Advances in neuroimaging 
and volumetric techniques have exquisitely enabled in-vivo 
quantification of magnetic resonance-based hippocampal 
volumetry. Relatively recently, hippocampal volume (HV) has been 
a research target for studies concerned with imaging biomarkers of 
neurological and neuropsychiatric diseases. Significant changes in 
the HV have been described in a number of clinical conditions 
LQFOXGLQJ $O]KHLPHU¶V GLVHDVH (Convit et al., 1997, Kramer et al., 
2004, Prestia et al., 2011), depression (Baare et al., 2010, Beyer 
et al., 2004, Bremner et al., 2000, Javadapour et al., 2010, Lloyd 
et al., 2004, MacMaster and Kusumakar, 2004), epilepsy 
(Briellmann et al., 2002, Marsh et al., 1997), schizophrenia 
(Koolschijn et al., 2010, Seidman et al., 2002), post-traumatic 
stress disorder (Wignall et al., 2004), and lately in association with 
chronic pain (Mutso et al., 2012).  
The impact of chronic pain on hippocampal volume (HV) however 
has been minimally explored and remained largely controversial. 
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HV reduction was reported in some chronic pain states 
(Zimmerman et al., 2009, Mutso et al., 2012), with some evidence 
that stress (Vachon-Presseau et al., 2013) or depression (Brown et 
al., 2002) may be mediating factors. Conversely, a meta-analysis 
of morphometric studies of wide chronic pain aetiologies 
(Smallwood et al., 2013a) reported an enlargement of HV in 
association with chronic pain. The published studies, were however 
limited by the use of automated volumetric techniques (Mutso et 
al., 2012) and studies reviewed by Smallwood et al (Smallwood et 
al., 2013a), which is arguably considered less advantageous over 
manual volumetry (Cherbuin et al., 2009, Morey et al., 2009, Shen 
et al., 2010), or further limited by small and heterogeneous sample 
sizes (Zimmerman et al., 2009).  
 
The impact of chronic pain on hippocampal function has been 
intensely investigated in animal models (Mutso et al., 2012). Mutso 
and co-workers found that persistent neuropathic pain significantly 
affected the neurogenesis in the sub-granular zone of 
hippocampus. Moreover, when compared with pain-free controls, 
mice with neuropathic-like persistent pain exhibited behavioural 
abnormalities and showed less cellular quantity per hippocampal 
slice. The investigators emphasized 0that this was indicative of a 
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decrease in neurogenesis rather than degeneration, as revealed by 
bromodeoxyuridine (BrdU) labelling. 
 In the same aforementioned study, hippocampal volume was also 
assessed in three different chronic pain conditions in humans 
(chronic back pain CBP, complex regional pain syndrome CRPS, 
and knee OA) in reference to healthy controls, n=15 each. It was 
found that bilateral hippocampal volumes were significantly smaller 
in CBP and CRPS but not in OA patients relative to healthy controls, 
suggesting that hippocampal volume may be differentially affected 
by distinct chronic pain syndromes. In another study by 
Zimmerman et al (Zimmerman et al., 2009), a trend for smaller 
hippocampal volume (p=0.06) was found in a 20 non-demented 
elderly patients with chronic pain. However the study can be 
criticized for the heterogeneity of the studied cohort, which 
collectively included patients with OA, peripheral neuropathy and 
spinal stenosis.  
Chronic pain related cognitive changes were not evaluated in either 
of the aforementioned studies. It is conceivable that pain 
experience involves cognitive-evaluative as well as sensory-
discriminative and motivational-affective dimensions (Melzack R. 
and Casey K., 1968). Previous work suggests that chronic pain is 
associated with cognitive dysfunction. There have been several 
studies, reviewed by Moriarty and others (Moriarty et al., 2011), 
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reporting that chronic pain patients evidence more cognitive 
dysfunction compared to pain-free matched controls. However, in 
the same review, authors also presented a percentage of studies 
5/30 that reported no association between chronic pain and 
impaired cognitive function. Moreover, the affected cognitive 
domains may vary between different chronic pain aetiologies. For 
example, in chronic fatigue syndrome (involves widespread muscle 
and joint pain) and fibromyalgia, impairments in learning and 
working memory were noted, but processing speed (impaired in 
chronic fatigue syndrome) and attention (impaired in fibromyalgia) 
were differentially affected (Glass, 2006). In a study of 
musculoskeletal pain, 32% of patients (n=73) had cognitive 
impairment in at least one cognitive domain (Kewman et al., 
1991).    
The pain influenced cognition is further evidenced from studies e.g. 
reporting incrementally reduced cognitive performance (working 
memory) with increasing levels of experimental painful stimulation 
(Buhle and Wager, 2010), and others reporting cognitive 
improvements upon pain relief (Jamison et al., 2003, Tassain et 
al., 2003),W¶VEHHQVXJJHVWHGWKDWSDLQDIIHFWVFRJQLWLYHIXQFWLRQ
particularly on tasks that require attention that is already being 
diverted to coping with pain (Park et al., 2001).  
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The mechanistic basis of pain related cognitive impairment is 
however poorly understood and remains open to speculations, with 
some researchers proposed that persistent pain emerge over other 
demands for attention (Eccleston and Crombez, 1999), while 
others suggested that chronic-pain related neuroplastic changes 
impact upon brain functions including cognition via e.g. 
connectivity reorganizations (Hart et al., 2000). However, the 
exact neurobiological mechanism remains largely unknown. 
Moriarty and colleagues (Moriarty et al., 2011) proposed a model 
based on three potential mechanistic theories (though not tested) 
that may explain the pain-related cognitive impairment namely; 1) 
limited resources, 2) altered neuroplasticity, and 3) dysregulated 
neurochemistry. Theories 1 and 3 are beyond the scope of this 
thesis, therefore the focus of the current study will be directed to 
the pain-related structural neuroplasticity; namely the hippocampal 
volume correlates of chronic pain and its putative linking role 
between chronic pain and impaired cognition.  
 
Hippocampal volume measured by magnetic resonance imaging 
has been consistently shown as a strong predictor of cognitive 
decline in non-painful conditions (den Heijer et al., 2010, 
Grundman et al., 2002, Wolf et al., 2001), and depression is 
consistently known to impact on hippocampal volume (Campbell et 
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al., 2004, Videbech and Ravnkilde, 2004). It is not clear whether 
persistent arthritic pain, a primarily nociceptive disorder, is 
associated with hippocampal volume change, and putatively related 
cognitive impairment and low mood. 
 
2.2.2.2 Aims and hypothesis 
The aim of this study is to investigate the HV, cognitive function 
and mood in patients with chronic painful knee OA. I hypothesize 
that: Chronic knee OA pain is associated with a reduction in 
hippocampal volume and patients will show global cognitive and 
delayed recall memory dysfunction, and these two; HV loss and 
cognitive decline are associated, with the former also linked with 
low mood. 
 
2.2.2.3 Methods 
Subjects 
A detailed description of participants recruited for this study is 
provided in chapter 5. In brief, all patients (n=31, age= 64.61± 
8.36; 15 females) and all pain-free healthy controls (n=22, age= 
61.30± 7.46; 13 females) were included. 
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Data acquisition  
Brain magnetic resonance imaging 
Brain MRI has bee described in details in chapter 5. In summary, 
data acquisition involved the used of 3T scanner (Discovery 750, 
GE Medical Healthcare, Milwaukee, US) with a 32-channel head 
coil, to acquire 3D structural brain scans at a native resolution of 
1mm3. 
 
Global cognition and delayed recall  
Cognitive ability was assessed during a face-to-face interview using 
MoCA test (described previously in chapter 5), and a delayed recall 
data was derived from a sub-scale in the MoCA test defined as the 
ability to remember a list of 5 words following two trials of 
immediate recall and a third, for which the score is appointed, after 
a short period of time occupied by some other questions in the 
assessment. To investigate the HV correlates of depression and to 
control for its coQIRXQGLQJ HIIHFW %HFN¶V 'HSUHVVLRQ ,QYHQWRU\
(BDI) (Beck et al., 1996) was used to assess depressive symptoms 
in all participants.  
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Volumetric methodology 
Hippocampal volumetry and intracranial volume measurement 
Measurements were performed using same protocol as in study I. 
Statistical analysis 
Analyses were performed using IBM-SPSS v20. Data were tested 
for normality. Independent t-test (2-tailed) was used to compare 
corrected mean differences between groups for volumetric data, 
and independent samples Mann-Whitney U test was used for 
between group comparisons of depression and cognitive data. 
ANCOVA tests were performed to account for age and sex, and 
correlation analysis was performed using Pearson correlation. 
 
2.2.2.4 Results 
Cognition and depression levels in all participants 
General cognition, delayed-recall memory, and depression results 
in KOA patients and controls are shown in table 1.  
Similar cognition and delayed recall scores were noted in KOA 
patients relative to HCs. KOA patients however, recorded 
significantly higher levels of depression, however still subclinical in 
the range of minimal to moderate depression (Spreen, 1998).  
(As described previously in chapter 5, educational status, 
handedness, and body mass index were similar in both groups). 
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Table 1. Cognition and depression data of KOA patients vs. HC 
 MoCA 
0-30 
Delayed 
recall 
(0-5) 
BDI 
(0-63) 
KOA: 
Mean 
Median 
Range 
 
27.4 
28 
20-30 
 
3.77 
4 
1-5 
 
6.32 
7 
0-19 
HC: 
Mean 
Median 
Range 
 
27.2 
27 
23-30 
 
3.41 
3.5 
0-5 
 
2.19 
1 
0-9 
p-value* =0.63 0.34 =0.001 
KOA= knee osteoarthritis, HC= healthy control, MoCA= Montreal cognitive assessment, BDI= 
%HFN¶VGHSUHVVLRQLQYHQWRU\*Based on Independent samples Mann-Whitney U test. 
 
Volumetric results 
Hippocampal and intra-cranial volumes were normally distributed. 
Results are summarized in table 2. On average, KOA patients had 
significantly larger HV bilaterally Fig. 3, however ICV was similar 
among groups. 
 
Table 2. Volumetric data (cm3) for ICV and normalized (right and left) 
hippocampal volumes represented as mean (SD) 
 N-Rt. HV N-Lt. HV ICV 
KOA 2.24 (0.31) 2.16 (0.26) 1498.6 
(157.4) 
HC 2.06 (0.26) 1.92 (0.28) 1489.5 
(155.4) 
p-value* =0.031 =0.003 =0.84 
N-Rt. and N-Lt HV= normalized left and right hippocampal volumes. ICV= intracranial volume. 
*Based on independent samples t-test. 
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By accounting for age and sex (ANCOVA), differences remained 
significant for Rt. HV (2.26± 0.05 vs. 2.03± 0.06, adjusted mean± 
std. error; F=8.5 p=0.005), and for Lt. HV (2.18± 0.04 vs. 1.89± 
0.05, adjusted mean± std. error; F=16.2 p<0.001), and continued 
non-significant for ICV (F= 0.5 p=0.49).   
 
Figure 3. Box-plots showing normalized hippocampal volumes in KOA patients compared 
to HCs 
 
Hippocampal volume correlates of pain-related behaviours and pain 
characteristics  
No significant correlation was found, in KOA group, between right 
or left HV and cognitive ability, delayed recall or depression, 
controlled for the partial effects of age and sex.  
Partial correlation analysis (controlled for age and sex) between HV 
and pain duration, chronic pain severity, and affective and sensory 
components of pain, showed only a significant moderate positive 
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correlation between pain duration and left HV (r=0.4 p=0.03). 
Cognition in HC correlated significantly with left HV (r=0.52 p=0.02 
controlled for age and sex). 
 
2.2.2.5 Discussion 
The main aim of this study was to investigate the putative impact 
of chronic pain due to knee OA on hippocampal volume and 
FRJQLWLYH IXQFWLRQ +RZHYHU WKH QXOO K\SRWKHVLV WKDW µWKHUH LV QR
pain-related cognition G\VIXQFWLRQ¶ FRXOG QRW EH UHMHFWHG LQ WKLV
cohort. Interestingly, the hippocampal volume in knee OA patients 
was on average significantly larger than that in age- and sex-
matched healthy controls. The next intriguing question that 
naturally follows is that why hippocampal volume would not only be 
preserved but also showing significant enlargement in this cohort? 
This is contradicting and inconsistent with what has been reported 
by others (Mutso et al., 2012, Zimmerman et al., 2009), i.e. 
smaller HV associated with chronic pain. However, Mutso et al 
studied three chronic pain condition including knee OA, but 
interestingly HV was found reduced in all but the knee OA group, 
which authors attributed to the uniqueness of brain profiles (and I 
presume, also behavioural changes such as mood and cognition as 
a consequence) in different chronic pain states. 
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Mutso and colleagues highlighted that the variance in neuropathic 
component of chronic pain among different conditions may be 
accountable for such neurobiological differences. The two groups 
studied by Mutso et al, where patients had smaller HV namely; 
chronic back pain and chronic regional pain syndrome both were 
potentially having larger neuropathic component (Mutso et al., 
2012). The neuropathic-like component in this studied cohort was 
investigated previously (by myself) using the PainDETECT 
questionnaire (Freynhagen et al., 2006), and it was found that only 
less than 10% of patients were considered to have neuropathic-like 
symptoms which was also consistent with independent knee OA 
study (Ohtori et al., 2012), involved 92 patients where only 5.4% 
and 15.2% were fouQG WR µOLNHO\¶ DQG µSRVVLEO\¶ KDYH QHXURSDWKLF
component respectively. The hypothesis of neuropathic influential 
role on HV is supported by preclinical studies of neuropathic models 
WKDW VKRZHG UHGXFHG QHXURJHQHVLV UDWH LQ UDW¶V KLSSRFDPSXV
(Mutso et al., 2012), and a functional disturbance in the fronto-
hippocampal circuits that resulted in neuropathic pain-related 
working memory deficits in rats as recently shown by Cardoso-Cruz 
and co-workers (Cardoso-Cruz et al., 2013). 
 
Very few medications are know to induce HV enlargement such as 
Lithium (Yucel et al., 2008), which enhances neurogenesis as found 
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in preclinical studies (Chen et al., 2000), but none of the studied 
patients were taking Lithium for medical purposes.  Medications 
taken for pain and disease-related comorbidities may on the other 
hand induce significant volumetric reduction. Opioid analgesics, for 
instance, are known to rapidly alter grey matter volume in several 
brain regions in as short as one month of regular administration as 
shown by Younger and other researchers in a study where 
hippocampus was among three regions which had shown 
volumetric decreases (Younger et al., 2011). 
Several studies have documented opiates chronic use-related 
inhibition of neurogenesis and apoptosis both in animals (Hauser et 
al., 2000, Mao et al., 2002) and in human (Hu et al., 2002) with 
particular impact on cognition and memory. A recent review on the 
impact of psychotropic drugs on hippocampal neurogenesis in adult 
animal models was conducted by Kubesova et al, (Kubesova et al., 
2012), and authors presented compelling evidence that high doses 
of opiates can have a negative impact on neurogenesis via different 
molecular mechanisms, and consequently may result in cognitive 
impairment during drug withdrawal as well as induction of anxiety 
and depression upon chronic use. Medication intake for this studied 
cohort was documented (see appendix 4 supplementary table 1), 
and only five patients were on regular, but simple analgesics 
namely; Paracetamol alone, except one patient was regularly 
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taking Paracetamol along with Aspirin. As 5 patients only out of 31 
were on regular, yet non-opioid painkillers, one may hypothesise 
that the non-negative impact of chronic pain on either HV or 
cognition seen in this cohort may be attributed to the lack of effect 
from strong medications taken for pain. However, the moderating 
effect of medication on cognition in chronic pain need to be 
confirmed and it warrants further investigation.  
 Depression status was evaluated in the studied participants, and 
chronic painful KOA was found associative with more depressive 
disorders in sufferers relative to matched controls. This is plausible 
in the light of large body of evidence from large-scale surveys and 
chronic pain reviews, which showed that 21% of patients with 
chronic pain had been diagnosed with depression because of their 
pain (Breivik et al., 2006b).  Chronic pain and depression may 
exacerbate one another (Morley, 2008), and furthermore may 
share a similar neurotransmitters and mechanism of action of 
therapeutic pharmacological drugs (Goesling et al., 2013).  
Brown and co-workers found in a structural equation modelling 
analysis that depression significantly mediated the relationship 
between chronic pain and cognitive functioning in one hundred and 
twenty one rheumatoid arthritis patients (Brown et al., 2002). 
Although the hippocampal volume was not investigated, their 
findings may suggest a hypothetical bio-psychological model in 
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which chronic pain leads to depression, which results in reduced HV 
with subsequent impact on cognition. Similar mediating model was 
presented with stress a potential factor mediating chronic pain and 
reduced HV (Vachon-Presseau et al., 2013). However, the 
outcomes of this study argue against this model, as both cognition 
and HV were preserved, and no link could be found between 
depression and HV, although only few of the patients had mild to 
moderate, but no one had clinical depression. 
The finding of larger HV found in the studied population is well in 
line with the outcome of a meta-analysis involved 23 chronic pain 
imaging studies (Smallwood et al., 2013a). However, the 
mechanism by which HV changes in either direction remains 
intriguingly unknown.  
 
2.2.2.6 Conclusion 
In this study, sufferers of chronic pain due to knee osteoarthritis 
presented with larger hippocampal volumes, normal cognition but 
lower mood relative to matched controls. It can be concluded that 
persistent arthritic pain, a model of chronic nociceptive pain does 
not reduce hippocampal volume nor impair cognition, and stress 
related HV loss does not explain the observed mildly lower mood. 
In contrast, the chronic pain experience seems to increase HV 
perhaps due to an unknown mechanism warranted further studies 
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to characterize the complex role of the hippocampus in pain 
progression.  
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2.3 Anterior cingulate cortex in chronic 
pain: The relationship between sub-regional 
volumetric and cortical thickness and the 
behavioural and phenotypic features of 
chronic OA knee pain 
The anterior cingulate cortex (ACC) is one of the largest limbic 
regions (MacLean, 1990), and anatomically considered part of the 
ventromedial frontal cortex encompaVVLQJ %URDGPDQQ¶V DUHD 
and adjacent regions (Gasquoine, 2013). It is a key structure 
involved in emotion, cognition, and executive functions (Carter et 
al., 1999, Stevens et al., 2011). ACC is often subdivided into two 
major parts; dorsal ACC (dAC&FRPSULVHV%$E¶-F¶DQG¶)LJ
1) and is thought to be associated with attention and cognitive 
functions (Bush et al., 2000, MacDonald et al., 2000), whereas the 
rostral-ventral part (includes BA 24a-c and 32 and ventral areas 25 
and 33; Fig 1) is engaged in emotional and affective behaviours 
(Devinsky et al., 1995, Vogt et al., 1995).  
 
Figure. 1: A Schematic representation of cytoarchitectural areas of dorsal (red) and 
rostral-ventral (blue) parts of ACC [modified from (Bush et al., 2000)] 
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With recent advances in structural and functional neuroimaging 
techniques, a better and more specific localization of functional 
characterizations of ACC sub-divisions has been achieved. For 
example, a four-region model of the ACC has been defined on 
structural imaging based on individual microscopic and functional 
properties (McCormick et al., 2006) to allow investigation of 
specific volumetric correlates of various brain related disorders. 
McCormick and colleagues developed an MRI-based segmentation 
protocol that enabled a reliable investigation of the volumetric 
features of ACC sub-regions namely the dorsal, rostral, subcallosal, 
and subgenual parts Fig 2. 
 
Figure 2: the ACC, divided into 4 distinct regions (dorsal, rostral, subcallosal and 
subgenual) using landmarks-based planes A, B and C. From  (McCormick et al., 2006) 
 
The ACC plays a major role in chronic pain processing (Jones and 
Derbyshire, 1996), and is considered a pivotal region in the medial 
pain system (Vogt et al., 1993), which is concerned with the 
affective-motivational and cognitive-evaluative dimensions of pain 
  
 
Chapter 7: Anterior Cingulate Cortex in Chronic Pain  
 
  
140 
response (see chapter 1). It is now recognized that individual parts 
of ACC are differentially engaged in mediating distinctive aspects of 
pain and pain-related emotions (Vogt, 2005).  In this chapter, 
which will be centred primarily on the morphological changes of 
ACC in chronic pain, the structural correlates of ACC sub-divisions 
of chronic pain in knee OA will be investigated in two separate 
experiments, in accordance with the functional characterization of 
each sub-region.     
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2.3.1 Study I: The anterior cingulate sub-
regional volumetric correlates of behavioural 
features in chronic painful knee OA  
2.3.2 Introduction 
Recently, functional magnetic resonance imaging has provided an 
outstanding advance in localizing different aspects of pain with 
their neural substrates. The brain regions that are involved in 
processing sensory and affective components of pain, for example, 
can be disentangled in terms of spatial localization, as shown in an 
empathy-for-pain study which revealed involvement of affective 
(mainly activation of anterior insula and rostral ACC) but not 
sensory aspects of pain (Singer et al., 2004).   
In this study, the volumetric changes of ACC parts will be studied 
in accordance with the following rationales: 
1- Cognition and attention: Dorsal ACC is implicated in 
cognition and attention, and pain seems to impose a 
negative impact on these functions and interrupt cognitive 
processing (Buffington et al., 2005), or divert attention 
towards pain (Eccleston and Crombez, 1999).  dACC appears 
to play a mediating role between pain and cognitive 
disruption (Davis et al., 1997). Buffington et al investigated 
the activation patterns in the ACC during cognitive task 
performance using fMRI in patients with persistent pain due 
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to knee OA as well as in healthy controls, and found that the 
ACC activation patterns were different between the two 
groups such that healthy subjects showed more diffuse 
activations compared to knee OA patients (Buffington et al., 
2005). 
2- Affection and emotions: The ACC has been consistently 
shown to code for affective dimensions of pain (Rainville et 
al., 1997, Sawamoto et al., 2000), including unpleasantness 
and suffering (Vogt et al., 1996). Spatial dissociation studies 
of anterior cingulate function revealed evident recruitment of 
rostral part (Fig 3) in affective-emotional processing (Whalen 
et al., 1998), and deactivation during cognitive task 
performance.  
 
Figure 3: (A) Significant activation of rostral ACC during negative- compared to neutral 
word presentation block. (B) Decreased fMRI signal during task performance. [Adapted 
from (Whalen et al., 1998)]  
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Although pain is consciously perceived as a uniform experience, 
it is not uniformly engaged throughout the brain or the 
cingulate (Vogt, 2005).  A meta-analysis (Vogt et al., 2003) of 
PET or fMRI studies of healthy subjects that monitored 
recognition, recall, and retrieval of emotional material revealed 
45 cingulate activations, (plotted on the medial surface, Fig 4). 
Sites activated by sadness or happiness were distinct from 
those activated by fear or anger Fig 4. 
 
Figure 4: Activation sites in ACC in association with specific emotion: happiness (yellow), 
sadness (blue), anger (red), and fear (green). Courtesy (Vogt et al., 2003) 
 
It has been postulated that the subgenual ACC (sgACC) (BA 25) 
shows sad events-related activation that is associated with 
personal events and not necessarily with the noxious 
stimulation (Vogt, 2005). Vogt argues that the sadness 
paradigms used to provoke subgenual activity may not be 
relevant to the individual pain-induced internal state. The 
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affective-emotional correlates of ACC volume in chronic knee 
OA pain that will be investigated in this study will be spatially 
limited to the rostral parts which comprise rostral and sub-
callosal (BA 24a-c, 32 and 33), but not the sub-genual ACC. 
The sub-genual part is however largely involved in depressive 
and mood disorders (Drevets et al., 2002), that was further 
reflected by an abnormal reduction in subgenual GM volume in 
association with major depressive disorder and bipolar disorder 
(Drevets et al., 2008). Interestingly, post-mortem neuro-
pathological assessment of subgenual ACC confirmed GM 
reduction and revealed a decrease in glial cells but not neurons 
as per Drevets et al.  
(The sub-divisional definitions used in this chapter are in 
accordance with the terminology used by McCormick et al in 
their volumetry protocol, which was adapted for the ACC 
volumetric measurements. The rostral part is also known as 
pre-genual in the ACC literature).  
 
3- Pain catastrophizing: 3& LV GHILQHG DV ³DQ H[DJJHUDWHG
negative mental set brought to bear during actual or 
DQWLFLSDWHG SDLQIXO H[SHULHQFH´ (Sullivan et al., 2001). PC 
can be associated with more emotional distress and 
intensified pain experience (George et al., 2011, Martin et 
  
 
Chapter 7: Anterior Cingulate Cortex in Chronic Pain  
 
  
145 
al., 2011, Campbell et al., 2012) including in knee OA pain 
(Forsythe et al., 2008). Furthermore, the tendency to 
catastrophize may contribute to pain chronicity even upon 
curative treatment of the cause (Forsythe et al., 2008, 
Martin et al., 2011).  
PC has been found significantly associative with increased 
activity in the ACC (Gracely et al., 2004, Seminowicz and 
Davis, 2006).  While catastrophizing as a psychological 
predictor of pain experience has been widely studied, little is 
known about its neural correlates. 
 
The ACC has been investigated in pain imaging literature mainly as 
a key region of the pain matrix that is elicited during experimental 
nociceptive stimulation, and largely involved in central pain 
processing. However, the role of ACC in pain related cognitive and 
emotional behaviours has remained minimally explored, and 
moreover the volumetric correlates of ACC parts as sub-regions of 
interest with such behaviours in chronic pain have not been 
studied. 
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2.3.3 Aims and hypothesis 
The aim of this study is to investigate the volumetric correlates of 
individual ACC sub-divisions with the specific behavioural function 
(based on fMRI findings- explained above) in chronic knee OA pain. 
The following hypotheses will be independently tested: 
1) Dorsal ACC is involved in cognitive function (which is 
allegedly impaired in chronic pain) and hence its volume will 
co-vary with the cognitive performance in KOA patients 
2) Rostral ACC volume will correlate with the affective 
components of chronic pain in KOA patients, and volumetric 
changes in subgenual ACC will correlate with variation in 
depressive symptoms among patients 
3) Individual tendency to pain catastrophizing is associated with 
morphometric variations in emotional pain processing centres 
namely the rostral ACC. 
2.3.4 Methods 
2.3.4.1 Subjects 
A detailed description of participants recruited for this study is 
provided in chapter 5. In short, all patients (n=31, age= 64.61± 
8.36; 15 females) and all age- and sex-matched pain-free healthy 
controls (n=22, age= 61.30± 7.46; 13 females) were included. 
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2.3.4.2 Data acquisition  
Brain magnetic resonance imaging 
The brain MRI protocol has been described in detail in chapter 5. In 
summary, data acquisition involved the used of 3T scanner 
(Discovery 750, GE Medical Healthcare, Milwaukee, US) with a 32-
channel head coil, to acquire 3D T1-weighted structural brain scans 
at a native resolution of 1mm3. 
 
Affective dimension of pain, cognitive ability, depression, and pain 
catastrophizing 
3DWLHQWV¶ GDWD RI DIIHFWLYH FRPSRQHQWV RI SDLQ ZHUH GHULYHG IURP
the affective descriptors of pain in the self-administered McGill pain 
questionnaire (Melzack, 1975), (a copy of the questionnaire is 
included in appendix 4). In brief, the affective qualities are derived 
from a group of descriptive words in terms of tension, fear, and 
autonomic properties that are part of the pain experience (Melzack 
and Katz, 2013). 
General cognition was assessed during a face-to-face interview 
using the Montreal cognitive assessment test (Nasreddine et al., 
2005), previously described in chapters 5 and 6. 
Depression levels in all participants were assessed using the self-
DGPLQLVWHUHG%HFN¶V'HSUHVVLRQ,QYHQWRU\(Beck et al., 1996). 
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Pain catastrophizing was evaluated using the self-administered 
pain catastrophizing scale (PCS) (Sullivan et al., 1995), which 
consists mainly of 13 statements regarding various thoughts and 
feelings while in pain. Detailed description of the used 
questionnaires is provided in chapter 5. 
 
Volumetric measurement techniques 
Anterior cingulate volumetry and protocol development 
3D-Slicer, open source software Mac version 4.1 (Pieper et al., 
2006) was used for manual delineation of individual anterior 
cingulate and intracranial volumes. The software allows for 
exchangeable visualization and tracing of the region of interest 
(ROI) in three different planes as well as an automated calculation 
of ROI volume. Anterior cingulate sub-regions were traced and 
measured on coronal with the use of sagittal and axial views to aid 
defining borders and complement accurate delineation, following 
the protocol by McCormick et al (McCormick et al., 2006). Although 
these four regions were separately segmented, the rostral and 
subcallosal parts were combined to form one ROI indicating the 
pre-genual or rostral ACC, as explained in the introduction. To 
reduce observer bias images were duplicated and flipped (using the 
same technique implemented previously for hippocampal manual 
volumetry), so that all ACC ROIs were outlined on the left side of 
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the image, and the observer blinded to image laterality. I carried 
out all manual segmentations, and high intra-rater, and inter-rater 
reliability using 10 cases of original data were achieved against a 
second observer (Kurdistan Abdulla, a MSc student in our division 
who was trained to use 3D slicer for manual volumetry in her MSc 
project). Intra- and inter-class correlations recorded 92% and 
86%; 95% CI= 0.72-0.98 p<0.001 and 0.53-0.96 p<0.001, 
respectively for dorsal ACC, and 94% and 88%; 95% CI= 0.78-
0.98 p<0.001 and 0.60-0.97 p<0.001, respectively for rostral-
ventral ACC. 
Definition of anterior cingulate boundaries 
General rules: Three vertical planes A, B and C were used to 
divide the ACC into its 4 sub-regions (Figure 1).  
Plane A: defines the caudal borders of rostral ACC and separates it 
from the dorsal ACC (superiorly) and from the subcallosal ACC 
(inferiorly). Plane A is drawn on the coronal view one slice forward 
to the slice in which the two sides of the anterior corpus callosum 
are no longer connected through the genu (Fig. 5). 
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Figure 5: Plane A is drawn one slice forward past where the two sides of the corpus 
callosum are no longer connected through the genu.  From (McCormick et al., 2006) 
 
Plane B: defines the posterior boundary of the subcallosal ACC. 
(the anterior boundary has been already defined by plane A). Plane 
B is drawn one coronal slice before the putamen is seen within the 
basal ganglia (Fig. 6) 
 
Figure 6: plane B is drawn one slice anterior to when the putamen is first visualized within 
the basal ganglia. From (McCormick et al., 2006) 
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Plane C: defines the posterior boundary of the dorsal ACC. Plane C 
is drawn first on the sagittal view as a vertical line through the 
middle (or tip) of the first gyrus anterior to where the ascending 
marginal sulcus joins the prominent cingulate sulcus horizontally 
(Fig. 7) 
 
Figure 7: Plane C is drawn in the sagittal plane as a vertical line through the tip of the 
first gyrus anterior to where the ascending ramus becomes horizontal. From (McCormick 
et al., 2006) 
Grey matter of ACC parts was segmented every second slice as per 
0F&RUPLFN¶VSURWRFROIRUDOOUHJLRQVH[FHSWIRUWKHVXEJHQXDOZKLFK
was segemeted on every slice. The four segmented parts are 
shown in Fig. 8. Althought, shown on sagittal views for better 
outlook, practically, the segmetation was carried out on coronal 
planes. 
 
Figure 8: Manual segmetation of ACC 4 ROIs using 3D Slicer sofware; green= dACC, 
yellow= rACC, brown= scACC, and blue= sgACC. 
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Intracranial volume measurement 
Intracranial volume (ICV) was measured as described previously in 
chapter 6. In brief, ICV was measured following the method of 
Eritaia et al (Eritaia et al., 2000), which involves ICV 
segmentations at a rate of one every ten slices. Results were used 
to correct ROI volumes for differences in head size following the 
adjustment method by Jack et al (Jack et al., 1989b). For 
volumetric normalization of an ROI the following equation was 
used: 
Normalized ROI volume = 
 Raw ROI volume ± [B (ICV ± group mean ICV)], 
³%´ LV WKH VORSH RI UHJression of ROI volume on ICV across the 
study population.    
2.3.4.3 Statistical analysis 
Analyses were performed using IBM-SPSS v20. Data were tested 
for normality. Independent t-test (2-tailed) was used to compare 
normalized mean differences between groups for volumetric data, 
and independent samples Mann-Whitney U test was used for 
between group comparisons of pain related behavioural data. 
Correlation analysis was performed using Pearson correlation 
controlled for the partial effects of age and sex. 
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2.3.5 Results 
2.3.5.1 Demographic data 
Demographic data were described previously in chapter 5. Knee OA 
patients and healthy controls were matched in age and sex. 
Educational status, handedness, and body mass index were similar 
between both groups. 
 
2.3.5.2 Pain-related behavioural features 
Cognitive data for both groups was described in chapters 5 and 6. 
In brief, similar scores of general cognition were recorded in both 
groups: range= 20-30, median=28 for knee OA vs. range= 23-30, 
median=27 for HC; p=0.63; independent samples Mann-Whitney U 
test.   
Affective component of pain in knee OA: The affective ratings, as 
derived from McGill pain questionnaire, can range from 0-14 with 
the higher being worse. Knee OA patients had the following 
statistics: mean= 1.2, SD=2.4, median=0, and a range of 0-11. 
Knee OA patients presented with higher levels of depression: 
range=0-19, median=7 vs. range=0-9, median= 1; p=0.001; 
independent samples Mann-Whitney U test. 
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Pain catastrophizing scale has a range between 0 and 52, with the 
higher being more catastrophizing. Patients and HCs recorded 
similar scores (p=0.69; independent samples Mann-Whitney U 
test).  Knee OA patients scored 11.8± (9.97) with a range of 0-41 
and HCs=12.05± (8.15) and a range of 0-29. 
 
2.3.5.3 Volumetric measures 
The normalized data of dorsal, rostral, and subgenual ACC, as well 
as ICV measures in knee OA and HC groups are shown in table 1.  
All data of ACC sub-divisions (except for subgenual parts p<0.03) 
as well as ICV were normally distributed in both groups, p>0.06, 
(Shapiro-Wilk test). There was no significant difference in any of 
the studied volumetric data between knee OA patients and HCs.  
 
Table 1. Volumetric data (cm3) for normalized (Rt. And Lt.) dorsal and rostral 
ACC, and ICV volumes in knee OA and HC groups represented as mean (SD) 
 N-Rt. 
dACC 
Volume 
N-Lt. 
dACC 
Volume 
N-Rt. 
rACC 
Volume 
N-Lt. 
rACC 
Volume 
N-Rt. sgACC 
Volume 
N-Lt. sgACC 
Volume 
ICV 
KOA 4.3 
(0.81) 
4.04 
(0.76) 
2.19 
(0.45) 
2.66 
(0.71) 
0.34 
(Median=0.35, 
range= 0.19-
0.78) 
0.40 
(Median=0.38, 
range= 0.08-
0.70) 
1498.6 
(157.4) 
HC 4.2 
(0.63) 
3.76 
(0.72) 
2.3 
(0.57) 
2.89 
(0.62) 
0.33 
(Median=0.32, 
range= 0.11-
0.50) 
0.42 
(Median=0.39, 
range= 0.17-
0.87) 
1489.5 
(155.4) 
P-
value* 
=0.54 =0.19 0.43 0.22 0.64 0.95 =0.87 
N-Rt. and N-Lt  (dACC, rACC, sgACC)= normalized right and left dorsal, rostral, and 
subgenual ACC volumes. ICV= intracranial volume. *Based on independent samples t-
test, except for sgACC where independent samples Mann-Whitney U test was used. 
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2.3.5.4 Correlation analysis 
1- General cognitive performance and dorsal ACC volume in 
knee OA patients 
No significant correlation was found between scores of 
general cognition and either side of dorsal ACC volume 
(p>0.6 controlled for age and sex). 
 
2- Affective dimension of chronic pain in knee OA and rostral 
ACC volume, and depression levels with subgenual ACC 
volume 
No significant correlation was found between scores of pain 
affective ratings and either side of rostral ACC volume 
(p>0.3 controlled for age and sex). 
No significant correlation was found for depressive symptoms 
ZLWKVJ$&&YROXPHS!6SHDUPDQ¶VUKRFRUUHODWLRQ 
 
3- Pain catastrophizing and rostral ACC volume  
A modest but significant correlation was found between pain 
catastrophizing scores and left rostral ACC, i.e. higher PC 
scores with larger left rACC volume r=0.37, (p=0.047 
controlled for age and sex), Fig 9. 
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Figure 9: Scatter plots and regression line showing a positive relationship between PCS 
and left rostral ACC volume 
 
2.3.6 Discussion 
The grey matter volumetric correlates of two functionally distinct 
parts of ACC namely the rostral-ventral part, which is involved in 
pain related emotional processing and the dorsal part, associated 
with cognitive performance, were independently investigated in 
relation to pain related behaviours specifically; cognition, affection, 
depression, and pain catastrophizing.  There was no significant 
covariance in general cognition, depression, or affective dimension 
of pain with volumetric changes in the functionally corresponding 
parts. Of note, cognition in patients did not differ from that in HCs, 
and furthermore, chronic pain in knee OA seemed not very 
influential with regard to its impact on negative affective feelings, 
as data of the latter did not vary much and furthermore was low in 
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the studied group, with a mean of 1.2, median=0, and a variance 
of 5.8 (squared SD of 2.41). While inferences will be limited by the 
cross sectional design of the study, it can be argued that the 
normal findings of ACC volume may explain such stability in pain-
related behaviours in the studied population. 
    
Contrariwise, left rostral ACC volume increased with higher pain 
catastrophizing scores. This suggests that structural alterations in 
this area, which is involved in emotional pain processing and 
interoception, may mediate emotional negative bias towards pain 
experience. This accords well with the concept that PC reflects 
increased attention and emotional response to pain processing as 
shown in patients with fibromyalgia (Gracely et al., 2004). The 
study findings are also consistent with and may explain reported 
increased activities within the rostral ACC, insula, and dorsolateral 
prefrontal cortex in healthy subjects with higher PC scores 
(Seminowicz and Davis, 2006).  The fact that the grey matter 
volume was not abnormal in this area provides preliminary 
evidence for a dispositional rather than acquired nature.   
 
The preserved cognitive function in the studied cohort has been 
discussed previously in the hippocampal volume correlates, chapter 
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6, and will be reiterated briefly in here.  There is a large body of 
evidence to suggest that chronic pain is associative with cognitive 
impairment, for review see (Moriarty et al., 2011), and in 
musculoskeletal pain 32% of patients may present with cognitive 
dysfunction in at least one cognitive domain (Kewman et al., 
1991). Two main intriguing disputes naturally emerge which 
remain poorly understood in this context 1) what is the neural 
substrate of pain-cognition relationship? And 2) why is cognition 
impaired in some but preserved in other chronic pain states? The 
answer to these questions is beyond the scope of this thesis, and 
indeed these queries may be considered as highlights for future 
directions. Putative neural links between pain and cognition have 
been investigated here using unprecedented rigorous 
morphometric techniques both in this and the hippocampal 
chapters, however in the absence of cognitive impairment in this 
cohort, further investigations of neural mechanisms may deem 
purposeless.  
 
My hypotheses for such variability between chronic pain diseases in 
relation to cognitive impairment was discussed in chapter 6, and 
briefly, it could lie in other moderating factors that are not present 
in the studied cohort or in the investigated clinical condition. 
Medication effect e.g. use of opioids (Hu et al., 2002) is expected 
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to impact upon GM volume,  and since such and other medication 
intake is likely to be a disease specific, consequent effects may 
hypothetically vary accordingly. Sleep disturbance (Jongsma et al., 
2011), or neuropathic component of pain which can vary according 
to different chronic pain aetiologies, as recently shown in preclinical 
models of neuropathic-like pain with subsequent cognitive deficits 
Mutso et al., 2012), have been highlighted in the literature and 
may hold accountable as potential moderating factors.  
 
Robert et al (Hart et al., 2003) underlined the significance of stress 
as a plausible contributing factor in the pain-impaired cognition 
relationship. The role of stress was also emphasized by Vachon-
Presseau (Vachon-Presseau et al., 2013) as a mediating factor 
between chronic pain and hippocampal volume reduction. Stress 
was not assessed in this studied cohort, nonetheless stress and 
also depression (Brown et al., 2002), as putative pain-cognition 
mediators would hoverer be expected to influence upon 
hippocampal volume (Duric and McCarson, 2006, McEwen, 2001) 
which, the latter was found preserved and furthermore significantly 
larger in the studied knee OA patients when compared to matched 
healthy controls. These findings provide evidence that depression 
may not explain cognitive disorder in chronic pain due to knee OA, 
and argue for the complexity of the mechanism of chronic pain 
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related abnormal behaviours warranted further studies to 
investigate this complex relationship. 
The low ratings of affective component of knee OA pain reported by 
the studied patients may sound counterintuitive at first, as knee 
OA pain is a leading cause of disability (Murray and D., 1997). 
However, it is predictable that the qualities of pain experience may 
largely vary among different chronic pain diseases. In as study of 
three chronic pain conditions (fibromyalgia, OA, and low back 
pain), it was found that patients with OA presented comparatively 
with the lowest ratings of affective pain descriptors, followed by 
low back pain, and the highest scoring was recorded in 
fibromyalgia patients (Marques et al., 2001). It has been argued 
that pain does not necessarily have to have an affective component 
(Horn et al., 2012) in certain circumstance; Horn et al called it the 
³VDIHVLWXDWLRQ´ZKHQSDLQ LVSUHGLFWDEOH LQ WHUPVRI LQWHQVLW\DQG
course, and hence it would likely elicit very low degrees of pain 
unpleasantness. Although, this hypothesis was confirmed by Horn 
and co-workers in an acute state of painful experience, it 
emphasizes that affective component of chronic pain may be 
modulated by context and cognitive appraisal of pain (Horn et al., 
2012). 
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2.3.7 Conclusion 
Dorsal and rostral parts of ACC did not show volumetric 
abnormalities in association with chronic painful knee OA, nor had 
they any volumetric covariance with the cognitive performance or 
pain affective component respectively. However, higher scores of 
pain catastrophizing correlated significantly and positively with 
increases in left rostral ACC sizes suggesting that it may underlie 
the pain catastrophizing tendency in patients with chronic knee 
pain.    
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2.4 Study II: Anterior cingulate and 
central pain sensitisation: Cortical thickness 
correlates in chronic pain in knee OA 
2.4.1 Introduction 
Central sensitization is defined by the International Association for 
WKH 6WXG\ RI 3DLQ DV ´DQ LQFUHDVHG UHVSRQVLYHQHVV RI QRFLFHSWLYH
neurons in the central nervous system to their normal or 
VXEWKUHVKROG DIIHUHQW LQSXW³ (Merskey and Bogduk, 1994). The 
increase in dorsal horn neural responses is a well-understood 
mechanism of pain sensitisation in rodent models (Li et al., 2013, 
Wu et al., 2005b) including MIA models (Sagar et al., 2011). Direct 
measurement of CNS neuronal activity in humans cannot be made 
and therefore direct evidence of neuronal hyper-excitability may 
not be provided (Curatolo et al., 2006). However, central 
sensitisation in humans can be indexed by, for instance, secondary 
punctate or pressure hyperalgesia (Woolf, 2011). 
 
Mechanical hyperalgesia at the painful knee in OA is thought to 
result from peripheral deep tissue sensitisation, however 
widespread hyperalgesia at remote sites (Lee et al., 2011a), and 
for review (Suokas et al., 2012), is likely to be explained by one 
possible mechanism that is central sensitisation (Pavlakovic and 
Petzke, 2010). Interindividual differences in pain sensitivity may 
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however also reflect a number of predisposing factors notably, 
female sex: women show consistently lower mechanical and 
thermal pain thresholds (Racine et al., 2012, Riley et al., 1998), 
and are at greater risk of chronic pain disorders including OA 
(Mogil, 2012). Female knee OA patients report higher levels of pain 
and higher physical and pain related disability (Hame and 
Alexander, 2013, Keefe et al., 2000). 
 
As discussed in chapter 1, the pain intensity in knee osteoarthritis 
can be quite variable ranging from hardly perceptible to 
immobilizing, and the severity of pain in knee osteoarthritis cannot 
often be predicted from the degree of structural local damage. 
Several studies (Kornaat et al., 2006, Link, 2009, Phan et al., 
2006) have reported no significant correlation between the severity 
of pain and structural knee osteoarthritic lesions. Therefore, the 
degree of pain perceived is unlikely to be due to peripheral 
sensitization alone (Lee et al., 2011b). These findings along with 
other outcomes such as secondary hyperalgesia (Imamura et al., 
2008) and pain at rest (Schaible et al., 2002), suggest a central 
mechanism of pain sensitization in knee OA (Jones et al., 2012).  
The contribution of supraspinal structures to central sensitization is 
evidenced from brain functional imaging like functional MRI and 
magnetoencephalography (MEG). Studies have reported increased 
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activities in structures including the brainstem, thalamus, 
cingulate, insula, middle frontal, posterior parietal, and primary 
and secondary somatosensory cortices, in association with 
experimentally induced mechanical hyperalgesia (Lee et al., 2008, 
Maihofner et al., 2010, Mainero et al., 2007, Zambreanu et al., 
2005). Gwilym and co-researchers (Gwilym et al., 2009) 
investigated the supraspinal (brainstem) correlates of punctate 
stimuli in areas of referred pain (indicative of possible central 
sensitization) in chronic hip OA using fMRI. Authors found 
significantly higher activity in the periaqueductal grey in response 
to punctate stimulation suggesting its role in central sensitization. 
The structural correlates, on the other hand, have received less 
focus from researchers particularly in chronic pain disorders, 
though attempts have been recently made to investigate the 
cortical thickness correlates of thermal thresholds in healthy young 
subjects (Erpelding et al., 2012).  
 
The role of ACC in central sensitization is of particular interest; 
preclinical studies have shown molecular and microstructural 
changes in the ACC in association with synaptic potentiation (Chen 
et al., 2012, Li et al., 2010, Wu et al., 2005a). The long term 
potentiation of synaptic transmission in the ACC is likely to impose 
a contribution towards sustainability of chronic pain (Zhuo, 2014). 
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Interestingly, in humans, those who regularly practice meditation, 
known for its endogenous analgesic effect, the ACC was found 
thicker with longer periods of practicing, and meditators had 
significantly higher pain thresholds (Grant et al., 2010).  
The exact role of ACC in central sensitization however remains 
poorly understood in sufferers of chronic pain, and the extent by 
which ACC contributes to sustainability and hence chronification of 
pain is unclear.   
2.4.2 Aim and hypothesis 
The aim of this study is to investigate the anterior cingulate cortical 
thickness correlates of pain hyper-sensitization in patients with 
chronic painful knee OA, and weather sex is a moderating factor of 
such relation. I hypothesize that cortical thickness changes in ACC, 
will associate with reduced pain thresholds due to central 
sensitization, and these changes will be more pronounced in 
females. 
2.4.3 Methods 
2.4.3.1 Subjects 
A detailed description of participants recruited for this study has 
been provided in chapter 5. In brief, patients (n=31, age= 64.61± 
  
 
Chapter 7: Anterior Cingulate Cortex in Chronic Pain  
 
  
166 
8.36; 15 females) and age- and sex-matched pain-free healthy 
controls (n=22, age= 61.30± 7.46; 13 females) were included. 
2.4.3.2 MRI and cortical thickness analysis 
Brain scanning and cortical thickness analysis have been described 
in details in chapters 5 and 9, respectively. Values of average 
cortical thickness of total ACC bilaterally were derived from 
freesurfer output data, for both knee OA patients and HCs. Total 
ACC comprised rostral, mid, and dorsal ACC as per the default atlas 
implemented by freesurfer. Further whole brain vertex-wise 
analysis was performed to localise significant correlates with pain 
sensitivity.      
 
2.4.3.3 Quantitative Sensory Testing (pressure pain 
threshold PPT) 
Pressure pain thresholds (PPTs) were recorded by a trained single 
rater (MW) using a digital algometer (Somedic AB, Sweden) with 
three repetitions at the index finger, sternum, medial tibia, and at 
the medial and lateral joint lines of the painful knee (Described 
previously in details in chapter 5). The average of the last two 
readings for the three non-local sites was used to indicate non-
knee or remote PPTs, and those from knee joint lines to indicate 
knee or local PPTs.   
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2.4.3.4 Statistical analysis 
Difference in anterior cingulate cortical thickness between knee OA 
and HC groups was tested using ANCOVA while controlling for age 
and sex. Further correlation analysis within knee OA group was 
perforPHGXVLQJ3HDUVRQ¶VFRUUHODWLRQFRQWUROOHGIRUSDUWLDOHIIHFWV
of age and sex.  
QDEC (freesurfer statistical and visualization tool) was used to 
perform surface based correlation analysis, with significance 
accepted at p<0.001 uncorrected, controlled for age and sex. 
Independent samples t-test was used to compare means of PPTs 
between groups. 
2.4.4 Results 
One dataset from a Knee OA participant was discarded due to a 
technical error. Knee PPTs were significantly lower in Knee OA vs. 
HC participants (p=0.03, table 1), but no differences were noted in 
PPT at remote sites.  Neither knee nor remote PPTs correlated with 
chronic pain severity or duration. In each subgroup, no difference 
was found between males and females for PPTs at the knee and 
remote sites (table 2). 
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Table 1: Pressure pain threshold measurements for participants  
 Average knee PPT 
KPa (M± SD) 
Average non-knee 
PPT 
KPa (M± SD) 
Knee OA 
(n=30) 
281.4± 152.4 227.3± 106.5 
HC  
(n=22) 
385.1± 182.9 253.3± 107.2 
P value* 0.03 0.39 
*Independent sample t-test 
 
Table 2: Pressure pain threshold measurements for sexes in subgroups 
 Average knee 
PPT 
KPa (M± SD) 
Average non-knee 
PPT 
KPa (M± SD) 
Male Knee 
OA 
(n= 16) 
313.2± 172.5 243.2± 121.7 
Female Knee 
OA (n=14) 
245.1± 121.4 209.2± 86.9 
P value 0.23 0.39 
Male HC 
 (n= 9) 
391± 175.9 271.8± 105.7 
Female HC 
(n=13) 
381± 194.6 240.5± 110.5 
P value* 0.9 0.51 
*Independent sample t-test 
Data of average thickness of ACC in both groups (knee OA and HC) 
are summarized in table 3. No significant difference in ACC 
thickness was found between groups. 
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Table 3: Average AC cortical thickness in knee OA vs. HC participants 
 Right ACC 
Average CT 
Left ACC 
Average CT 
Knee OA 
(n=30) 
2.49± 0.11 2.54± 0.11 
HC  
(n=22) 
2.53± 0.13 2.56± 0.11 
P value* 0.27 0.53 
*Independent sample t-test 
AC cortical thickness differences remained non-significant bilaterally after 
adjusting for age and sex p>0.3 ANCOVA. 
 
Moderate but significant positive correlation was found between 
thickness of the left ACC and higher remote PPTs (r= 0.46 
p=0.013), controlled for partial effects of age and sex, Fig. 1. No 
such relation was found in HCs.  
 
Figure 1: Scatter plots and regression lines marked by sex depicting relation between Lt. 
ACC thickness and remote pressure pain thresholds. (Female R2= 0.49, Male R2=0.01) 
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Vertex-wise correlation analysis in Knee OA patients revealed that 
thickness of the left anterior cingulate cortex correlated positively 
with remote PPTs. Namely, higher pain sensitivity (lower PPTs) was 
associated with cortical thinning in the left anterior cingulate 
(p<0.001 uncorrected, controlled for age and sex, Fig. 2A). A 
similar correlation was noted for the knee PPTs (p<0.001 
uncorrected, controlled for age and sex, Fig. 2B). This relationship 
was significantly moderated by sex (scatter plots and correlation 
graph Fig. 3; t=2.8, p=0.01 and t=2.6, p=0.02, multiple 
regression tests for non-knee and knee sites respectively). No 
relationship emerged in healthy controls for both knee and non-
knee PPTs.  
Of note, focal ACC change was the only cluster that showed 
significant correlation in both hemispheres, though it did not 
survive multiple test correction. Anatomical localization revealed 
that the cluster spanned over anterior part, middle anterior part, 
and pericallosal sulcus, as per the latest Destrieux atlas a2009s 
implemented in freesurfer (Destrieux et al., 2010), Fig 3. 
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Figure 2: Correlation between cortical thickness and pressure pain thresholds. A: non-
knee and B: knee- sites. Higher scores of pressure pain threshold significantly correlate 
with thickening in the ACC (r=0.72, p<0.001 and r=0.7 p<0.001 for A and B respectively, 
adjusted for age and sex). Scatter plot and correlation graph marked by sex showing a 
significant sex moderating effect p<0.02. 
 
 
 
Figure 4: Inflated cortical surface to illustrate location of cluster that showed positive 
cortical thickness correlation with higher remote PPTs. 1=anterior part of ACC, 2= mid-
anterior part of ACC, and 3=pericallosal sulcus. ROI=region of interest.  
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2.4.5 Discussion 
In this study, it was shown that mechanical pain thresholds 
correlated with left anterior cingulate cortical thickness in patients 
suffering from knee OA, which was notably and significantly 
moderated by sex such that women exhibited more pronounced 
effect. Pressure pain thresholds only differed between knee OA 
patients and HCs at the affected joint and sex had no influential 
effect.    
Quantitative sensory testing has been widely used to characterize 
sensory and pain perception in both normal and chronic pain 
conditions (Suokas et al., 2012, Pavlakovic and Petzke, 2010), yet 
little is known about its neural correlates especially in painful 
states. Here, it was found that higher pain sensitivity both at the 
affected joint and remote sites were associated with thinning in the 
anterior cingulate cortex. In human studies ACC has been 
consistently found to be involved in processing the emotional and 
affective components of experimental and clinical pain (Devinsky et 
al., 1995, Peyron et al., 2000, Tolle et al., 1999, Vogt et al., 1996). 
Interestingly, adults practicing Zen meditation (Grant et al., 2010) 
were found to be less sensitive to pain and to have thicker cortex 
in the anterior cingulate compared to non-meditating controls. 
Moreover cortical thickness in the ACC correlated with the number 
of years of meditation. In another longitudinal experimental pain 
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study by Stankewitz et al (Stankewitz et al., 2013), it was found 
that only a subgroup of sensitizers developed post-experimental 
GM density reduction in the ACC as well as other brain areas 
involved in pain processing and modulation. Furthermore, the 
sensitizers group exhibited less GM density in several areas 
including the ACC when compared to a control group and a 
subgroup of habituaters respectively.  
 
The plasticity seen in the ACC in association with higher pain 
sensitivity is supported by cumulative evidence from preclinical 
studies (Chen et al., 2012, Li et al., 2010, Wu et al., 2005a) that 
show a synaptic potentiation enhancing microstructural and 
molecular changes in the ACC, suggesting that the ACC is a key 
structure in central sensitization. The concept of long term 
potentiation (LTP), a potential neurobiological substrate of learning 
and memory (Bliss and Collingridge, 1993), has led some 
researchers (Ji et al., 2003) to postulate that similar mechanisms 
are involved in central sensitization and hence persistency of pain 
(Zhuo, 2014), however, the cortical thinning seen in the ACC in 
sensitizers in this study argue for complex ultrastructural changes. 
It is not clear whether such plastic changes at the synaptic level 
are putatively of molecular and functional nature only or they are 
accompanied by microstructural plasticity e.g. synaptic re-
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organization. However, the findings from this study provide some 
evidence that changes may involve structural reorganization. The 
fact that no abnormal difference was found in left ACC in patients 
when compared to HCs, and that the cortical thickness correlation 
with pain sensitivity was seen only in patients suggests that the 
changes could be of acquired nature that is related to chronic pain 
in the studied knee OA cohort.  
2.4.6 Conclusion 
In conclusion, the study findings demonstrate that higher sores of 
mechanical pain sensitivity are correlated with reduced cortical 
thickness in the anterior cingulate highlighting its potential key role 
in the process of central sensitization. The sex moderating effect 
may partially explain the higher prevalence and comorbidity rates 
of chronic knee OA pain in females. 
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2.5 Voxel-based morphometric 
correlates of chronic pain in knee OA 
patients 
2.5.1 Introduction 
Chronic pain, as a syndrome involving multiple dimensions, is 
expected to impact upon extensive brain networks concerned with 
different aspects of pain including sensory, affective, and cognitive 
domains. Voxel based morphometry (Ashburner and Friston, 
2000b) has been the most popular morphometric tool of choice to 
investigate GM changes on a voxel by voxel levels. Several 
neuroimaging studies have reported morphological cerebral 
changes in various chronic pain states (Kuchinad et al., 2007, 
Schmidt-Wilcke et al., 2006, Rodriguez-Raecke et al., 2009, 
Apkarian et al., 2004, Draganski et al., 2006, Burgmer et al., 2009, 
Buckalew et al., 2010b, Schmidt-Wilcke et al., 2005, Seminowicz et 
al., 2010, Schmidt-Wilcke et al., 2008, Gwilym et al., 2010b). Most 
studies found reductions, yet of unknown nature, in GM density, 
volume or in fewer circumstances, where surface-based 
morphometry was implemented, decreases in cortical thickness 
were observed. However, the distribution of pain-related GM 
changes is highly varied between studies even when studying 
identical primary aetiologies of chronic pain disorders. The affected 
regions are also inconsistent between studies of musculoskeletal 
disorders (chapter 4), including chronic painful hip osteoarthritis 
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(Gwilym et al., 2010b, Rodriguez-Raecke et al., 2009), and knee 
OA (Baliki et al., 2011).  
Brain regions that show higher activity during noxious stimulation 
include, by large convergence, the secondary somatosensory 
cortex, insula, anterior cingulate cortex, and with less consistency 
the thalamus and primary somatosensory cortex (Peyron et al., 
2000), and frontal and parietal lobes (Peyron et al., 2000). By 
contrast, structural brain changes associated with different chronic 
pain conditions, as reviewed and meta-analysed by Smallwood et 
al (Smallwood et al., 2013b), were consistently found, as voxel-
based morphometric reductions, in several clusters spanning over 
areas considered as part of the known pain matrix but also in areas 
that are largely outside the pain matrix.  The largest and most 
significant cluster of reduced grey matter volume in patients with 
chronic pain as per Smallwood et al was noted covering regions 
including right putamen and claustrum, insula, and right posterior 
inferior frontal gyrus. Other areas of reduced GM involved ACC, 
medial frontal gyrus, insula, superior temporal gyrus, thalamus, 
paracentral lobule, and superior, middle and inferior frontal gyri.  
 
The correlation of chronic pain-related GM changes with the 
intensity of perceived pain is not clearly elucidated. Functional MRI 
studies found that experimental pain intensity to correlate 
  
 
Chapter 8: Voxel-based Morphometric Correlates of Chronic Pain in Knee OA  
 
  
177 
positively with activity in the primary somatosensory, cingulate, 
motor and premotor cortex, and negatively in medial parietal, 
perigenual cingulate and medial prefrontal regions (Porro et al., 
1998). In chronic pain conditions, higher intensity of spontaneous 
pain in fibromyalgia was found to correlate with greater intrinsic 
connectivity between insula and default mode network and 
executive attention networks (Napadow et al., 2010). 
The structural brain correlates on the other hand have not received 
as much attention from researchers particularly in MSK disorders, 
and findings to date seem controversial. Some studies reported 
positive correlation between average (normally over past 4 weeks), 
or acute (on day of scanning) pain severity and GM volume 
(Gwilym et al., 2010a), negative correlation (Schmidt-Wilcke et al., 
2006, Younger et al., 2010), or no correlation (Buckalew et al., 
2008, Baliki et al., 2011). Of Note, Baliki and co-workers studied 
three chronic pain conditions (chronic back pain, complex regional 
pain syndrome, and knee OA) and found no relation with GM 
volume in any group.  
 
Literature of MSK pain imaging is scarce and in particular of studies 
of pain in osteoarthritis. Furthermore, studies to date have been 
limited by sample size, heterogeneity of studied cohort and less 
rigorous morphometric techniques. In this study, up-to-date voxel-
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based morphometric technique using DARTEL (Diffeomorphic 
Anatomical Registration using Exponentiated Lie algebra) 
(Ashburner, 2007), implemented in SPM8 (Statistical Parametric 
Mapping8: http://www.fil.ion.ucl.ac.uk/spm) was used, which 
evidently offers improvement in spatial normalization and more 
reliable analysis outcome (Mak et al., 2011) comparable with 
manual morphometry, which is considered as a gold standard in 
volumetric measurements (Cherbuin et al., 2009, Morey et al., 
2009, Shen et al., 2010).  
 
2.5.2 Aims and hypothesis 
The aim of this study is to investigate whether chronic pain due to 
primary nociceptive knee OA is associated with abnormal grey 
matter structural changes as compared to age and sex matched 
controls, and to determine whether GM changes are related chronic 
pain severity in sufferers of knee OA. I hypothesize that knee OA 
patients will show grey matter reduction in areas involved in pain 
processing, and that chronic average pain intensity will correlate 
with volumetric changes in areas concerned with the sensory 
aspects of pain namely in the lateral thalamus and somatosensory 
cortex 
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2.5.3 Methods 
2.5.3.1 Subjects  
Patients (n=31, age= 64.61± 8.36; 15 females) and age- and sex-
matched pain-free healthy controls (n=22, age= 61.30± 7.46; 13 
females) were included. A detailed description of participants 
recruited for this study is provided in chapter 5. 
 
2.5.3.2 Data acquisition 
Brain MR imaging involved the used of 3T scanner (Discovery 750, 
GE Medical Healthcare, Milwaukee, US) with a 32-channel head 
coil, to acquire 3D structural brain scans at a native resolution of 
1mm3. Full description is provided in chapter 5. 
 
2.5.3.3 Chronic pain severity 
Average pain severity over four weeks prior to scanning was 
derived from a response to a question in the self-administered 
PainDETECT questionnaire (Freynhagen et al., 2006), which used 
WKHIROORZLQJVWDWHPHQW³+RZVWURQJZDVWKHSDLQGXULQJWKHSDVW
 ZHHNV"´ DQG SDWLHQW FRXOG FKRRVH WKHLU UHVSRQVH EDVHG RQ D 
scale from 0 to 10, which represent none and maximum 
respectively. 
  
 
Chapter 8: Voxel-based Morphometric Correlates of Chronic Pain in Knee OA  
 
  
180 
2.5.3.4 Voxel based morphometry 
VBM-DARTEL was implemented using standard procedure and 
default parameters except where stated below, to investigate GMV 
differences between knee OA patients and healthy controls, and to 
investigate the GMV correlates with pain severity, using SPM8 
implemented in Matlab R2012a (The Math Works Inc., Natick, MA, 
USA). DARTEL was used to create study-specific templates for 
segmented tissues and to enhance accuracy of inter-subject 
alignment. Pre-processing steps included manual intervention to 
later improve automated image registration, involved adjusting 
orientation and setting origin to anterior commissure for all images 
XVLQJ WKH µ'LVSOD\¶ DQG µ&KHFN 5HJLVWUDWLRQ¶ IHDtures in SPM8. 
Segmented GM images were then normalized to MNI space and 
smoothed using isotropic Gaussian kernel of 8mm full-width at 
half-maximum (FWHM). In the modulation step, preserve was 
FKDQJHG WR µSUHVHUYH YROXPH¶ WR \LHOG *0 YROXPH UDWKHU WKDQ
concentration. Smoothed images were used to test for focal 
differences in GMV between groups (knee OA vs. HC) using 
independent samples t test (implemented in the Factorial Design 
Specification SPM8) with intracranial volume as a global calculation 
to account for head size difference, (ICV was manually measured 
for each subject, as explained in chapter 6). Voxel-based 
correlation between GM volume and chronic pain severity was 
performed using multiple regression design (SPM8), with age and 
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sex treated as covariates of no interest. Significance was accepted 
at p<0.001 uncorrected. 
 
2.5.4 Results 
Demographic and behavioural data were presented in details in 
chapter 5. 
2.5.4.1 Chronic pain severity     
Data of pain severity, which could range 0-10, were normally 
distributed in patients (p>0.06, Shapiro-Wilk test), and recorded 
the following statistics: a mean of 4.77 and SD= 0.43 (median=5, 
range=1-10).  
2.5.4.2 VBM results 
Between-group differences 
VBM comparisons revealed two clusters of significantly reduced 
grey matter volume in patients compared to HC (p<0.001, 
uncorrected), namely in the left dorsolateral prefrontal cortex (MNI 
-45, 12, 44) and right lower cerebellum (MNI 8, -56, -64) Fig. 1. 
However, these results did not survive multiple test corrections. 
There were no regions of larger GMV in patients relative to HC.  
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Figure 1: Regions of less grey matter volume in patients compared to healthy controls are 
presented in left DLPFC (set of images on the left), and right lower cerebellum (VIIIb) 
(images on the right), (p<0.001 uncorrected). 
 
Correlation analysis 
Chronic pain severity did not correlate with any grey matter 
volume changes. 
 
2.5.5 Discussion 
Voxel-based morphometric analysis revealed that patients with 
chronic pain due to knee OA had less grey matter volume in the 
left dorsolateral prefrontal cortex and right lower cerebellum 
(VIIIb), but no correlation was found between GM changes and 
average pain severity. The lack of correlation with pain severity is 
consistent with study of chronic pain conditions and in particular in 
knee OA patients (Baliki et al., 2011). There is good evidence to 
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suggest that DLPFC (Graff-Guerrero et al., 2005, Veldhuijzen et al., 
2009) and cerebellum (Casey et al., 1994, Iadarola et al., 1998), 
along with other structures, participate in a neural network 
involved in pain processing. 
The lack of consistency in GM findings among similar studies raises 
an intriguing question: why do findings vary between and even 
within identical chronic pain conditions? I have carried out a 
systematic review of MSK chronic pain neuroimaging studies 
(chapter4), and some selected studies of the review (based on 
comparability with the current study in terms of e.g. sample size, 
scanning and morphometric techniques, chronic pain condition) will 
be contrasted here to investigate the potential underlying causes of 
inconsistency (table 1). As can be seen from the table, several 
confounders may contribute to the discordance observed between 
chronic pain imaging studies. First, demographic factors such as 
age and sex are likely to vary with subsequently different results. 
Some specific disorders e.g. fibromyalgia are more prevalent and 
hence expected to be dominated by females, and age on the other 
hand can interact with the disease to change the brain (Ceko et al., 
2013). Second, heterogeneity in scanning and methodological 
procedures including scanning parameters, analysis approach and 
statistical method and significance threshold, may also influence 
the outcome. For instance, field strength can impose considerable 
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regional impact on VBM results (Tardif et al., 2010). Third, the 
multitude of pain related factors with regard to duration, severity, 
emotional and cognitive aspects as well as pain comorbidities e.g. 
psychological changes, lack of mobility and proper sleep, as well as 
medications may impact upon the findings. For example, Hsu and 
co-workers (Hsu et al., 2009) studied two groups of chronic 
fibromyalgia patients with and without affective disorders 
compared to matched healthy controls (n=29 each), and found GM 
deficits in the group with, but not in the group without affective 
disorders, when post-hoc analysed. Although some factors seem 
un-modifiable, most can be addressed especially those related to 
methodological issues where international and harmonized protocol 
can be developed and implemented, see for example, the ADNI 
SURMHFW $O]KHLPHU¶V 'LVHDVH 1HXURLPDJLQJ ,QLWLDWLYH
http://www.adni-info.org/).    
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Table 1: Sample of comparable MSK studies including current study, showing main characteristics and outcomes  
Study Condition, 
Sample size 
Age 
Mean 
(SD) 
Sex 
(M: F) 
Pain duration 
Mean (SD)  
Average Pain 
severity mean 
(SD) and range 
Matched 
group 
Tesla/ 
voxel size/ 
smoothing 
(FWHM) 
P value Findings 
Total/ROI analysis 
Present study Knee OA 
n=31 
64.6 
(8.4) 
(16: 15) 114.6 (96) 
 
4.8 (2.4) 
1-10 
n=21 age 
and sex 
matched 
HCs 
3T/ 
1mm3/ 
8 mm 
<0.001 un-
corrected 
P<HC: Lt. DLPFC, and Rt. 
Lower cerebellum 
P>HC: none 
 
(Apkarian et 
al., 2004) 
CBP 
n=26 
47 
(12.6) 
 
NA 
135.6± (136.8) NA  
Pain severity on 
scanning day= 
6(2.3) 
n=26 age 
and sex 
matched 
1.5T/ 
2 protocols/ 
12 mm 
 
<0.05 corrected P<HC: bilateral DLPFC (Total 
analysis), and Rt. Thalamus 
(mask) 
P>HC: none 
 
(Hsu et al., 
2009) 
Fibromyalgia 
n=29 
Median=
41.7 
Female 
only 
153.6± (99.6) NA n=29 age 
and sex 
matched 
3T/ 
0.9x0.9x1.5
mm/ 
10mm 
<0.001 un-corr. 
For whole brain, 
<.05 corr. (ROI)  
P<HC: none (Total analysis), 
and Lt. ant. insula (mask) 
P>HC: none 
 
(Rodriguez-
Raecke et al., 
2009) 
1ry hip OA 
n=32 
66.8 (9) (13: 19) 88.2 NA n=32 age 
and sex 
matched 
3T/ 
FOV=256x2
56,1mm of 
240 slices/ 
10mm 
<0.001 un-
corrected 
P<HC: ACC, Rt. Insula, Lt. 
DLPFC, amygdala, brain stem 
P>HC: left middle frontal gyrus 
 
(Baliki et al., 
2011) 
CBP n=36 
CRPS n=28 
Knee OA n=20 
48.2(11.4) 
40.6(7.4) 
53.5(7.4) 
(23:13) 
(4:28) 
(16:4) 
147.9(137.9) 
39.3(40.8) 
146.7(114) 
NA 
Pain severity on 
scanning day was 
available 
Total of 
n=46,26F 
Age=38.8(1
2.5) 
3T/ 
1mm3/ 
8 mm 
<0.01 corrected CBP<HC: insula, S2, pre/post 
central, temp. lobe 
CRPS<HC: insula, orbitofrontal 
OA<HC: insula, mid ACC 
No increases in any patient 
group vs. HC 
(Wartolowska 
et al., 2012) 
Rheumatoid 
arthritis 
n=31 
Median= 
57 
(9:22) Median= 180 NA  
Pain severity on 
scanning day,  
median=6.5 
n=28 age 
and sex 
matched 
HCs 
3T/ 
1mm3/ 
~7 mm 
<0.05 corrected P<HC: intracranial volume 
P>HC: nucleus accumbens, 
caudate nucleus  
 
OA= osteoarthritis, CBP= chronic back pain, CRPS= chronic regional pain syndrome, P= patients, HC= healthy control, DLPFC= dorso-lateral prefrontal cortex, ACC= 
anterior cingulate cortex, NA= not available  
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Despite inconsistent findings, there seems to be an overlap between 
studies in the DLPFC. The DLPFC (found reduced in patients) is of 
particular importance because of its modulatory role in nociceptive 
transmission (Boggio et al., 2008, Brighina et al., 2011). Repetitive 
transcranial magnetic stimulation of left prefrontal cortex in healthy 
subjects showed a significant increase in thermal pain thresholds 
(Borckardt et al., 2007), supporting its proposed inhibitory role in 
pain perception. The results of this study are compatible with a key 
finding of reduced bilateral DLPFC (however, reduction was larger and 
more significant on left side) in chronic back pain patients (Apkarian 
et al., 2004), and a reduced left DLPFC in another surface-based 
morphometric study of low back pain patients (Seminowicz et al., 
2011), and importantly in chronic pain due to hip OA (Rodriguez-
Raecke et al., 2009). Notably, a significant thinning of left DLPFC with 
longer pain was found in the surface-based correlation analysis 
performed on the same cohort (cluster 12 in Fig. 2, chapter 9). 
 
The nature of such reduction in DLPFC is not clear, and whether such 
a change would lead to functional disturbance of its inhibitory role 
and hence a putative contribution to pain persistency remains 
intriguingly and mechanistically unknown. Interestingly, a case-
control study (Grachev et al., 2000) of proton magnetic resonance 
spectroscopy revealed reductions of N-acetyl aspartate (NAA) and 
glucose (relative to creatine/phosphocreatine complex) in the left 
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DLPFC in patients with chronic back pain, but not in the cingulate, 
insula, thalamus or sensorimotor regions. NAA is known to be 
localized primarily within neurons and is widely used as a marker for 
functional and structural neuronal integrity (Tsai and Coyle, 1995). 
NAA levels can exhibit relative decreases in neurodegenerative 
diseases such as $O]KHLPHU¶V (Adalsteinsson et al., 2000, Schuff et 
al., 2002). Its relative reduction in DLPFC found in chronic pain 
patients (Grachev et al., 2000) may suggest atrophic changes. 
However, longitudinal studies have shown reversibility of chronic-pain 
related reductions in DLPFC following therapeutic treatment that was 
also accompanied by a significant pain relief as found in chronic back 
pain (Seminowicz et al., 2011), and in chronic pain due to hip OA 
(Rodriguez-Raecke et al., 2009).  
 
These findings argue for non-degenerative plastic change, however it 
remains unproven and of unclear mechanisms. As discussed 
previously (chapter 3) it has been proposed that these changes may 
represent neuroanatomical substrate for the disease, an 
epiphenomenon or even an artefact (Reiss et al., 2004b). Simple 
change in cell size, shrinkage or atrophy of neurons or glia, changes 
in the intra-cortical axonal architecture (synaptic loss) have been 
suggested (Rodriguez-Raecke et al., 2009, May, 2008). A concept of 
changes in the extracellular matrix without substantial involvement of 
neurons or neuroglia was offered by Schmidt-Wilcke and colleagues 
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(Schmidt-Wilcke et al., 2008), supporting their idea by a piece of 
growing evidence showing that extracellular matrix influences neural 
cell activity. These mechanisms are thought to be secondary to, or in 
conjunction with a reduction in the cerebral blood flow, as proposed 
by Gwilym and co-workers (Gwilym et al., 2010a).  
The finding of GM changes in cerebellum is less consistent among 
chronic pain states, however in MSK disorders, GM changes in 
cerebellum are likely to be attributed to a combined effect of pain and 
gait modification i.e. altered gate (Gwilym et al., 2010a), which is 
evident in lower limb OA disorders. Little is known about the specific 
role of VIIIb part of cerebellum in nociception, however preclinical 
studies showed its activation during visceral noxious stimulation 
(Saab and Willis, 2003).   
 
2.5.6 Conclusion 
Patients with chronic painful knee OA showed reduced grey matter 
volume in left DLPFC and right lower cerebellum, but no correlations 
were noted with average pain severity. The role of DLPFC in chronic 
pain perception is noteworthy and warrants further multimodal 
investigations to understand the mechanism of its involvement in 
pain chronification and the possibility of its therapeutic targeting.  
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2.6 Surface-based morphometric changes 
in chronic pain due to knee OA 
2.6.1 Study I: Cerebral cortical remodelling in 
chronic knee osteoarthritis pain: Effects of pain 
duration and female sex  
2.6.1.1 Introduction 
Several neuroimaging studies have reported morphological cerebral 
changes in various chronic pain states (Kuchinad et al., 2007, 
Schmidt-Wilcke et al., 2006, Rodriguez-Raecke et al., 2009, Apkarian 
et al., 2004, Draganski et al., 2006, Burgmer et al., 2009, Buckalew 
et al., 2010b, Schmidt-Wilcke et al., 2005, Seminowicz et al., 2010, 
Schmidt-Wilcke et al., 2008, Gwilym et al., 2010b). Most studies 
found a reduction in GM density, volume or cortical thickness, but 
also increases in some areas such as hippocampus and 
parahippocampal (Smallwood et al., 2013b). The mechanism by 
which these changes take place in either direction is largely unknown 
and furthermore the distribution of pain-related GM changes is highly 
varied between studies also when studying identical primary 
aetiologies of chronic pain disorders.  
The correlations between the duration of pain and the extent of 
structural brain changes appear inconsistent. Some studies reported 
negative correlations i.e. less GM volume or white matter integrity 
with longer pain (Apkarian et al., 2004, Schmidt-Wilcke et al., 2006, 
Kuchinad et al., 2007, Buckalew et al., 2010a, Baliki et al., 2011, 
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Wartolowska et al., 2012), while others found positive correlations 
(Younger et al., 2010, Moayedi et al., 2011) or no correlation 
(Draganski et al., 2006, Schmidt-Wilcke et al., 2007, Buckalew et al., 
2008, Hsu et al., 2009, Gustin et al., 2011). These discrepancies may 
reflect a random error due to small sample sizes, limitations of the 
grey matter volume estimation or true biological differences in 
underlying pain characteristics or predisposing factors. As mentioned 
in previous chapters, the female sex is a known risk factor for OA and 
related pain. Women are at greater risk of chronic pain disorders 
including OA (Mogil, 2012). Female knee OA patients report higher 
levels of pain and higher physical and pain related disability (Hame 
and Alexander, 2013, Keefe et al., 2000). There are some reports 
suggesting that people with smaller brains, which may be linked to 
developmental or genetic differences, are more liable to chronic pain 
disorders (Wartolowska et al., 2012) 
 
Importantly, most pain neuroimaging studies have low power not 
allowing controlling for the multitude of factors that influence cortical 
morphometry that may not be well controlled between groups. Apart 
from relevant comorbidities such as depression and anxiety, simple 
training tasks such as a few weeks of juggling (Draganski et al., 
2004), common lifestyle factors such as  alcohol consumption 
(Momenan et al., 2012, Pfefferbaum et al., 1992) and genetic factors 
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are known to affect brain morphometry (Peper et al., 2007, Kolb et 
al., 2011).  
 
Quantification of grey matter changes can be achieved using different 
image analysis techniques, however measuring the cortical thickness 
using a surface-based approach arguably improves robustness over 
standard volumetric methods; cortical thickness assessment provides 
a directly interpretable metric, and is more sensitive allowing for 
detection of sub-voxel changes (Liu et al., 2012b, Pereira et al., 
2012), less sensitive to inaccuracies of spatial normalization and 
smoothing (Bookstein, 2001, Augustinack et al., 2013), and has been 
well validated (Lee et al., 2006, Rosas et al., 2002, Salat et al., 
2004). Only recently, the use of surface based morphometric 
approach to investigate cerebral correlates of chronic pain has gained 
considerable research attention. However, the directional and spatial 
patterns are still inconsistent among different chronic pain conditions 
using this approach (Frokjaer et al., 2012, Jensen et al., 2013, Kong 
et al., 2013, Messina et al., 2013, Seifert et al., 2012, Seminowicz et 
al., 2011). To the best of my knowledge and based on literature 
search (performed 2013 and updated March 2014) using combined 
terms (cortical thickness AND pain AND osteoarthritis) entered into 
web of knowledge (www. webofknowledge.com) and PubMed 
(http://www.ncbi.nlm.nih.gov/) search engines, cortical thickness 
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investigation has not been done previously in chronic pain due to OA 
disorders 
 
2.6.1.2 Aims and hypothesis  
To overcome some of the main limitations of previous studies, I 
chose to characterize the interrelations of cortical thickness and 
duration of persistent pain in a homogenous group of patients with 
painful knee OA. This approach is more powerful than voxel-based 
morphometric assessment of cortical grey matter (Pereira et al., 
2012), and allows a more meaningful interpretation of results than 
those obtained from between group comparisons.  
In this study I investigate the neocortical changes in chronic knee OA 
pain with a primary aim to evaluate the cortical thickness relation to 
pain duration rectified by sex. I hypothesise that pain-related 
reductions in cortical thickness: 
x Are more pronounced in neocortical areas related to pain 
processing in patients as compared to matched healthy controls; 
x Progress over the duration of chronic pain; and 
x Are more pronounced in women 
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2.6.1.3 Methods 
Subjects 
A detailed description of participants recruited for this study has been 
provided in chapter 5. In brief, patients (n=31, age= 64.61± 8.36; 
15 females) and age- and sex-matched pain-free healthy controls 
(n=22, age= 61.30± 7.46; 13 females) were included. Participants 
were further divided, in line with previous reports (Baliki et al., 
2011), into those with pain duration of 5 years or less (short pain 
duration- SPD group, n=12) or more than 5 years (long pain 
duration- LPD group, n=19). Although the division by time was based 
on median-split of pain duration in the aforementioned study, it was 
chosen here to investigate whether changes after several years of 
persistent pain would be comparatively more pronounced  
 
Brain Magnetic resonance Imaging 
MR scanning has bee described in details in chapter 4. Briefly data 
acquisition involved the used of 3T scanner (Discovery 750, GE 
Medical Healthcare, Milwaukee, US) with a 32-channel head coil, to 
acquire 3D structural brain scans at a native resolution of 1mm3. 
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Cortical thickness analysis 
Cortical reconstruction and thickness estimation was performed using 
the Freesurfer software package (Mac version 5.1.0 available online 
http://surfer.nmr.mgh.harvard.edu/). Briefly the processing involves 
removal of non-brain tissue(Segonne et al., 2004), transformation 
into Talairach space, intensity normalization(Sled et al., 1998), 
tessellation of the grey matter white matter boundary, automated 
topology correction(Segonne et al., 2007, Fischl et al., 2001), and 
surface deformation is then performed to indicate the grey/white and 
grey/cerebrospinal fluid borders based on detection of greatest shift 
in intensity(Fischl and Dale, 2000, Dale and Sereno, 1993, Dale et 
al., 1999). The method uses both intensity and continuity information 
from the entire three dimensional MR volume in deformation 
procedures to produce representations of cortical thickness, 
calculated as the closest distance from the grey/white boundary to 
the grey/CSF boundary at each vertex on the tessellated surface. The 
reconstruction output is then visually inspected and any parcellation 
inaccuracies are manually corrected. The maps produced are not 
restricted to the voxel resolution of the original data thus are capable 
of detecting changes at sub-millimetre levels. Procedures for the 
measurement of cortical thickness have been validated against 
histological analysis(Rosas et al., 2002) and manual 
measurements(Salat et al., 2004).  
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Statistical analysis 
Based on the distribution of data independent t-test or independent 
samples Mann-:KLWQH\8WHVWVRU)LVKHU¶V([DFWWHVWZHUHXVHGWR
examine group differences for age, BMI, pain severity, sensory, 
affective (parametric), MoCA, BDI, pain duration and painDECTECT 
scores (non-parametric). Between group comparisons of sex, 
handedness and educational status were assessed using Chi-Squared 
tests.  
QDEC (freesurfer statistical and visualization tool) was used to 
perform whole-brain surface based correlation and between group 
analysis controlled for age. Significance was set at p<0.025 
(corrected for multiple comparisons using false discovery rate FDR) to 
account for repeated testing of both hemispheres.  
To further characterize putative sex effects, subgroup analysis in 
male and female patients were performed.  
Results of within group whole cortical analysis are reported as mean± 
SD with p<0.05 FDR corrected and at uncorrected p<0.001 for 
between group comparisons. Global and region-of-interest analyses 
are reported at the p<0.05. 
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2.6.1.4 Results 
Demographic data and pain characteristics 
Demographic data and pain characteristics were described in details 
in chapter 5. SPD and LPD groups did not differ in age, sex 
distribution or pain characteristics (McGill and painDETECT pain 
scores, acute or chronic pain severity). Only depression scores were 
higher in the LPD group (table. 1). However depression symptoms 
ranged from minimal to upper limit of mild depression (Spreen, 
1998). 
 
Table 1: Demographic data and pain characteristics of short vs. long pain groups 
 Age 
(Y) 
Sex 
(M: F) 
Pain 
duration 
(Months) 
C. Pain 
severity 
0-10 
VAS 
0-10 
Sensory 
0-42 
Affective 
0-14 
Pain-
DETECT 
0-38 
BDI 
0-63 
 
 
 
SPD 
n=12 
Mean 61.7  39.5 5.6 2.7 12.6 1.5 10.3 3.75 
SD 7   2.8 2.8 6.4  6.5  
Median   36    0.5  2 
Range 45.4-72  12-60 2-10 0-9 4-28 0-11 0-23 0-14 
Ratio  5:7        
 
 
LPD 
n=19 
Mean 66.4  162 4.3 2.3 11 1 12.2 8 
SD 8.8   2.1 1.8 8.2  5.7  
Median   120    0  7 
Range 48.3-81  72-456 1-8 0-5.5 0-29 0-7 1-25 0-19 
Ratio  11:8        
P-value 0.13§ 0.4ĭ < 0.001¶ 0.14§ 0.64§ 0.56§ 0.57¶ 0.4§ 0.02¶ 
SPD= Short Pain Duration, LPD= Long Pain Duration. §= Independent t-test. ¶= Independent samples 
Mann-Whitney U Test. ĭ  )LVKHU¶V([DFW7HVW 
 
Cortical thickness findings in chronic painful knee OA participants 
The average cortical thickness was less in KOA compared to HC for 
the left hemisphere (2.36± 0.1 vs. 2.42± 0.09 p< 0.03), total brain 
(2.36± 2.42 vs. 2.42± 0.09 p<0.04) and borderline reduced for the 
right hemisphere (2.37± 0.09 vs. 2.42± 0.08 p=0.05) using 
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independent samples t-test. However after accounting for age and 
sex, similar trends did not reach significance (left hemisphere, 
p=0.07 and whole brain, p=0.087 ANCOVA). 
 
Whole brain vertex-based analysis showed that thinner cortex in the 
right posterior inferior frontal (rPIF) gyrus and sulcus (Brodmann 
area 44), and right pre-central and sub-central gyri (Brodmann areas 
4 and 43) in KOA, p<0.001 uncorrected, controlled for age and sex 
(Fig. 1). However, findings did not survive multiple test correction. No 
differences were seen for the left hemisphere.  
For the between-group differences the analysis was re-run after 
exclusion of one HC (was on Zopiclone) to explore if this can have a 
confounding effect on the results. This revealed no change in the 
results significance. 
 
Figure 3: Cortical thickness differences between knee OA participants and healthy controls 
rendered on the Freesurfer reconstructed average brain (left) and the inflated cortical 
surface (right). Blue/cyan indicated knee OA<HCs (p<0.001 uncorrected) 
 
  
Chapter 9: Surface-based Morphometric Changes in Chronic Knee OA Pain  
 
  
198 
Correlations of cortical thickness with pain duration in chronic knee 
OA patients 
Average CT of left and right hemispheres and total brain, correlated 
moderately negatively with the duration of pain r=-0.50 (p=0.005), 
r=-0.58 (p=0.001), and r=-0.54 (p=0.002) respectively; controlled 
for age. Stratified for sex, correlation of pain duration was strongly 
negatively correlated in women, but not in men for the left (r=-0.75; 
p=0.002), right hemisphere (r=-0.81; p=0.0004), and total CT (r=-
0.78; p=0.001) all controlled for the effect of age. 
Detailed vertex-based whole brain revealed extended bilateral areas 
with 13 clusters (right 1-9, and left 10-13 ranked according to Z-
score, Fig. 2 and table 2) where pain duration correlated negatively 
with cortical thickness i.e. thinner cortex with longer pain (p<0.025, 
FDR corrected). However, clusters appear located largely outside the 
known cortical pain centres e.g. the somatosensory cortex, insula, 
anterior cingulate cortex (Peyron et al., 2000), they are largely 
extended over frontal and parietal lobes, which the latter show higher 
activities during noxious stimulation (Peyron et al., 2000). As some 
clusters spanned over several regions (e.g. cluster 1 with a surface 
area of 12382.5mm2 included 15 regions), sub-clusters were 
anatomically detailed and description can be found in supplementary 
data, (appendix 5, table 1). No positive correlations were seen at 
uncorrected p<0.001 levels. 
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Figure 4: Inflated cortical surface maps showing progressive cortical thinning with longer 
pain duration (right hemisphere; top, and left hemisphere; bottom). Significance at p<0.025 
FDR-corrected for multiple comparisons and controlled for age.  
 
Table 2: Clusters of significant negative correlation with pain duration (Rt. & Lt. 
hemispheres) 
Cluster  Max Size 
(mm2) 
Tal 
X 
Tal 
Y 
Tal 
Z 
Brodmann 
Area  
Anatomy 
R       1 -5.6 12382.5 30.7   -41.9 49.1 2 Intraparietal sulcus  
2 -5.2 9714.8 24.2   56.3 7.3 10 Transverse frontopolar 
gyri and sulci 
3 -3.1 556.9 43.9 8 18.9 44 Inferior part of the 
precentral 
4 -3 568.5 38.3 9.1 -37 38 Temporal pole 
5 -2.9 364.7 15.1 -46.2 49.4 5 Marginal branch of the 
cingulate sulcus 
6 -2.5 121.1 47.5 -17.7 2.6 22&42 Anterior transverse 
temporal gyrus (of 
Heschl) 
7 -2.3 97.6 48.3 -8.8 -18.2 22 Superior temporal sulcus 
(parallel sulcus) 
8 -2.2 23.4 58.2 -56.7 5.3 39 Middle temporal gyrus 
9 -2.2 27.3 43.8 9.6 6.9 44 Opercular part of the 
inferior frontal gyrus  
L    10 -4.7 11949.8 -38 -61.5 27. 39 Superior temporal sulcus 
(parallel sulcus) 
11 -2.8 254.6 -6.6 -4.5 57.9 6 Superior frontal gyrus 
12 -2.5 88 -39.3 23.8 26.9 46 Inferior frontal sulcus 
13 -2.5 49.8 -15.4 50.1 31.1 9 Superior frontal gyrus 
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Female and male Knee OA subgroup analysis 
Female KOA (n=15) showed strong negative correlation of cortical 
thickness with pain duration similar to the main group effect 
(p<0.025 FDR corrected, controlled for age) appendix 5, 
supplementary Fig 1. Areas of >100 mm2 included right precuneus, 
fronto-marginal gyrus and sulcus, middle frontal gyrus, middle 
temporal gyrus, superior frontal gyrus, temporal pole, and left 
superior temporal sulcus, posterior transverse collateral sulcus, 
superior and middle frontal gyri, fronto-marginal gyrus, short insular 
gyrus, and precuneus. For all clusters and detailed sub-clusters see 
appendix 5, supplementary data, table 2. However, comparing female 
OA with female HC (n=13) did not show any differences on global 
levels at p<0.001 uncorrected, controlled for age. 
Conversely, male KOA  (n=16) did not show significant correlations 
between cortical thickness and pain duration.  
 
Long vs. short duration of chronic OA pain 
Vertex-based analysis showed that LPD, but not SPD had thinner 
cortices in the left post-central sulcus and right inferior frontal and 
precentral gyri, when compared to HC (p<0.001 uncorrected, 
controlled for age and sex). There was no difference between short 
and long pain groups, controlled for age and sex. 
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To determine the quantitative cortical thickness effect of pain 
duration, further illustrative analysis by averaging cortical thickness 
over the four regions showing the strongest association between CT 
and pain duration (Fig. 3) revealed significantly reduced thickness in 
KOA vs. HC in the left mesial parieto-occipital cluster (Fig. 3C: Knee 
OA 2.2mm± 0.02 vs. HC 2.3 mm± 0.02 adjusted means± SE, 
F=6.83, p=0.012) and in the left temporo-parietal cluster (Fig. 3D: 
Knee OA 2.4mm± 0.02 vs. HC 2.5mm± 0.03 F=5.14, p=0.028, 
controlled for age and sex).  
 
Figure 5: Four regions (A-D; Rt. Superior parietal and frontal pole, and left mesial parieto-
occipital and temporo-parietal, respectively) labelled for region of interest analysis (purple) 
defined from clusters with strongest negative correlation with pain duration in knee OA 
group. Scatter plots and correlations marked by sex for pain duration and ROIs A-C, 
indicating cortical thickness decreases over the duration of pain 
 
Subgroup comparisons (HC, SPD and LPD) (Fig. 4) showed similar 
results: significant differences in cluster (C) F=4.2, p=0.02 and 
cluster (D) F=5.8, p=0.006. Further post-hoc analysis (Tukey HSD), 
located the differences in clusters (C and D) between LPD vs. HC 
(p=0.015 and p=0.005 respectively). In addition, LPD was found to 
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have thinner cerebral cortex in cluster (B) compared to SPD 
(p=0.042). There were no differences seen between SPD and HC.  
  
Figure 6: Bar charts of regions of interest mean age and mean adjusted cortical thickness 
and 95% CI for short and longer pain groups in reference to healthy controls 
 
Surface-based correlation analysis with pain duration was repeated 
after removing one dataset with very long pain duration (38y) that 
may have driven the results and behaved as an outlier. Similar, 
however less in size and number, clusters were found that survived 
multiple test correction p<0.05, controlled for age (Fig 5). Clusters 
were predominantly spanning over bilateral parietal, right frontal, and 
bilateral precuneus areas 
 
Fig 5: Clusters of significant thinning with longer pain in knee OA patients after removal of 
one outlier. p<0.05 corrected, controlled for age. 
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2.6.1.5 Discussion 
Progressive and widespread cortical thinning was found in chronic 
knee OA pain preferentially in female patients, and largely located 
outside of known pain processing areas. The right inferior posterior 
gyrus in patients showed a tendency reduced cortical thickness. 
Patients with longer pain duration showed extended and bilateral 
cortical thinning after controlling for age effects using whole brain 
analysis. There was also a significant negative correlation of 
moderate strength between pain duration and global and hemispheric 
cortical thickness. This confirms a link between cerebral 
morphometric changes and chronicity of pain symptoms. The notion 
that chronic pain may lead to neocortical atrophy was first proposed 
by Apkarian and co-workers (Apkarian et al., 2004). Interestingly, 
while several papers report on grey matter density or volume loss 
assumed to accumulate with pain chronification, the association with 
pain duration is controversial.  In a volumetric study of chronic back 
pain (Apkarian et al., 2004), grey matter was found to shrink by 
about 1.3cm3 per year. However, after controlling for age and sex, 
the variance in grey matter explained by pain duration was largely 
abolished.  No previous study in OA established significant correlation 
between pain duration and grey matter density controlling for age 
(Rodriguez-Raecke et al., 2009, Gwilym et al., 2010a, Baliki et al., 
2011, Rodriguez-Raecke et al., 2013), however a subgroup analysis 
(Baliki et al., 2011) suggested that negative correlations with pain 
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duration and grey matter density only emerged after several years of 
persistent pain in multiple brain areas. 
 
The findings of progressive neocortical thinning is furthermore well in 
line with negative correlations shown between GM volume or density 
and pain duration in other musculoskeletal disorders including chronic 
back pain (Apkarian et al., 2004, Schmidt-Wilcke et al., 2006), 
rheumatoid arthritis (Wartolowska et al., 2012). Fibromyalgia 
patients were also found to show an overall negative association 
between pain duration and total grey matter (Kuchinad et al., 2007) 
and cortical thickness (Jensen et al., 2013).  However, the nature of 
these progressive morphometric changes in chronic pain is largely 
unknown. The cumulative effect of morphometric changes over 
several years to decades of chronic pain shown in this study and by 
others argues strongly for but cannot prove them to result from the 
chronic pain experience. There are no longitudinal studies to 
demonstrate the progression individually, and the slow progression 
would be challenging for designing such studies. 
However, there are some longitudinal studies before and after pain 
relief providing good evidence for at least partial reversibility of 
morphometric findings (Rodriguez-Raecke et al., 2009, Gwilym et al., 
2010b, Seminowicz et al., 2011). There is partial overlap of regions 
showing increase in GM volume/density after pain relief between 
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these studies, and only little overlap with the regions identified here 
to show the most pronounced linear cortical thinning over the course 
of chronic pain. While at first counter-intuitive, a spatial dissociation 
may be explained by the multidimensional experience of chronic pain 
and related comorbidities. Chronic OA pain may result in reduced 
quality of life (Reginster, 2002, Salaffi et al., 2005), reduced 
exercise, impaired sleep and long-term medication that may 
contribute to the pattern of progressive cortical thinning.  
The observed pattern of cortical thinning with increasing duration of 
chronic OA pain in this study showed substantive overlap with the 
default mode network (DMN). The DMN is increasingly recognized as 
a core brain network related to homeostasis and introspection as 
opposed to task-oriented brain functions (Raichle et al., 2001, 
Buckner et al., 2008). The most striking overlap we found was in the 
inferior parietal, retrosplenial and posterior cingulate but with lesser 
extent to the medial frontal and lateral temporal.   The DMN shows 
reduced brain activity during experimental pain conditions as during 
most other tasks (Baliki et al., 2008a, Buckner et al., 2008). 
Moreover during rest DMN functional connectivity appears to be 
disrupted in a number of chronic pain conditions including 
musculoskeletal (Napadow et al., 2010, Kornelsen et al., 2013, 
Bolwerk et al., 2013, Baliki et al., 2008a). This may reflect an 
abnormal state of self-referential thought that is directed towards 
pain (Smallwood et al., 2013b). Our findings of cortical thinning with 
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increased chronic pain duration in the DMN may explain the 
functional disruption seen in resting state fMRI studies. 
There is a large body of evidence on individual predisposing factors 
predicting chronification of pain after an acute tissue injury 
(McGreevy et al., 2011). Female gender appears to predispose to 
chronic knee OA pain: In an extensive review by Fillingim et al 
(Fillingim et al., 2009) chronic pain prevalence was found higher in 
women including in knee OA pain. Furthermore, females were 
consistently reported (Fillingim et al., 2009) to show higher 
sensitivity than males to different experimental pain modalities 
(except ischemic pain). Importantly, in this study pain duration 
affected cortical thickness mainly in female knee OA participants. 
Some of the study participants had experienced chronic pain for 
several decades with a maximum of 38 years. Nevertheless, even 
when excluding this subject, similar results were found (Fig 5).  
Also pain related depression is reported in epidemiological studies as 
twice as prevalent in women compared to men (Munce and Stewart, 
2007), but I did not find a clear differences in depression scores 
between the studied male and female knee OA patients, although 
power was limited by sample size and furthermore, none of the 
patients presented with more than mild-moderate symptoms. Sex 
differences in pain processing have also been widely reported in fMRI 
studies in experimental visceral pain (Berman et al., 2006), heat pain 
(Derbyshire et al., 2002, Henderson et al., 2008), muscle and 
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cutaneous pain (Henderson et al., 2008). There are a number of 
possible causative factors explaining the sex differences including 
psychosocial (Derbyshire, 1997) genetic (Wang et al., 2008) or 
hormonal (Kowalczyk et al., 2010) predispositions. In this study only 
postmenopausal women were included which limits hormonal 
heterogeneity.  
 
This study revealed only minor changes in cortical thickness with 
global reduction in knee OA patients with chronic pain that failed 
significance after controlling for age and sex. Whole brain analysis 
found reduced cortical thickness in the right posterior inferior frontal 
(BA 44), and precentral and sub-central (BA 4 and 43) (p<0.001 
uncorrected controlled for age and sex), which did not survive FDR 
correction. The findings accord partially with the neuroimaging 
literature of chronic pain in that chronic pain patients exhibit grey 
matter reductions in association with pain when compared to age and 
sex matched pain-free controls, yet with less agreement as to which 
areas are involved. Findings in the studied patient cohort were 
exclusively right hemispheric supporting the hypothesis that pain 
processing may be dominantly right lateralized (Symonds et al., 
2006).  
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The finding of reduced cortical thickness in the right posterior inferior 
frontal (PIF) cortex is furthermore well in line with a recent meta-
analysis involving 23 volumetric studies of chronic pain highlighting 
right PIF as one of the regions with most significant and consistent 
grey matter reduction in chronic pain patients. In several functional 
MRI studies the inferior frontal gyrus has consistently shown activity 
during nociceptive stimulation (Tolle et al., 1999, Brooks et al., 2002, 
Moulton et al., 2005, Ochsner et al., 2006, Kong et al., 2010), and 
during empathy for pain or vicarious pain (Lamm et al., 2011, 
Vachon-Presseau et al., 2012). Indeed the right inferior frontal has 
been found to relate to emotion and pain experience among the 
range of other functions it is involved in e.g. cognition and gustation, 
as revealed by functional characterization (Smallwood et al., 2013b). 
Taken together these data support the notion that chronic arthritis 
pain related activation of the right PIF induces structural cortical 
remodelling.  
 
2.6.1.6 Conclusion 
In summary, cortical thickness analyses in chronic painful knee OA 
have shown that chronic pain is associated with widespread slowly 
progressive neocortical thinning preferentially in female patients 
exhibited in extended areas largely outside the known pain 
processing area.  
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2.6.2 Study II: surface-based exploratory 
investigations: Preliminary results from cortical mean 
diffusivity, gyrification, and longitudinal analyses 
2.6.2.1 Cortical mean diffusivity mapping to study cortical 
alterations in chronic pain 
2.6.2.1.1 . Introduction 
The cellular microstructure, within the parenchyma of brain tissue, 
influences the Brownian molecular motion via barriers and 
compartments formed by tissue components such as nerve and glia 
cells, axons, intracellular organelles, myelin sheaths and intra- and 
extracellular matrix (Beaulieu, 2002). Mean diffusivity (MD) can be 
readily quantified from diffusion tensor imaging data. It allows 
quantifying the magnitude of water diffusion (Schmierer et al., 2007), 
and hence is sensitive to disruption of brain tissue integrity resulting 
in any change of diffusion barriers (Pierpaoli et al., 1996). 
DTI-derived MD can be altered by several brain microstructural 
factors associated with neurodegeneration such as cell loss, 
membrane or cell organelle damage, altered extracellular matrix 
demyelination, axonal loss or gliosis (Wheeler-Kingshott et al., 2003). 
These changes will lead to higher MD values that are consistently 
seen in diseases such as AO]KHLPHU¶VGLVHDVH(Kantarci et al., 2005). 
However, cortical MD may appear elevated in brain atrophy if partial 
volume (PV) effects are not accounted for, hence the CSF PV effects 
need to be supressed in order to achieve reliable results. Assessment 
of PV-corrected MD across the cerebral cortex thus has the potential 
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to provide information regarding the ultrastructural status of the 
cortex, which in turn may help to elucidate the mechanisms 
underlying the cortical morphometric changes, reported in study I.  
For example, if cortical thinning is a predominantly 
neurodegenerative process, MD would be expected to increase in line 
with the loss of integrity of the ultrastructural barriers that 
accompanies neurodegeneration; conversely, a stable or reduced MD 
values will emphasise that neurodegenerative processes are unlikely 
and other mechanisms such as ultrastructural synaptic reorganization 
are possible which warrant further investigations.  
 
2.6.2.1.2 . Aims and hypothesis  
To investigate the ultrastructural mechanisms that may underlie the 
cortical morphometric changes observed in association with chronic 
knee OA pain. The cortical microstructural tissue properties (as 
measured by MD) will be evaluated in KOA patients and matched HCs 
both globally and in areas that had shown pain-related changes in the 
morphometry studies presented previously. I hypothesize that the 
cortical thickness changes reflect brain plasticity rather than atrophic 
changes and will not be associated with mean diffusivity increases.   
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2.6.2.1.3 . Methods 
Subjects 
A detailed description of participants is provided in chapter 5, 
patients (n=31, age= 64.61± 8.36; 15 females) and age- and sex-
matched pain-free healthy controls (n=22, age= 61.30± 7.46; 13 
females) were recruited and scanned.  
 
Magnetic resonance imaging and data analysis 
MRI was performed at 3T (Discovery 750, GE Medical Healthcare, 
Milwaukee, US) using a 32-channel head coil, and DTI was acquired 
during the same scanning session in which the anatomical MRI was 
performed. Diffusion tensor images were acquired using spin-echo 
echo-planar imaging (EPI) with b=1000 s/mm2 along 30 non-
collinear directions, plus one b=0 volume, TR=5600ms, TE=89.0ms. 
Voxel sizes were 1.75 x 1.75 x 2.2 mm3 for 12 patients and 5 
controls or 2.2 x 2.2 x 2.2 mm3 for the remaining participants.  As 
mentioned in chapter 5, quality assessment of DTI data and some 
pre-processing steps were carried out by Diane Reckziegel (a PhD 
student, medical physics, University of Nottingham) 
 
Diffusion tensor imaging data were analysed using FSL version 5.0 
(Smith et al., 2004). Following eddy correction, brain mask was 
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created and non-brain voxels were removed using the FSL brain 
extraction tool (BET) (Smith, 2002). MD maps were derived using 
FSL diffusion toolbox (FDT), and subsequently underwent PV 
correction using the method described by Koo et al (Jeon et al., 2012, 
Koo et al., 2009) implemented in Matlab 2010 (The Math Works Inc., 
Natick, MA, USA). To further investigate any group differences and 
perform within-group correlation analyses, both predefined regional 
and whole-brain (global) cortical MDs were calculated.  To derive the 
global MD values, all PV-corrected MD maps were firstly transferred 
and projected onto the cortical surface of both hemispheres for each 
subject. The average MDs were extracted in all the ROIs based on the 
same parcellation algorithm to the measurement of cortical thickness. 
These values were then summed up with weights of their 
corresponding surface areas, respectively, to obtain the overall MD in 
each hemisphere. In addition, the MD values in the exact ROIs 
defined by the significant findings from the cortical thickness analyses 
were also extracted. All of these processes were performed with 
Freesurfer software package (Unix-based calculation tools).  
 
Statistical analysis 
For derived global or selected regions of interest metrics, 
independent t-test and ANCOVA (with age and sex as covariates) 
were used to compare the chronic painful knee OA (KOA) group, its 
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subgroups (SPD, LPD) and HC. Results are reported as mean± SD at 
the significance threshold of p<0.05. 
2.6.2.1.4 . Results 
A subgroup from the main study involved 15 chronic knee OA 
patients (65± 7.5y; 5 females), and 21 age- and sex matched HCs 
(61± 7.4y; 12 females). 
 
There was no significant difference in average global cortical MD 
between KOA patients and HC, nor was there any significant 
correlation of MD values globally with the pain duration in KOA group 
(controlled for the partial effects of age and sex).  
Cortical MD analysis in areas which had shown cortical thinning in 
KOA patients relative to HCs (illustrated in Fig. 1) revealed 
significantly lower MD in KOA vs. HC in the right posterior inferior 
frontal rPIF (0.95± 0.11 x10-3mm2/s vs. 1.07± 0.22 x10-3mm2/s; 
F= 6.9, p=0.013), but with no difference in the right sub-central 
(F=0.2, p=0.62, ANCOVA with age and sex as covariates).  
 
Figure 1: Areas of cortical thickness differences between knee OA participants and healthy 
controls for which mean diffusivity scores were derived. 
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By comparing the MD values with those in HCs, no significant 
differences were seen in Knee OA patients for any of the 4 ROIs,  
(which had shown strongest cortical thinning with longer pain 
duration, illustrated in Fig. 2), (controlled for age and sex), nor was 
there any significant correlations in these ROIs MD with either pain 
duration or corresponding CorTh  (p>0.2 and p>0.12, respectively). 
 
Figure 2: Four regions with strongest negative correlation with pain duration in knee OA 
group for which mean diffusivity scores were derived. 
 
MD in the left anterior cingulate cortex of KOA participants (which 
had shown cortical thinning with higher local and remote pain 
sensitivity; illustrated in Fig. 3, below- quantitative sensory testing 
study) did not correlate with local or remote PPTs. However, a 
tendency was found for a negative correlation between left ACC MD 
and ACC CorTh  (r=-0.52 p=0.07).  
And lastly, cortical mean diffusivity analysis for right sub-central, 
(which was thinner in KOA patients with higher remote mechanical 
pain sensitivity compared to patients with lower pain sensitivity, 
illustrated in Fig. 4, below: quantitative sensory testing study) 
revealed no differences between patients/ or more sensitive patients 
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and HCs p>0.7, and there were no significant correlations between 
right sub-central MD values and regional CorTh, local or non-local 
PPTs.  
2.6.2.1.5 . Discussion 
As hypothesised, there were no increases in cortical mean diffusivity 
in association with chronic pain, and the MD of cortical parenchyma 
did not change with pain duration. There are no comparable studies 
published in musculoskeletal or other chronic pain disorders 
investigating the interrelation between pain duration and cortical MD.  
Decreased MD reflects an ultrastructural alteration with less freely 
diffusion water protons due to more diffusion barriers or more 
tortuous diffusion paths. In fact, such changes were described in 
brain plasticity induced by a learning/memory task in rodent 
(Blumenfeld-Katzir et al., 2011). The authors further studied the 
histological correlates of these activity-dependent reductions in 
diffusivity showing that MR diffusion can index structural remodelling 
mainly of dendritic splines and glial processes.   
 
To my best knowledge this is the first study to investigate the cortical 
ultra-structural correlates of chronic pain in musculoskeletal 
disorders. The results are however generally well in line with previous 
studies: Gustin and colleagues (Gustin et al., 2010) in a voxel-based 
study found predominantly lower MD in patients with persistent 
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neuropathic pain compared with matched controls in numerous GM 
areas.  In a study of chronic irritable bowel syndrome (Ellingson et 
al., 2013), MD was found reduced within the globus pallidus but also 
increased values were found within the thalamus in patients. In a 
study of migraine patients (Liu et al., 2013), authors failed to detect 
any significant MD differences after one year of patients follow-up. 
This is intriguing as I found no MD changes in areas of progressive 
cortical thinning with pain duration whereas MD was reduced in right 
PIF that showed no association with pain duration but cortical 
thinning compared with controls. This may indicate differential local 
microstructural alterations with different pain phenotypes and pain 
progression despite uniform cortical thinning.  
2.6.2.1.6 Conclusion 
In this sub-study, I have shown that the progressive cortical thinning 
exhibited in patients with knee osteoarthritis is not accompanied by 
microstructural tissue damage, favouring an ultrastructural re-
organizational rather than neurodegenerative changes. 
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2.6.2.2 Cortical folding morphology: Gyrification index and 
its correlates of chronic pain in patients with knee OA  
2.6.2.2.1 . Introduction 
Gyrification index (GI) is a measure of the cortical folding morphology 
that is calculated as a ratio of the whole length of the inner folded 
(buried within the sulcal folds) cortex to the length of outer exposed 
contour (Zilles et al., 1988). GI increases proportionally to the 
number of gyri (Harris et al., 2004), and it can provide a novel 
biomarker into the mechanisms involved in developmental diseases, 
aberrant development or abnormal aging (Mangin et al., 2010). GI 
can be obtained to characterize the cortical folding both for global 
brain and specific region of interest, and is sensitive to the magnitude 
(depths of sulci or heights of gyri) as well as to the frequency of 
folding (number of sulci/gyri) (Luders et al., 2012). 
 
Cortical gyrification patterns have been studied in patients with 
neurodegenerative and neuropsychiatric diseases (Debbane et al., 
2009, Liu et al., 2012a, Nesvag et al., 2014, Zhang et al., 2009, 
Zhang et al., 2014), as well as in some healthy subjects e.g. those 
who practice certain physical and spiritual exercises known to 
promote endogenous analgesia such as meditation (Luders et al., 
2012). However, investigations of GI in chronic pain states have not 
been established previously. GI has been found to vary in, and hence 
a strong predictor of e.g. psychiatric syndromes and neurologic 
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disorders and therefore it may provide insight into the underlying 
neuro-anatomical correlates of chronic pain.  
The widespread cortical thinning observed with on-going pain shown 
previously in study I, suggests that the neocortex is structurally 
altered by processes related to or moderated by pain. GI variations in 
pain could be affected by such acquired plastic changes, but it could 
also be due to neurodevelopmental or genetic factors that could 
influence development of chronic pain and manifest as altered GI. 
There is some evidence for a relation between the surface 
morphology of the brain indexed by GI metrics and underlying 
connections and hence functional connectivity (Wallace et al., 2013, 
White and Hilgetag, 2011). While grey matter volume, density or 
cortical thickness, have been widely investigated in a range of chronic 
pain states, gyrification as an additional morphological and brain 
geometric feature has not been studied, to the best of my knowledge, 
in chronic pain. 
 
2.6.2.2.2 . Hypothesis and aims 
The aim of this sub-study is to evaluate the gyrification patterns in 
chronic pain due to knee OA, and to investigate the gyrification 
correlates of chronic pain in areas that had shown strongest relation 
of thinning with longer pain. I hypothesize that:  
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 Patients with chronic knee OA pain will show pain related global 
GI differences relative to that in matched controls, and 
variations will be pronounced in areas that had shown strongest 
cortical thinning with longer pain, as shown in study I 
 Changes in GI will correlate with pain duration, indicating a 
possible acquired maladaptive nature. 
 
2.6.2.2.3 . Methods 
Subjects, data acquisition, and image processing  
Description of participants included and image acquisition and 
processing have been provided above in Study I. All participants of 
the main research were included here: patients (n=31, age= 64.61± 
8.36; 15 females) and age- and sex-matched pain-free healthy 
controls (n=22, age= 61.30± 7.46; 13 females). 
 
Cortical gyrification index calculation 
Imaging-based three-dimensional metrics of gyrification index were 
calculated according to the freesurfer-based method developed by 
Schaer and co-workers (Schaer et al., 2008) %DVLFDOO\ 6FKDHU¶V
method, which is a 3-dimensional implementation of the standard 2-
dimensional method proposed by Zilles and co-worker (Zilles et al., 
1988), relies on calculating the GI as a ratio of the whole length of 
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the inner folded cortex to the length of outer visible contour. The 
computation involves Freesurfer-based 3D cortical outer surface 
recreation that will serve as a basis for GI calculation. The latter is 
calculated at each vertex as a ratio of cortical areas of circular region 
centred on the vertex divided by the area of a disc with the same 
radius (Schaer et al., 2012). For comparisons, individual 
reconstructed cortical surfaces were averaged and registered to 
Talairach template, and GI maps were projected on the surface for 
further surface-based statistical analysis using QDEC. 
 
Statistical analyses 
Vertex-wise between group comparisons (controlled for age and sex) 
and within group correlations (controlled for age) of GI were 
performed using QDEC- the Freesurfer statistical and visualization 
tool. GI values for ROIs were extracted individually based on findings 
in study I (Fig 3). ANCOVA (with age and sex as covariates) were 
used to compare values between Knee OA and HC. Correlation 
analysis for ROI GI with pain GXUDWLRQZDVSHUIRUPHGXVLQJ3HDUVRQ¶V
correlation while controlling for the partial effects of age and sex.  
Given that no GI data have been previously established in chronic 
pain imaging, results here are considered preliminary and significance 
was accepted at uncorrected threshold of p<0.01 for total brain and 
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p<0.05 for ROI analyses. This allows for an exploratory 
characterization that can provide a framework for future studies. 
 
2.6.2.2.4 . Results 
Group differences in GI 
Whole brain analysis revealed that KOA patients had larger 
gyrification index bilaterally in the superior parietal, and smaller 
gyrification index in the right temporal pole; p<0.01 uncorrected, 
controlled for age and sex (Fig. 1 and 2) 
 
Figure 1: Group difference in right hemispheric gyrification. Areas with larger gyrification 
index in KOA patients (superior parietal) are depicted in yellow/ orange whereas areas with 
smaller gyrification index in KOA patients (temporal pole) are depicted in cyan/ blue. p<0.01 
uncorrected, controlled for age and sex. 
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Figure 2: Group difference in left hemispheric gyrification. Areas with larger gyrification index 
in KOA patients (superior parietal) are depicted in yellow/ orange, p<0.01 uncorrected, 
controlled for age and sex. 
 
ROI analysis 
The local GI for areas that had shown most significant cortical 
thinning with longer pain was individually derived and between group 
comparisons revealed that: knee OA patients had significantly higher 
local GI values in the right superior parietal, 3.19±0.25 vs. 
3.07±0.30 (adjusted mean± std. error), F=8.2; p=0.006, controlled 
for age and sex, Fig 3. 
 
Fig 3: Bar graphs showing mean local GI and 95% CI for right superior parietal cortex 
(cluster 1, circled in the illustrative image), patients showed higher local GI; p=0.006 
adjusted for age and sex 
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Correlation analysis 
Whole KOA group 
Correlation analysis between global GI and pain duration for all KOA 
patients revealed a significant positive correlation in the bilateral 
anterior insula (p<0.01 uncorrected controlled for age and sex; Fig. 
4). No negative correlations were found in either hemisphere.  
 
Figure 4: Cortical areas, which showed positive correlation in whole KOA group between GI 
and pain duration namely; bilateral anterior insula) and scatter plots of corresponding ROI, 
p<0.01 uncorrected, controlled for age and sex.   
 
Correlation analysis for ROIs 
Moderate but significant positive correlation was found between pain 
duration and local GI in cluster C (left mesial parieto-occipital), and 
cluster D (left temporo-parietal), p=0.03 and p=0.001 respectively, 
controlled for partial effects of age and sex, Fig 5. 
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Fig 5: Scatter plots and regression lines showing correlation between pain duration and local 
GI in the left mesial parieto-occipital (cluster C), and left temporo-parietal (cluster D). 
p=0.03 and p=0.001 respectively controlled for age and sex. 
 
2.6.2.2.5 . Discussion 
Group differences in gyrification index revealed that KOA patients 
exhibited predominantly larger GI bilaterally mainly in the superior 
parietal cortex. These areas do strikingly overlap with areas that 
showed most significant cortical thinning with longer pain. This was 
further confirmed by ROI analysis where comparison of mean local GI 
of right superior parietal between knee OA and HC groups revealed 
that knee OA patients had significantly higher local GI.  Whole brain 
correlation analysis between changes in gyrification index and pain 
duration revealed only positive correlations (no negative correlations) 
in bilateral anterior insula, and ROI analysis showed significant 
positive correlation between pain duration and local GI in the left 
mesial parieto-occipital (cluster C), and left temporo-parietal (cluster 
D). By controlling for the effect of age I aimed to disentangle GI 
changes related to chronic pain from changes as a factor of aging.   
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This study is the first to address cortical gyrification correlates of 
chronic pain. Generally, the 3D imaging-based gyrification index 
computation has been relatively recently developed. The search 
WHUPV³J\ULILFDWLRQLQGH[´JDYHUHFRUGVDVDWRSLFVHDUFKLQZHE
of knowledge (www.webofknowledge.com) and 80 records in PubMed 
(http://www.ncbi.nlm.nih.gov/pubmed), (as per 14 Feb. 2014).  
Gyrification index as an additional brain morphology biomarker can 
provide valuable information associated with the disease development 
and progression. The genetic impact on cortical morphogenesis 
cannot be ignored; however, GI can be influenced by both genetic 
and non-genetic factors. The genetic impact nonetheless can be less 
influential than environmental effects as shown in a mono (MZ) and 
di-zygotic (DZ) twin study (Hasan et al., 2011), where it was found 
that the GI in the prefrontal cortex did not show more similarity in MZ 
when compared to DZ twins. Furthermore, it is estimated that only 
30% of gyrification phenotypic variation can be explained by genetic 
variation (Rogers et al., 2010). The genetic predisposing factors (to 
brain morphogenesis and hence hypothetically to chronic pain) versus 
environmentally acquired changes cannot be disentangled in this 
study, which is further hampered by the cross-sectional design that 
limited any causal inferences. 
The cortical gyrification pattern and degree are thought to reflect 
attempts of optimal intra-cortical organization (Van Essen, 1997, 
Zhang et al., 2014), with maximum axonal connections within the 
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smallest possible volume to optimize interregional connections 
(Klyachko and Stevens, 2003). The change in gyrification index could 
be influenced by tensions in the underlying white matter connections 
(Herculano-Houzel et al., 2010), and therefore these changes may 
indicate underlying white matter re-organizational or disruption 
changes.  
 
The increases in GI seen in the studied cohort along with evidence of 
their positive correlations with pain duration may indicate re-
organizational processes associated with or moderated by the on-
going chronic knee OA pain process. The spatial overlap between 
findings of higher GI changes and cortical thinning with longer pain 
suggest a putative compensational structural changes by which 
increases in the surface area (yet to be confirmed) accompany the 
observed cortical thinning, in which case the overall volume will be 
theoretically preserved which again supports re-organizational non-
degenerative changes.  
 
2.6.2.2.6 . Summary  
The results of gyrification index correlates of chronic knee OA pain 
presented here are considered preliminary. I highlight the importance 
of investigating GI in chronic pain as an additional and complemental 
tool to understand the neuro-anatomical predispositions or 
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consequences of chronic pain. There are no comparable studies 
published in musculoskeletal or other chronic pain disorders 
investigating the interrelation between pain duration and cortical GI. 
In this study, an exploratory characterization was presented that can 
provide a framework for future studies.
 
2.6.2.3 Longitudinal investigations and future directions 
2.6.2.3.1 . Introduction 
Most studies on the morphological brain changes in chronic pain have 
been cross sectional leaving the question of temporal relationship 
between chronic pain and brain morphology intriguingly unanswered. 
Longitudinal studies at various stages of chronic pain with same 
patients as their own controls would allow better understanding the 
causal relationships between structural brain changes and chronic 
pain. Findings that support the hypothesis that morphological brain 
changes are secondary to persistent pain include:  
x The reversibility of structural brain changes following therapeutic 
pain relief (Gwilym et al., 2010b, Rodriguez-Raecke et al., 2009, 
Seminowicz et al., 2011),  
x The changes in grey matter due to repetitive painful stimulation 
(Teutsch et al., 2008), and  
x The correlation between duration of pain and the degree of grey 
matter shrinkage i.e. GM decrease with longer pain (Apkarian et 
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al., 2004, Schmidt-Wilcke et al., 2006, Kuchinad et al., 2007, 
Buckalew et al., 2010a, Baliki et al., 2011, Wartolowska et al., 
2012). 
The dynamic influential relationship between chronic pain and brain 
morphology is poorly understood. There are no longitudinal studies to 
demonstrate the progression individually, and the slow progression 
would be challenging for such studies.  
In this pilot study I assess the progressive effect of chronic pain on 
brain cortical thickness while controlling for the confounding effect of 
age.  
 
2.6.2.3.2 . Methods 
Subjects, data acquisition, and image processing  
Seven patients (from the main study) with chronic knee OA pain were 
scanned twice, 12 months apart in a sub-study that was initially 
designed to investigate the temporal relationship between chronic 
pain and brain changes. However, due to time constraints this study 
could not be accomplished hence only pilot results will be presented. 
Data acquisition and image processing have been described 
previously in chapter 5. Demographics at first scan involved the 
recruitment of six males and one female (age= 65.1± 7.4). Patients 
suffered from chronic knee OA pain for 7.1± 3.3 years at first scan. 
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Cortical thickness analysis  
Steps for cortical thickness analysis have been described in details 
previously. 
Statistical analyses 
Vertex-wise between first and second scan comparisons (controlled 
for age) was performed using QDEC (the statistical and display tool of 
freesurfer). Ideally, results would be accepted at p< 0.05 corrected 
for multiple comparisons, however for the purpose of pilot evaluation, 
results will be presented at p<0.05 uncorrected, adjusted for age. 
This would allow for an exploratory characterization that can provide 
a framework for future studies. 
  
2.6.2.3.3 . Results 
Average group differences between first and 12-month later scans 
revealed a progressive cortical thinning in several areas bilaterally 
including the precentral fig. 1, superior parietal, and postcentral. 
However, cortical thickness increases were also detected bilaterally in 
areas included parsopercularis and lateral-orbito-frontal p<0.05 
uncorrected, adjusted for age. 
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Fig. 1: scatter graph shows the dynamic change of precentral cortical 
thickness in patients with chronic painful knee OA over a period of 12 
months controlled for age. 
 
2.6.2.3.4 . Discussion 
The aim of this pilot study was to explore the dynamic cortical 
thickness changes in chronic painful knee OA over a period of one 
year. Although no conclusion can be derived from this study as it is a 
pilot one with only seven subjects included and furthermore liberal p 
value was adopted, findings highlight the importance of following up 
the temporal relationship between chronic pain and brain 
morphology. Both decreases and increases in cortical thickness were 
observed, however and regardless the pattern of cerebral change, 
this experiment provides some framework for further studies to 
dynamically evaluate the brain structural plasticity secondary to pain.  
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The 12-month period was chosen arbitrary due to time restrictions, 
however, one would expect cumulative effect of morphometric 
changes over several years to decades of chronic pain as it has been 
so far indexed by the correlations between grey matter volume or 
density and pain duration in musculoskeletal disorders as in e.g. 
chronic back pain (Apkarian et al., 2004, Schmidt-Wilcke et al., 
2006), rheumatoid arthritis (Wartolowska et al., 2012) and 
fibromyalgia (Kuchinad et al., 2007). This argues for but cannot 
prove them to result from the chronic pain experience.  
The complexity of pain experience arising not only from the 
multidimensionality nature of pain itself but also from the association 
of multiple co-morbidities, overall change in quality of life (Tuzun, 
2007) and pain-related medications, for which future studies need to 
account for in order to figure out any dynamic relationship. Moreover, 
such changes are expected to be subtle which requires highly 
sensitive techniques in order to be detected. 
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3.1 Summary of the results 
The overall purpose of this area of research was to use advanced 
structural neuroimaging measures and image analysis techniques to 
quantify and investigate morphological brain correlates of chronic 
pain in a primarily nociceptive disorder due to knee osteoarthritis. An 
imaging-based attempt was made to explore, in part, the mechanism 
of such changes in chronic pain in humans. 
The demographics of the selected patients represent a sector of 
chronic pain sufferers with a broad range of pain characteristics and 
diverse associative behaviours. Chronic knee OA pain patients were 
recruited resulting in a cohort with a mean age of 65 years (standard 
deviation 8.4 years) and balanced sex distribution (16M: 15F). Pain 
duration ranged between 12-456 months with a median of 96 
months, and average pain severity over four weeks prior to scanning 
extended between 1 and 10 out of 10 with a mean of 4.8. The 
sensory component of chronic pain recorded values between 0-29 /42 
with a mean of 11.6, whereas the affective dimension was in the 
range of 0-11 /14 with a mean of 1.2. The investigation of 
neuropathic component of chronic pain in the studied cohort revealed 
less than 10% of neuropathic-like symptoms. An effort was made to 
age and sex match patients with pain free controls for further case-
control comparisons. Overall, patients and healthy controls were 
similar in age, sex, BMI, handedness, educational levels, and 
furthermore patients showed no significant distinction from controls 
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in general cognitive ability, pain catastrophizing tendency, or trait 
anxiety. However, significant differences were found between groups 
such that patients exhibited higher but subclinical and below 
moderate rates of depression, as well as higher levels of state 
anxiety.     
The main brain morphological and putatively inter-linked behavioural 
findings in chronic pain patients can be summarised as follow: 
1) Patients with chronic knee OA pain had larger hippocampal 
volume and preserved general cognitive function. Contrary to 
the belief that chronic pain leads to a reduction in hippocampal 
volume and allegedly to cognitive deficits, the results of 
chapter 6, study 1, contradicts previous studies showing such a 
relation, in the studied patients with chronic pain due to knee 
OA. Moreover, findings from this study also suggest that the 
model of stress or low mood mediating between chronic pain 
and hippocampal shrinkage may not always explain this 
relation.  
2) Manual volumetric studies of ACC subdivision (chapter 7, study 
1), revealed that larger volumes of left rostral ACC (concerned 
with emotional aspects of pain processing) correlated 
significantly and positively with higher scores of pain 
catastrophizing suggesting a tight coupling between rostral 
ACC structure and the catastrophizing tendency in chronic knee 
pain. Such negative behaviour of catastrophizing may largely 
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contribute to chronification of pain, more emotional distress, 
intensified pain experience, and moreover catastrophizers are 
more likely to develop intractable pain even upon removal of 
causative agent.  
3)  The cortical thickness correlation analysis (chapter 6, study 2), 
demonstrated that higher sores of remote mechanical pain 
sensitivity were correlated with reduced cortical thickness 
solely in the left anterior cingulate.  Although this result did 
pass multiple test correction for the whole brain analysis, the 
finding was confirmed by ROI analysis, highlighting the 
potential key role of the left ACC in the process of central 
sensitization 
4) Voxel-based morphometric analysis (chapter 7) showed that 
patients had less grey matter volume in left DLPFC (p<0.001, 
uncorrected). This tendency of reduction in volume may reflect 
a functional disturbance in the DLPFC role of chronic pain 
inhibition. Although consistent with findings from other studies 
of chronic pain particularly of MSK origin, it is noteworthy that 
results need to be confirmed with more robust corrected 
analysis.  The importance of DLPFC in pain modulation 
warrants further multimodal investigations to understand the 
mechanism of its involvement in pain chronification and the 
possibility of therapeutic targeting.  
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5) In chapter 8, study 1, a vertex-wise cortical thickness analysis 
was performed and results provided provisional evidence for 
extensive cortical thinning with progressive pain irrespective of 
aging, and preferentially in females with chronic knee OA.    
6) Preliminary results from partially investigating the mechanism 
of cortical thinning in patients were presented in study 2, 
chapter 8. Results suggest a non-degenerative cortical 
remodelling reflecting potential morphological maladaptive 
plasticity in association with chronic pain due to knee OA.  
 
3.2 Limitations and methodological 
problems 
There are a few limitations in this research that need further 
consideration. First, the sample size of the study was powered to 
detect 0.25mm cortical thickness changes (Pardoe et al., 2013), and 
compares favourably with most previous morphometric studies. I 
however acknowledge limited power for the subgroup analysis that 
may be responsible for results that did not survive the multiple test 
correction. Second, the study was limited by not performing small 
volume corrections so that analysis could be restricted to a mask of 
interest to increase the statistical power. Third, female patients 
suffered from pain for longer time (range= 12-450 Months) than 
males did (12-180), therefore the sex differences have to be 
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interpreted with caution, and further well-matched studies are 
required to confirm the study findings.  
The cross-sectional design of the study limits from describing 
dynamic and temporal associations and not allowing inferring on 
causal relationships. The study participants underwent careful 
phenotyping to investigate interrelations with pain duration, severity 
and pain sensitization and to account for depression and cognitive 
performance, but detailed questionnaires on insomnia or quality of 
life were not included.  
A number of methodological issues could potentially impact on the 
validity of the results, and therefore need to be considered 
1) While the rationale for using different significance thresholds 
(corrected / uncorrected) throughout the research was 
explained individually in corresponding studies, for overall 
conclusion it is necessary to consider uncorrected results as 
preliminary requiring confirmation by further studies. 
2) An attempt was made to carefully record and account for 
potential confounders, however still there are some factors that 
may have the potential to affect or mediate effects of brain 
changes were not considered in the study design such as 
activity monitoring and pain related sleep disturbance. 
3) Some limitations are related to the inherent features of image 
analysis software; for example, VBM requires proper image 
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registration (Bookstein, 2001), which can be problematic with 
atypical brains, and in order to achieve reliable parcellation by 
freesurfer with least manual intervention, excellent image 
contrast resolution is mandatory, which I acknowledge that 
was not the case with the empirically obtained scanning 
sequence, and as a consequence moderate to major manual 
corrections were needed in most analysis outcomes. However, 
results were carefully inspected and manually corrected 
whenever needed, and a random sample comprised 25% of 
data analysed by freesurfer were further inspected and scored 
for quality by a researcher with freesurfer expertise (Dr R 
Dineen), see appendix 6, table1.       
4) Analysis with images flipped to account for differences in 
contra-laterality between somatic source of nociception (knee) 
and corresponding brain hemisphere could have been 
performed.  The reason that I did not do so is that there is no 
strong evidence in pain neuroimaging to suggest laterality 
effect in pain-related grey matter changes. This was tested by 
Rodriguez-Raecke et al (Rodriguez-Raecke et al., 2009) in 
patients with chronic pain due hip OA and no subsequent 
change in results was found.   
5) While every effort was taken to carefully match cases and 
controls leaving chronic OA pain as the only difference 
whenever feasibly possible, I confess that it was very difficult 
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to recruit elderly patients who are medically well apart from 
being unfortunate to suffer from chronic knee osteoarthritic 
pain. Therefore, the use of antihypertensive and diuretic drugs 
was allowed in the selection criteria, and I acknowledge their 
impact could potentially have had influential effects on the 
results obtained.  
6) I acknowledge the problem of testing multiple hypotheses on 
the same group of patients. However, the way these 
hypotheses were formulated may be considered independent. 
The chance of having type I error may increase when trying to 
detect a significant finding between two variables in different 
locations. For instance, if testing the relationship between 
chronic pain duration and cognitive function reveals no change 
in, for example, the hippocampus, the attempt of trying to find 
such an effect in another location e.g. the anterior cingulate, 
then the frontal lobe and so on, will result in some positive 
findings found just by chance alone (type I error or false 
positive result). This is pretty much applicable to the surface 
based analysis where significant findings are tested using a 
vertex-based (several thousands of vertices per hemisphere) 
approach, for which correction for multiple testing is essential.          
The hypotheses presented in this thesis were framed 
independently, with each test being performed on a relevant 
brain structure e.g. chronic pain and cognition with regard to 
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the hippocampus, affective component of pain and the anterior 
cingulate cortex and so on ,¶OO MXVWTXRWHKHUHZKDW Perneger 
(Perneger, 1998) has written about what might be wrong about 
adjustments for multiple comparisons, in his paper that was 
published in the British Medical Journal  (http://www.bmj.com/) 
and cited more than 2800 times as per December 2014 (www. 
scholar.google.co.uk ³Such information is usually of no 
interest to the researcher, who wants to assess each variable in 
its own right. A clinical equivalent would be the case of a doctor 
who orders 20 different laboratory tests for a patient, only to 
be told that some are abnormal´ (Perneger, 1998). 
Furthermore, although adjustments for multiple testing will 
decrease the likelihood of type I error, the chance for type II 
error will increase resulting in true important findings being 
deemed as non-significant.  Perneger adds WKDW ³Simply 
describing what tests of significance have been performed, and 
why, is generally the best way of dealing with multiple 
FRPSDULVRQV´(Perneger, 1998). 
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3.3 Implications 
The research presented in this thesis has used advanced 
neuroimaging and image analysis techniques to principally investigate 
grey matter changes in chronic pain due to knee OA.  Previous 
studies have mostly used individual modalities of image analysis 
often implementing VBM approach. Manual volumetry (with 
meticulous technique) is considered the gold standard for volumetric 
assessment of region of interest (Cherbuin et al., 2009, Morey et al., 
2009, Shen et al., 2010).  Furthermore, for whole brain cortical grey 
matter measurement surface based analysis is preferred over voxel 
based for a number of reasons including higher sensitivity to subtle 
changes, less vulnerability to problems due to registration and 
smoothing such as spatial mis-localization, well validated, and 
importantly, quantitative measures can be derived for further more 
specific analysis and direct interpretation. However, a combination of 
these modalities may offer more robustness over single approach and 
provide broad and more conclusive morphological profile of brain in 
chronic pain.  
The importance of this research from a translational perspective 
lies mainly in the fact that demonstration of in vivo changes of grey 
matter in association with chronic pain could potentially: 
 Provide neuroanatomical substrates for the disease (Reiss et 
al., 2004a), which consequently may offer a framework for 
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further investigational and therapeutic trials. For example, 
repetitive transcranial magnetic stimulation of left prefrontal 
cortex (which has shown reduction in patients in the studied 
cohort), showed a significant increase in thermal pain 
thresholds in healthy subjects (Borckardt et al., 2007), 
supporting its role in pain modulation namely; inhibition of 
nociceptive perception  
 Signify a specific morphological brain signature that can be 
used as a candidate biomarker in chronic pain to monitor pain 
therapy and responsiveness, determine eligibility for invasive 
treatment (Gwilym et al., 2010a), and predict pre-existing 
vulnerability and disease-driven changes (Davis, 2011, Mansour 
et al., 2013). 
 May provide an objective and questionnaire-alternative tool for 
SDWLHQW¶V SKHQRW\SLF FODVVLILFDWLRQ VXFK DV FKDUDFWHULVDWLRQ RI
pain catastrophizing and pain sensitization, and hence may help 
determine type of treatment for effective therapy. For instance, 
reduction of pain catastrophizing can reduce pain intensity, 
disability and main complaints including pain related depression 
as shown in chronic back pain patients (Smeets et al., 2006) 
 Highlight the need for a complementary tool to other imaging 
modalities e.g. fMRI, DTI, and MR spectroscopy for better 
understanding the role of the brain in pain processing and 
development of intractable pain chronicity. 
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  Although it may be better achieved with longitudinal studies 
and combined modalities, cross sectional findings may however 
help distinguishing pre-existing (e.g. genetic) from acquired 
(e.g. environmental) factors in the development of chronic 
pain. For example, it has been proposed that people with 
smaller brain volume, which may be linked to developmental or 
genetic differences, are more susceptible to developing chronic 
pain disorders (Wartolowska et al., 2012) 
However, larger and longitudinal studies are required to confirm 
structural changes in chronic pain and evaluate sensitivity and 
specificity of quantitative neuroimaging findings as an objective 
biomarker of the disease. 
  
3.4 Future directions 
Structural neuroimaging in chronic pain is a relatively recent field of 
research that has developed remarkably over the past decade. The 
first study to report morphological brain changes in chronic pain was 
conducted by Apkarian and co-workers about 10 years ago (Apkarian 
et al., 2004). Ever since the published articles on grey matter 
changes in chronic pain have risen dramatically from just 6 in 2005 to 
114 in 2013, (based on PubMed search, 
www.ncbi.nlm.nih.gov/pubmed performed on 23 December 2013).  
Our understanding of the central changes associated with chronic 
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pain has increased remarkably. However, there have been several 
shortcomings and limitations from previous studies, which I 
attempted to overcome in this thesis. The strength of the presented 
research is that it combines advanced imaging and more rigorous 
image analysis techniques to provide wide-ranging structural brain 
profile in chronic pain in carefully selected and well-characterized 
patients. The sample size was reasonably larger compared with 
previous studies and additionally based on power calculation to detect 
subtle changes at sub-millimetric levels. Manual morphometry of 
hippocampal volume in chronic pain and sub-divisional studies of 
anterior cingulate correlates were not investigated previously. The 
putative moderating effect of sex, which received less focus from 
researchers in previous investigations, was considered in this 
research. With-in group analysis that was carried out in study 1, 
chapter 8, offers more statistical power and direct interpretable 
results by eliminating confounding factors that cannot be easily 
controlled between groups. Last, but not least, the attempt of 
mechanistic investigations, using mean diffusivity and gyrification 
index analyses in chronic musculoskeletal pain, although in part 
considered preliminary, is a novel method that can provide a 
framework for future investigational studies. The preliminary analyses 
presented in the thesis can be tested in larger follow-on studies, with 
sample size informed by the preliminary results. 
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Nonetheless, several problems remain for future studies to resolve. 
Firstly, it is not known whether the findings reported are specific to 
the studied group or to the type of clinical disorder patients presented 
with. Secondly, the ambiguity between studies in the direction of grey 
matter changes and the inconsistency in the spatial locations need to 
be carefully considered and explained, probably better-tackled by 
exploiting multi-centre facilities using harmonized and tightly defined 
protocols. 
Thirdly, it would be more informative to investigate the dynamic 
correlates and temporal patterns of brain changes over time prior to 
treatment and after therapeutic intervention. However the slowly 
progressing changes would be challenging for designing studies 
investigating such changes.   
With the continuous advent of neuroimaging and image analysis 
techniques, it would probably be feasible and more revealing to 
investigate sub-divisional correlates of chronic pain e.g. different 
parts of hippocampus, sub-nuclear divisions of thalamus, so that 
results can be specific and more useful for further investigational 
studies or interventional trials.  
Finally, conjoint multimodal imaging research involving structural, 
functional, and chemical investigation of brain in chronic pain can 
provide invaluable insights into the central mechanisms of pain. 
Nevertheless, these investigations may contribute only to the 
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XQGHUVWDQGLQJRIWKHµELR¶ part of the biopsychosocial model of pain, 
which ultimately calls for further and more comprehensive research 
involving psychosocial investigations in order to effectively tackle the 
problem of chronic pain.     
 
3.5 Conclusion 
Complementary methods were used to investigate structural brain 
correlates of chronic pain in knee OA and putatively related psycho-
cognitive and sensory aspects. It can be concluded that persistent 
knee arthritic pain, a model of chronic nociceptive pain does not 
reduce hippocampal volume nor impair cognition, and stress related 
hippocampal volume loss does not explain the observed low mood. In 
contrast, the chronic pain experience seems to increase hippocampal 
volume perhaps due to an unknown mechanism warranted further 
studies to characterize the complex role of the hippocampus in pain 
progression. Morphometric correlates of left anterior cingulate cortex 
with pain catastrophizing and remote pain hypersensitivity emphasise 
the pivotal role of this limbic structure in emotional aspects of pain 
processing and central pain sensitization respectively.  
Chronification of pain was associated with progressive neocortical 
thinning preferentially in female patients in extended areas largely 
outside the know pain processing areas and without associated 
microstructural tissue damage. 
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4.2 Appendices: 
4.2.1 APPENDIX 1. ETHICAL COMITTEE APPROVAL 
Approval for the study has been granted by the following regulatory 
bodies: 
 Nottingham Local Research Ethics Committee 2 
(Local NHS research ethics committee regulating medical research 
involving patients and healthy volunteers) 
REC reference number: 10/H0408/115  
 4XHHQ¶V0HGLFDO&HQWUHResearch and Development 
Department 
(Regulating research performed within QMC) 
R&D reference: 11RH001 (CSP 57467) 
- The ethical approval was processed for the whole neuroimaging 
studies in our division including along with my structural MRI 
studies; functional MRI, 7 Tesla, pre-post knee replacement and 
longitudinal studies. My involvement was limited to structural 
imaging related issues during the application process, which was 
administered mainly by Laura Condon (post-doc), Sharon Forman 
(divisional secretary), under supervision by the head of the division 
and principal investigator Professor Dorothee Auer. 
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4.2.2 APPENDIX 2. FORMS USED IN THE STUDY 
Latest approved forms will be presented in the following order: 
 
 Participant information sheet for knee OA patients 
 Participant information sheet for healthy controls 
 Consent form for knee OA patients 
 Consent form for healthy controls 
 
  
 
Appendices 
 
  
283 
 
 
 
 
Faculty of Medicine & Health Sciences 
Version 1.6   27/07/12   Patients 
 
 
 
PATIENT INFORMATION SHEET 
 
³Imaging to Understand Pain in Osteoarthritis´ 
 
Name of Investigators: Prof Dorothee Auer, Prof David Walsh,  
Prof Brigitte Scammell, Prof Michael Doherty, Prof Nadina Lincoln,  
Dr  Laura Condon, Dr Jennifer Dixon, Mr Hamza Alshuft, Ms Anita French, Dr 
Naranjargal Dashdorj, Ms Maggie Wheeler 
 
 
You have been invited to take part in a research study. Before you decide whether to 
take part it is important for you to understand why the research is being done and what 
it will involve. Please take time to read the following information carefully and discuss it 
with friends and relatives if you wish to. Ask us if there is anything that is not clear or if 
you would like more information. Take time to decide whether you wish to take part or 
not. If you decide to take part you may keep this leaflet. Thank you for reading this. 
 
Background 
 
People with Osteoarthritis (OA) feel pain in their joints, particularly in the knee. This 
means that they may experience a persisting chronic pain which is processed in a 
specific way by the brain. By comparing the brains of patients with OA, patients with 
other musculo-skeletal pain, and healthy volunteers with no pain, we hope to better 
understand the nature of knee pain in OA.   
 
Why have you been chosen? 
 
You have been asked to take part because you have either: 
·  Been diagnosed with OA, 
·  Been diagnosed with musculo-skeletal lower back pain. 
·  You have previously taken part in research in Academic Rheumatology at The 
University of Nottingham. 
·  You have previously taken part in this program of research via questionnaire 
study (REC reference: 10/H0403/70),   
 
What will happen to me if I take part? 
 
If you volunteer you will be asked to complete some health questionnaires by post and 
attend the Division of Academic Radiology at the Queen¶s Medical Centre, or the Sir Peter 
Mansfield Magnetic Resonance Centre at the University of Nottingham on up to three  
occasions. During your visits you may be asked to do some or all of the following: 
·  Undergo an MRI scan of your knee. 
·  Undergo an MRI scan of your brain 
·  Undergo a quantitative sensory test (QST) to examine your threshold to different 
temperature and pressure sensations. 
·  Fill out some health questionnaires,  
·  Undergo an MRI scan of your brain as you feel manual pressure applied to your 
knee. 
·  You may also need to undergo an x-ray of your knee if there is no recent one 
available which was taken as part of your routine clinical care. 
 
The MRI scans can take place in up to two or three separate visits. This will be discussed 
with you by the investigator upon your first visit. If you are taking any strong painkiller 
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medications or NSAID¶s we would like you to stop taking them for 24 hours prior to your 
MRI scan and take paracetamol instead. Also, on the morning of your visit we may ask 
you to take a sample of your saliva in a container which we will provide for you and 
bring it along to your appointment. 
 
Do you have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a 
reason. Your level of ongoing care will not be affected should you choose to take part, or 
not to take part. If you do decide to take part, we would like to seek your permission to 
contact you again in the future regarding other research studies taking place at The 
University of Nottingham. 
 
What will happen to any samples I give? 
 
The samples will be analysed for levels of the hormone, cortisol, which is associated with 
stress. The samples will not become part of a human tissue bank and will be destroyed 
after the analysis is complete. 
 
What are the benefits of taking part? 
 
It is not thought that you will directly benefit from the research visits, as we are not 
trialling a new treatment or therapy. However, you will be helping us to better 
understand osteoarthritis pain which could in turn benefit you, and other osteoarthritis 
patients, in the future through the development of more effective treatment methods. 
The MRI scans are not, however, used for diagnostic purposes in individual cases, and 
are not reviewed for this purpose.  
 
What are the possible disadvantages and risks of taking part? 
 
In the event that a recent knee x-ray has not been carried out as part of routine clinical 
investigation we may need you to undergo a knee x-ray for which you will be exposed to 
a small amount of ionising radiation. This level of risk is deemed µtrivial¶ by The Health 
Protection Agency (HPA), and in radiation terms, is equivalent to approximately 34 days 
natural background radiation or a single flight to New York. 
 
Part of the QST procedure uses a small device (Peltier Thermode) applied to the skin 
which will become warm, and cool in temperature, and part of the procedure uses 
another small device (Pressure Algometer) to press against your knee.  
 
As described above, during one of the scans, you will feel a little pressure on your knee. 
This may be a little uncomfortable for you, and you can request that we stop at any 
time. Taking part will also mean taking time out of your normal activities, which may be 
for a few hours. This may inconvenience you, though we will be as flexible as we can 
with arranging a suitable time and day, and we will reimburse travel costs (30p per mile 
if you have driven or had a lift and full reimbursement of public transport travel upon  
production of the appropriate receipts). 
 
It is possible that if the MRI scan is undertaken by a pregnant woman it will harm the 
unborn child.  Pregnant women, or women who plan to become pregnant during the 
study period, must not therefore take part in this study.  Women who are at risk of 
pregnancy may be asked to have a pregnancy test before taking part to exclude the 
possibility of pregnancy.  Women who could become pregnant must use an effective 
contraceptive during the course of this study.  Any woman who finds that she has 
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become pregnant while taking part in the study should immediately tell the research 
doctor. 
 
As the MRI scan uses a magnetic field you should not take part in this study if you have 
any metallic foreign bodies in your body (Eg. Pacemaker, aneurysm clips, shrapnel, 
other metal fragments). Body piercings are allowed providing they can be removed. 
 
In the unlikely event that we should discover any significant unexpected findings on your 
MRI brain scans, MRI knee scans or knee x-ray, we will ask you to nominate whether 
you wish us to disclose this information to your GP, who will then discuss it with you. In 
some cases you will need to disclose a significantly abnormal finding to your employer, 
and it may affect your insurance status. 
 
What if I don¶t want to carry on with the study? 
 
Your participation is voluntary and you are free to withdraw at any time, without giving 
any reason, and without your legal rights being affected. If you withdraw then the 
information collected so far cannot be erased and that this information may still be used 
in the project analysis. 
 
Involvement of the General Practitioner/Family doctor (GP)  
We will seek permission to inform your GP should any abnormal findings be detected on 
your MRI brain scan, MRI knee scan, or knee x-ray, who will then inform you of the 
findings, rather than the research clinician.  
 
What if something goes wrong? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions.  Please contact Professor 
Dorothee Auer in the first instance, telephone 0115 823 1178. If you remain unhappy 
and wish to complain formally, you can do this through NHS complaints.  Details can be 
obtained from the Patient Advice and Liaison Service (PALS) at QMC by calling 0800 
1830204 
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the research will be 
kept on a password protected database and is strictly confidential. Any information about 
you which leaves the research unit will have your name and address removed so that 
you cannot be recognised from it.   
 
What will happen to the results of the research study? 
 
The results will be published in medical journals and will be submitted as part of a PhD 
thesis. You will not be identified in any way in any report or publication. If you ask, we 
can send you a summary of our findings when the project finishes. 
 
 
 
Who is organising and funding the research? 
 
This work is supported by the University of Nottingham and Arthritis Research UK.  
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Who has reviewed the study? 
 
All research in the NHS is looked at by independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by Nottingham Research Ethics Committee. 
 
Expenses & Payments 
 
Your travel expenses will be reimbursed upon production of a receipt/ticket. 
Alternatively, if you have travelled to your appointment using your own vehicle, your 
travel expenses will be reimbursed at 30p per mile. 
 
Contact for Further Information 
 
If you have any questions please feel free to contact:  
 
Maggie Wheeler 
Division of Academic Rheumatology, University of Nottingham, CSB Building, City 
Hospital Campus, Nottingham, NG5 1PB 
Tel: 0115 823 1676 Email: maggie.wheeler@nottingham.ac.uk 
 
 
Or the Chief Investigator: 
 
Professor. Dorothee Auer, Division of Academic Radiology, University of Nottingham, 
QMC Campus, Derby Road, Nottingham, NG7 2UH 
Tel: 0115 8231178 
E-mail: dorothee.auer@nottingham.ac.uk 
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HEALTHY VOLUNTEER¶S INFORMATION SHEET 
 
³Imaging to Understand Pain in Osteoarthritis´ 
 
Name of Investigators: Prof. Dorothee Auer, Prof. David Walsh,  
Prof. Brigitte Scammell, Prof. Michael Doherty, Prof. Nadina Lincoln,  
Dr. Laura Condon, Dr. Jennifer Dixon, Mr. Hamza Alshuft, Ms Maggie Wheeler 
 
 
You have been invited to take part in a research study. Before you decide whether to 
take part it is important for you to understand why the research is being done and what 
it will involve. Please take time to read the following information carefully and discuss it 
with friends and relatives if you wish to. Ask us if there is anything that is not clear or if 
you would like more information. Take time to decide whether or not you wish to take 
part. If you decide to take part you may keep this leaflet. Thank you for reading this. 
 
Background 
 
Patients with Osteoarthritis (OA) feel pain in their joints, particularly in the knee. This 
means that they may experience a persisting chronic pain which is processed in a 
specific way by the brain. By comparing the brains of patients with OA and the brains of 
healthy volunteers we hope to better understand the nature of knee pain in OA.   
 
What does the study involve? 
 
If you volunteer you will be asked to complete some health questionnaires by post and 
attend the Division of Academic Radiology at the Queen¶s Medical Centre, or the Sir Peter 
Mansfield Magnetic Resonance Centre at the University of Nottingham on up to three 
occasions. During these visits you may: 
 
·  Have an x-ray of your knee 
·  Undergo an MRI scan of your knee. 
·  Undergo an MRI scan of your brain at rest 
·  Undergo a quantitative sensory test (QST) to examine your threshold to different 
temperature and pressure sensations. 
·  Fill out some health questionnaires,  
·  Undergo an MRI scan of your brain as you feel manual pressure applied to your 
knee. 
·  Undergo an MRI scan of your brain after you have walked up and down for a little 
while. 
 
The MRI scans can take place in up to three separate visits. This will be discussed with 
you by the investigator upon your first visit. Also, we may ask you to take a sample of 
your saliva in a container (which we will provide for you) and bring it along to your 
appointment. 
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Why have you been chosen? 
 
You have been asked to take part because we need to compare patients with OA to 
healthy people of a similar age. 
 
Do you have to take part? 
 
It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this information sheet to keep and be asked to sign a consent form. If you 
decide to take part you are still free to withdraw at any time and without giving a 
reason. If you decide to take part in the study it may be that you are not called upon 
because we need to age-match the healthy control group to the OA patient group, 
however, we would like to seek your permission to contact you again in the future 
regarding other research studies taking place at The University of Nottingham. 
 
What will happen to any samples I give? 
 
The samples will be transferred to a commercial laboratory where they will be analysed 
for levels of the hormone, cortisol, which is associated with stress. They will not become 
part of a human tissue bank and will be destroyed after the analysis is complete. 
 
What are the possible benefits of taking part? 
 
It is not thought that you will directly benefit from the research visits. However, you will 
be helping us to better understand osteoarthritis pain which could in turn benefit 
osteoarthritis patients in the future through the development of more effective treatment 
methods. 
 
The MRI scans are not used for diagnostic purposes in individual cases, and are not 
reviewed for this purpose.  
 
 
What are the possible disadvantages and risks of taking part? 
 
We will need you to undergo an x-ray of your knee to confirm the health of your joint, 
which will mean that you will be exposed to a small amount of ionising radiation. This 
level of risk is deemedµtriviaO¶ by The Health Protection Agency (HPA), and in radiation 
terms, is equivalent to approximately 34 days natural background radiation or a single 
flight to New York. 
 
Part of the QST procedure uses a small device (Peltier Thermode) applied to the skin 
which will become warm, and cool in temperature, and part of the procedure uses 
another small device (Pressure Algometer) to press against your knee.   
 
As described above, during one of the scans, you will feel a little pressure on your knee. 
This may be a little uncomfortable for you, and you can request that we stop at any 
time. Taking part will also mean taking time out of your normal activities, which may be 
for a few hours. This may inconvenience you, though we will be as flexible as we can 
with arranging a suitable time and day, and we will reimburse travel costs (30p per mile 
if you have driven or had a lift and full reimbursement of public transport travel upon  
production of the appropriate receipts). 
 
It is possible that if the MRI scan is undertaken by a pregnant women it will harm the 
unborn child.  Pregnant women must not therefore take part in this study, neither should 
women who plan to become pregnant during the study.  Women who are at risk of 
pregnancy may be asked to have a pregnancy test before taking part to exclude the 
possibility of pregnancy.  Women who could become pregnant must use an effective 
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contraceptive during the course of this study.  Any woman who finds that she has 
become pregnant while taking part in the study should immediately tell her research 
doctor. 
 
As the MRI scan uses a magnetic field you should not take part in this study if you have 
any metallic foreign bodies in your body (Eg. Pacemaker, aneurysm clips, shrapnel, 
other metal fragments). Body piercings are allowed providing they can be removed. 
 
In the unlikely event that we should discover any significant unexpected findings on your 
MRI brain scans, MRI knee scans or knee x-ray, we will ask you to nominate whether 
you wish us to disclose this information to your GP, who will then discuss it with you. In 
some cases you may need to disclose a significantly abnormal finding to your employer, 
and it may affect your insurance status. 
 
What if I don¶t want to carry on with the study? 
 
Your participation is voluntary and you are free to withdraw from the study at any time, 
without giving a reason, and without your legal rights being affected. If you withdraw 
from the study then the information collected so far will not be erased and this 
information will be carried forward to be used in the project analysis. 
 
Involvement of the General Practitioner/Family Doctor (GP) 
 
We will seek permission to inform your GP should any significant unexpected findings be 
detected on your MRI brain scan, MRI knee scan, or knee x-ray, who will then inform 
you of these findings, rather than the research clinician. 
 
What if something goes wrong? 
 
If you have a concern about any aspect of this study, you should ask to speak to the 
researchers who will do their best to answer your questions.  Please contact Professor 
Dorothee Auer in the first instance, telephone 0115 823 1178. If you remain unhappy 
and wish to complain formally, you can do this through NHS complaints.  Details can be 
obtained from the Patient Advice and Liaison Service (PALS) at QMC by calling 0800 
1830204 
 
In the unlikely event that you suffer injury to yourself or damage to your property as a 
result in taking part in this research, the University does have an insurance policy to 
cover harm arising as a result of the defect in the design of the study.  In addition, all 
medical practitioners taking part in the research have personal medical negligence cover.  
 
Will my taking part in this study be kept confidential? 
 
All information which is collected about you during the course of the research will be 
kept on a password protected database and is strictly confidential. Any information about 
you which leaves the research unit will have your name and address removed so that 
you cannot be recognised from it.   
 
What will happen to the results of the research study? 
 
The results will be published in medical journals and will be submitted as part of a PhD 
thesis. You will not be identified in any way in any report or publication. If you ask, we 
can send you a summary of our findings when the project finishes. 
 
 
Who is organising and funding the research? 
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This work is supported by the University of Nottingham and Arthritis Research UK.  
 
Who has reviewed the study? 
 
All research in the NHS is looked at by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed and 
given favourable opinion by Nottingham Research Ethics Committee. 
 
Expenses & Payments 
 
Your travel expenses will be reimbursed upon production of a receipt/ticket. 
Alternatively, if you have travelled to your appointment using your own vehicle, your 
travel expenses will be reimbursed at 30p per mile. 
 
Contact for Further Information 
 
If you have any questions please feel free to contact:  
 
Maggie Wheeler 
Division of Academic Rheumatology, University of Nottingham, CSB Building, City 
Hospital Campus, Nottingham, NG5 1PB 
Tel: 0115 823 1676, Email: maggie.wheeler@nottingham.ac.uk 
 
 
Or, the Chief Investigator: 
 
Professor Dorothee Auer, Division of Academic Radiology, University of Nottingham,  
QMC Campus, Derby Road, Nottingham, NG7 2UH 
Tel: 0115 8231178, E-mail: dorothee.auer@nottingham.ac.uk 
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Version 1.6 27.07.12 Patient 
                                
 
 CONSENT FORM 
(Version 1.6 date 27/07/2012) 
 
Title of Study: Imaging to Understand Pain in Osteoarthritis 
 
REC ref: 10/H0408/115   
 
Name of Researchers: Prof. Dorothee Auer, Prof. David Walsh, Prof. Brigitte 
Scammell, Prof. Michael Doherty, Prof. Nadina Lincoln, Dr. 
Laura Condon, Dr Jennifer Dixon, Mr. Hamza Alshuft, Ms Anita 
French, Dr Naranjargal Dashdorj, Ms Maggie Wheeler 
   
Name of Participant: 
 
1. I confirm that I have read and understand the information sheet version number 1.6 
dated 27/07/12  for the above study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, and without my medical care or legal rights being 
affected. I understand that should I withdraw then the information collected so far 
cannot be erased and that this information may still be used in the project analysis. 
 
3. I understand that relevant sections of my medical notes and data collected in the study 
may be looked at by authorised individuals from the University of Nottingham, the 
research group and regulatory authorities where it is relevant to my taking part in this 
study. I give permission for these individuals to have access to these records and to 
collect, store, analyse and publish information obtained from my participation in this 
study. I understand that my personal details will be kept confidential. 
 
4. I agree to my GP being informed of my participation in this study. 
 
5. Should there be any abnormal findings on either the MRI scans, or x-rays taken as 
part of this study, I agree to my GP being contacted. 
 
GP name/address ........................................................................................................... 
 
6. I agree to having a saliva sample taken 
 
7. I agree to take part in the above study. 
 
8.  Only for those people who participated in the recent  questionnaire study on 
knee pain in osteoarthritis (REC reference: 10/H0403/70): 
·  I give permission for access to my results from questionnaire study 
     (REC reference: 10/H0403/70) (optional) 
 
9.  I give permission for the data from  this study to be accessed by researchers from the 
ARUK Pain Centre 
 
10.  I agree to being contacted regarding future research studies (optional) 
 
______________________  ______________     ____________________ 
Name of Participant   Date          Signature 
 
_______________________ _ ______________     ____________________ 
 Name of Person taking consent Date          Signature 
 
 
Please initial box 
 
  
Version 1.5 27.07.2012  Healthy Volunteer 
                                 
 
 
 CONSENT FORM 
(Version 1.5 date 27/07/12 ) 
 
Title of Study: Imaging to Understand Pain in Osteoarthritis 
REC ref: 10/H0408/115   
Name of Researchers: Prof. Dorothee Auer, Prof. David Walsh, Prof. Brigitte 
Scammell, Prof. Michael Doherty, Prof. Nadina Lincoln, Dr. 
Laura Condon, Dr Jennifer Dixon, Mr. Hamza Alshuft, Ms Anita 
French, Dr Naranjargal Dashdorj, Ms Maggie Wheeler 
    
 
Name of Participant: 
 
1. I confirm that I have read and understand the information sheet version 
number 1.5 dated 27/07/12  for the above study and have had the opportunity 
to ask questions. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason and without my legal rights being affected. 
I understand that should I withdraw then the information collected so far 
cannot be erased and that this information may still be used in the project 
analysis. 
 
3. I understand that data collected in the study may be looked at by authorised 
individuals from the University of Nottingham, the research group and 
regulatory authorities where it is relevant to my taking part in this study. I give 
permission for these individuals to have access to these records and to collect, 
store, analyse and publish information obtained from my participation in this 
study. I understand that my personal details will be kept confidential. 
 
4a I agree to having a saliva sample taken. 
 
4b I agree to having an x-ray of my knee.  
 
5. Should there be any significant unexpected findings on either the MRI scans, 
or x-rays taken as part of this study, I agree to my GP being contacted 
Name/Address of GP ......................................................................................... 
................................... ..........................................................................................  
 
6. I give permission for the data from  this study to be accessed by researchers 
from the ARUK Pain Centre 
 
7. I agree to take part in the above study. 
 
8.  I agree to being contacted regarding future research studies. (optional) 
 
______________________  ______________     ____________________ 
Name of Participant   Date          Signature 
 
_______________________ _ ______________     ____________________ 
 Name of Person taking consent Date          Signature 
Please initial box 
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4.2.3 APPENDIX 3.  Supplementary material for 
chapter 4 (systematic review) 
Table 1. Search terms used in identifying relevant literature 
Search engine: PubMed 
Search terms combination Records4 Potentially 
relevant5 
Relevant6 
O
s
te
o
a
r
th
r
it
is
 p
a
in
1
 
AND 
Brain structure 45 6 4 
GM3 4 3 3 
GM density 1 1 1 
Brain volume/ GM volume 2 2 2 
Brain morphology 14 4 3 
Cort* (cortex, cortical) 107 3 1 
Cerebral 50 8 3 
Brain imaging 20 6 2 
Brain MRI 13 5 2 
M
S
K
 p
a
in
2
 
GM 3 3 2 
GM density 1 1 0 
Brain volume 2 1 1 
Brain morphology 27 2 2 
GM volume 2 2 1 
Brain MRI 13 2 2 
C
h
r
o
n
ic
 p
a
in
 
GM 68 15 9 
GM density 12 3 3 
Brain volume 50 12 6 
Brain morphology 470 24 7 
GM volume 22 10 4 
Brain MRI 350 36 18 
1,Q3XE0HGWKHVHDUFKWHUP³RVWHRDUWKULWLVSDLQ´DQG³RVWHRDUWKULWLV$1'SDLQ´JLYHV
exactly same results. Searching was carried out 10-11June 2013. 2MSK= 
musculoskeletal, 3GM= grey matter. 4= records as they emerge from engine search 
without any filtering. 5= potentially relevant from information in title and abstract. 6= 
directly relevant as inferred from reading through the article. 
 
 
 
  
 
Appendices 
 
  
289 
Table 2. Quality assessment of studies included in the systematic review 
Study*Î 
CASP-Question
§
 
Ð 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Clearly focused issue 5 5 5 4 5 4 4 5 4 5 4 5 5 4 3 5 5 4 
Appropriate method to answer the 
question 
5 5 5 4 5 4 4 5 4 5 4 5 5 4 3 4 5 4 
Cases recruited in an acceptable 
way 
4 5 5 3 5 3 4 5 4 5 4 5 5 4 4 4 5 4 
Controls selected in an acceptable 
way 
4 4 4 3 4 3 4 4 3 4 4 5 4 4 3 4 4 4 
The exposure was accurately 
measured to minimize bias 
5 5 5 4 5 4 4 5 4 3 4 5 5 4 4 4 5 4 
Controlled for confounding factors  3 3 4 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 
The results are precise and 
believable 
4 5 4 3 4 2 4 4 3 4 4 4 4 4 3 4 4 4 
The results can be applied to the 
local population 
4 4 4 1 2 1 4 4 3 4 3 4 4 3 3 4 4 4 
The results fit with other available 
evidence 
5 4 4 3 4 2 3 4 3 5 3 5 4 4 4 4 4 4 
Quality score (%)= 
(n/45)*100 
87 89 89 64 89 60 78 89 69 87 76 93 89 78 69 82 89 80 
   §7KH DQVZHU WR &$63 TXHVWLRQV ZDV RULJLQDOO\ PDGH SRVVLEOH XQGHU  UHSOLHV <HV 12 RU FDQ¶W WHOO , KDYH PDGH D VOLJKW PRGLIication to enable 
quantitative scoring so that the answer will carry a score from 0-5 where 0 is completely NOT met and 5 is strongly fulfilled. *1-18 refers to studies 
included in the review, see next page for each corresponding study. 
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Studies (1-18, in table 2) included in the review were as follow: 
 
1) (Apkarian et al., 2004): Chronic back pain is associated with decreased prefrontal 
and thalamic grey matter density. 
 
2) (Draganski et al., 2006): Decrease of thalamic grey matter following limb 
amputation. 
 
3) (Schmidt-Wilcke et al., 2006): Affective components and intensity of pain 
correlate with structural differences in grey matter in chronic back pain patients. 
 
4) (Kuchinad et al., 2007): Accelerated brain grey matter loss in fibromyalgia 
patients: premature aging of the brain? 
 
5) (Schmidt-Wilcke et al., 2007): Striatal grey matter increase in patients suffering 
from fibromyalgia--a voxel-based morphometry study. 
 
6) (Buckalew et al., 2008): Chronic pain is associated with brain volume loss in older 
adults: preliminary evidence. 
 
7) (Hsu et al., 2009): No consistent difference in grey matter volume between 
individuals with fibromyalgia and age-matched healthy subjects when controlling for affective 
disorder. 
 
8) (Rodriguez-Raecke et al., 2009): Brain grey matter decrease in chronic pain is 
the consequence and not the cause of pain. 
 
9) (Buckalew et al., 2010a): Differences in brain structure and function in older 
adults with self-reported disabling and non-disabling chronic low back pain. 
 
10) (Gwilym et al., 2010a): Thalamic atrophy associated with painful osteoarthritis of 
the hip is reversible after arthroplasty: a longitudinal voxel-based morphometric study. 
 
11) (Younger et al., 2010): Chronic myofascial temporomandibular pain is associated 
with neural abnormalities in the trigeminal and limbic systems. 
 
12) (Baliki et al., 2011): Brain morphological signatures for chronic pain. 
 
13) (Gustin et al., 2011): Different pain, different brain: thalamic anatomy in 
neuropathic and non-neuropathic chronic pain syndromes. 
 
14) (Moayedi et al., 2011): Contribution of chronic pain and neuroticism to abnormal 
forebrain grey matter in patients with temporomandibular disorder. 
 
15) (Robinson et al., 2011): Grey matter volumes of pain-related brain areas are 
decreased in fibromyalgia syndrome. 
 
16) (Seminowicz et al., 2011): Effective treatment of chronic low back pain in humans 
reverses abnormal brain anatomy and function. 
 
17) (Wartolowska et al., 2012): Structural changes of the brain in rheumatoid 
arthritis. 
 
18) (Rodriguez-Raecke et al., 2013): Structural brain changes in chronic pain reflect 
probably neither damage nor atrophy. 
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4.2.4 Appendix 4. Recruitment poster, scanning, 
and pain related questionnaires 
1. Healthy volunteer recruitment poster 
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2. MRI safety questionnaire 
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3. Edinburgh handedness inventory 
 
4. Educational level 
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5. Pain catastrophizing scale (PCS) 
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6. McGill pain questionnaire
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7. PainDETECT 
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8. %HFN¶VGHSUHVVLRQLQYHQWRU\%', 
- Due to copyright restrictions BDI cannot be shown here 
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9. Spielberger, State-Trait Anxiety Inventory 
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10. Montreal cognitive assessment (MoCA) 
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Supplementary Table 1: Characteristics of Knee OA patients  
ID Sex Age 
(Y) 
Hande
dness 
Educ. level Pain duration 
(Y) 
Pain 
severity 
PRI PPI Pain-
DETECT 
BDI MoCA Dominant 
knee 
PCS S/T 
Anxiety 
Medications 
1 M 68 L 4 10 6 48 21 25 7 28 L 11 12/12 Paracetamol 
2 F 72 R 3 20 5 26 19 16 1 27 R 10 15/17 Atenolol, Simvastatin 
3 F 54 R 8 38 3 8 16 15 5 26 L 5 15/25 Tranexamic acid 
4 M 77 R 6 15 8 29 25 9 9 27 L 13 12/12 Thyroxin, Omeprazole, Silenium 
5 F 45 L 4 4 7 21 16 15 7 26 R 23 18/21 None 
6 M 66 R 4 15 2 8 13 5 14 29 R 10 10/13 None 
7 F 54 R 4 2 10 10 14 0 2 25 R 19 15/37 None 
8 F 59 NA NA 25 6 NA NA 19 7 20 L NA NA None 
9 F 59 R 4 3 4 15 19 12 1 28 L 24 16/25 None 
10 M 80 R 3 8 2 6 16 8 7 29 L 7 10/14 None 
11 F 71 R 6 14 3 15 15 6 1 26 L 1 10/11 Paracetamol 
12 M 65 R 8 5 5 12 16 6 1 27 L 0 10/12 None 
13 F 70 R 6 10 5 30 20 14 19 29 L 17 22/28 Losartan, Bendroflumethiazide, 
Prochlorperazine 
14 M 72 R 2 12 1 0 16 16 4 24 L 1 10/12 Atropine eye drops 
15 F 63 R 3 20 4 22 19 12 13 29 R 24 18/31 Paracetamol 
16 M 56 R 3 10 3 13 15 12 5 30 R 2 13/13 None 
17 M 67 R 4 10 2 10 12 7 7 28 R 7 15/15 Glucosamine, Bendroflumethiazide, 
Simvastatin 
18 M 80 R 2 10 2 16 12 17 8 27 L 8 10/22 Amlodipine 
19 M 57 R 8 10 4 10 16 10 8 29 R 1 21/17 None 
20 M 63 R 6 9 5 0 21 1 0 29 R 10 17/11 Paracetamol, Aspirin, Co-codamol, 
Lansoprazole, Glucosamine 
21 F 64 R 6 3 6 24 19 23 0 29 R 7 10/19 Enalapril, Levothyroxine, 
Bendroflumethiazide, Amitriptyline 
22 M 61 R 3 1 2 8 14 6 2 29 R 7 10/15 None 
23 M 63 R 2 5 2 5 14 6 1 30 L 2 10/14 None 
24 F 65 R 1 6 7 6 24 10 10 22 L 14 15/19 None 
25 M 65 R 6 3 5 26 12 15 4 . R 6 10/18 None 
26 F 67 R 1 5 7 10 17 4 5 30 R 2 24/21 None 
27 M 48 R 3 7 6 7 16 12 13 27 R 17 16/25 None 
28 F 65 R 3 7.5 7 25 17 18 13 27 R 41 14/20 Amlodipine 
29 F 72 R 2 5 7 21 20 18 14 28 R 34 26/25 Ramipril, Atorvastatin 
30 M 65 R 3 2.5 10 56 20 9 8 26 R 15 14/18 Amlodipine 
31 F 56 R 7 1 2 21 21 10 0 30 L 16 11/13 None 
Handedness= based on Edinburgh Handedness Inventory, Educational level= 1-8 (1 is post-graduate levels and 8 is none, PRI and PPI= Pain Rating and Present Pain Indices from 
0F*LOOSDLQTXHVWLRQQDLUH3DLQ'(7(&7%', %HFN¶V'HSUHVVLRQ,QYHQWRU\0R&$ 0RQWreal Cognitive Assessment, PCS= Pain Catastrophizing Scale, S/T= state and Trait 
anxiety.
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4.2.5 APPENDIX 5. Supplementary material for 
study 1, chapter 8 
Supplementary Table 1: Detailed description of regions included within each cluster 
that exhibited significant negative correlation with pain duration in knee OA patients 
Cluster  Size (mm2) Sub-clusters 
R       1 12382.5 Posterior ramus of lateral sulcus, temporal plane, superior temporal gyrus, supramarginal 
gyrus, post-central sulcus, intraparietal sulcus, angular gyrus, subcentral gyrus, superior 
parietal lobule, parieto-occipital sulcus, cuneus, calcarine sulcus, precuneus, superior occipital 
gyrus, superior parietal lobule 
2 9714.8 Fronto-marginal gyrus and sulcus, transverse fronto-polar gyri and sulci, orbital gyri and sulci, 
inferior and middle frontal sulci, inferior part of the precentral sulcus, precentral gyrus, middle 
frontal gyrus, superior frontal gyrus and sulcus, anterior part of the cingulate gyrus and sulcus, 
middle-anterior and middle posterior parts of the cingulate gyrus and sulcus 
3 556.9 Inferior frontal sulcus, inferior part of the precentral, sulcus, opercular part of the inferior 
frontal gyrus 
4 568.5 Temporal pole 
5 364.7 Marginal branch of the cingulate sulcus, precuneus 
6 121.1 Anterior transverse temporal gyrus (of Heschl), inferior segment of the circular sulcus of the 
insula 
7 97.6 Superior temporal sulcus (parallel sulcus) 
8 23.4 Middle temporal gyrus 
9 27.3 Opercular part of the inferior frontal gyrus  
L     10 11949.8 Lateral aspect of the superior temporal gyrus, superior temporal sulcus, temporal plane, 
posterior ramus of the lateral sulcus, supramarginal gyrus, post-central sulcus, superior 
parietal lobule, intraparietal sulcus, angular gyrus, sulcus intermedius primus, parieto-occipital 
sulcus, precuneus, subparietal sulcus, posterior-dorsal and middle-posterior parts of the 
cingulate gyrus and sulcus, marginal branch of the cingulate sulcus, posterior-ventral part of 
the cingulate gyrus and para-central lobule and sulcus 
11 254.6 Posterior medial part of superior frontal gyrus 
12 88 Superior part of inferior frontal sulcus 
13 49.8 Superior anterior part of frontal gyrus 
 
 
Supplementary Figure1.  
 
Figure 1: Surface map of progressive cortical thinning over pain duration in female Knee OA 
participants (p<0.025 FDR, controlled for age)  
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Supplementary Table 2: Detailed description of regions included within each cluster 
that exhibited significant negative correlation with pain duration in FEMALES only patients 
Cluster  Size (mm2) Sub-clusters 
R       1 12401.5 Posterior ramus of lateral sulcus, temporal plane, superior temporal gyrus and sulcus, 
sulcus intermedius primus, supramarginal gyrus, post-central sulcus, intraparietal sulcus, 
angular gyrus, superior parietal lobule, transverse occipital sulcus, middle occipital gyrus, 
middle occipital and lunatus sulcus, parieto-occipital sulcus, cuneus, calcarine sulcus, 
precuneus, subparietal sulcus, superior occipital gyrus, marginal branch of the cingulate 
sulcus, superior parietal lobule 
2 3315.9 Fronto-marginal gyrus and sulcus, transverse fronto-polar gyri and sulci, orbital gyri and 
sulci, inferior and middle frontal sulci, middle frontal gyrus, superior frontal gyrus and 
sulcus,  
3 2761.6 Opercular part of the inferior frontal gyrus, Inferior frontal sulcus, inferior part of the 
precentral sulcus, precentral gyrus, posterior part of middle frontal gyrus.  
4 242.3 Posterior part of middle temporal gyrus  
5 1084.8 Superior frontal gyrus 
6 274.1 Temporal pole 
7 12 Superior frontal sulcus  
8 8.8 Anterior part of inferior temporal gyrus 
L    9 13201.0 Lateral aspect of the superior temporal gyrus, superior temporal sulcus, anterior transverse 
temporal gyrus (of Heschl), temporal plane, posterior ramus of the lateral sulcus, 
supramarginal gyrus, subcentral gyrus and sulcus, post-central sulcus, superior parietal 
lobule, intraparietal sulcus, angular gyrus, sulcus intermedius primus, middle occipital 
gyrus, transverse occipital sulcus, cuneus, parieto-occipital sulcus, precuneus, subparietal 
sulcus, marginal branch of the cingulate sulcus 
10 1016 Posterior transverse collateral sulcus, collateral and lingual sulcus and gyrus, medial 
occipito-temporal gyrus  
11 1504 Superior frontal gyrus, middle-anterior part of the cingulate gyrus and sulcus, superior part 
of pre-central sulcus 
12 856.9 Inferior frontal sulcus, middle frontal gyrus 
13 814.1 Middle frontal gyrus and sulcus, fronto-marginal gyrus and sulcus, transverse fronto-polar 
gyrus and sulcus 
14 299.4 Short insular gyrus, superior segment of the circular sulcus of the insula, long insular gyrus 
and central sulcus of the insula 
15 206 Superior frontal gyrus 
16 125 Precuneus, marginal branch of the cingulate sulcus 
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4.2.6 APPENDIX 6. Quality assurance of freesurfer 
analysis output 
Table 1. Evaluation of freesurfer analysis output data by a second 
researcher with freesurfer expertise using criteria shown in the table 
Subject Holes Bumps Dura/skull Missing part 
of Gyrys/ 
Sulcus 
002 1 0 0 0 
007 0 0 0 2 
013 0 0 0 0 
017 0 0 0 2 
022 0 0 0 0 
027 0 0 0 2 
031 0 0 0 1 
037 0 0 0 0 
048 0 0 0 1 
053 0 0 0 0 
057 0 0 0 1 
062 0 0 0 0 
066 0 0 0 0 
 
 
 
